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Abstract 
 
The mammalian spinal cord contains the neuronal circuitry necessary to generate 
rhythmic locomotor activity in the absence of inputs from the higher brain centre or 
sensory system. This circuitry is regulated by local neuromodulatory inputs, which can 
adjust the strength and timing of locomotor output. The free radical gas nitric oxide has 
been shown to act as an important neuromodulator of spinal circuits, which control 
locomotion in other vertebrate models such as the tadpole and lamprey. Despite this, the 
involvement of the NO-mediated soluble guanylate cyclase/cyclic guanosine 
monophosphate secondary messenger-signalling pathway (NO/sGC/cGMP) in 
mammalian locomotion has largely been under-investigated. 
 
The NADPH diaphorase histochemical reaction was used to identify sources of NO in 
the lumbar spinal cord. The largest population NADPH diaphorase reactive neurons 
were located in the dorsal horn, followed by the laminae of the ventral horn, particularly 
around the central canal (lamina X) and lamina VII. NADPH diaphorase reactive 
neurons were found along a rostrocaudal gradient between lumbar segments L1 to L5. 
These results show that that discrete neuronal sources of NO are present in the 
developing mouse spinal cord, and that these cells increase in number during the 
developmental period postnatal day P1 – P12. NADPH diaphorase was subsequently 
used to identify NADPH diaphorase reactive neurons at P12 in the mouse model of 
ALS using the SOD
G93A
 transgenic mouse.  
 
Physiological recordings of ventral root output were made to assess the contribution of 
NO to the regulation induced rhythmic fictive locomotion in the in vitro isolated spinal 
cord preparation. Exogenous NO inhibits central pattern generator (CPG) output while 
facilitating and inhibiting motor neuron output at low and high concentrations 
respectively. Removal of endogenous NO increases CPG output while decreasing motor 
neuron output and these effects are mediated by cGMP. These data suggest that an 
endogenous tone of NO is involved in the regulation of fictive locomotion and that this 
involves the NO/sGC/cGMP pathway. 
 
Intracellular recordings from presumed motor neurons and a heterogeneous, 
unidentified sample of interneurons shows that NO modulates the intrinsic properties of 
spinal neurons. These data suggest that the net effect of NO appears to be a reduction in 
motor neuron excitability. 
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Chapter 1: General introduction  
 
1.1 Introduction  
 
Nitric oxide (NO) is a free radical, diatomic gas with a plethora of physiological and 
pathophysiological effects. While the role of NO in vasculature is well known and it has 
been described as a neuromodulator of non-mammalian locomotion, little is known 
about the role of NO in relation to mammalian locomotion. This general introduction 
will provide a brief background of the study of locomotion, detail the structure and 
function of the mammalian locomotor network and cover the modulatory mechanisms 
involved in locomotor activity. I will then describe NO signalling and outline the aims 
of this thesis.  
 
The isolated spinal cord has the capacity to generate a variety of spontaneous and 
coordinated locomotor behaviours, such as swimming, scratching, and walking. These 
movements are modulated in a variety of natural environmental circumstances, for 
example, during the transition from a walk to a gallop or to generate escape swimming 
in response to stress. In 1911, Thomas Graham Brown showed that the spinal cord 
contains sufficient circuitry to generate and maintain locomotion in the absence of 
supraspinal and sensory inputs. Brown postulated that proprioceptive inputs have a 
regulatory and not an intrinsic role in movement, that movement produced in the 
absence of afferents shared great similarity with movement when afferents remained 
intact, and that “The rhythmic sequence of the act of progression is consequently 
determined by phasic changes innate in the local centre” (Brown, 1911). In 1914, 
Brown went on to develop further the half-centre model, which he first postulated in his 
1911 study, to describe the spinal circuitry, which controls rhythmic locomotor activity. 
He hypothesized that an individual central pattern generator or CPG, which takes the 
form of a half-centre, controls each limb (though the term CPG was coined much later 
(Brown, 1914, Brownstone and Stuart, 2011). The half-centre CPG comprises two sets 
of excitatory interneurons that control the activity of flexor and extensor motor neurons. 
These two sets of excitatory interneurons are usually prevented from simultaneous 
activation by mutual inhibitory inputs during locomotion. Inhibition of one set of 
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excitatory interneurons is therefore tightly coupled to the activity of the other set of 
excitatory interneurons (termed reciprocal inhibition). Additionally, and by an 
undetermined mechanism, fatigue in one set of inhibitory interneurons causes a phase 
switch as inhibition is released from the antagonist set of excitatory interneurons.  
 
A contemporary of Brown, Charles Sherrington (who had published a detailed account 
of reflex control of hind limb muscles), preferred the reflex driven model for locomotor 
organisation, but conceded that the origins of the control of locomotion were most 
likely located in the spinal cord. The study of locomotion has been historically 
chronicled in detail in numerous reviews (Brownstone, 2006, Clarac, 2008, McCrea and 
Rybak, 2008, Brownstone and Stuart, 2011), so is not rehearsed further here. Partly as a 
consequence of Sherrington’s influence, the half-centre model remained unpopular for 
the subsequent sixty years as researchers investigated the reflex control of stepping. 
However there was a resurgence in interest in Brown’s approach during the late 1960s, 
notably because of the revival of the half-centre model by Anders Lundberg, and the 
subsequent body of research has re-established the half-centre model as a basis for 
understanding the function of the locomotor network in both vertebrates and 
invertebrates (Burke et al., 2001, Jankowska, 2001, Marder et al., 2005, Jankowska, 
2008). 
 
The nervous system is a complex network of neurons and, over the last century, 
delineating the precise cellular components of this complex network has proved 
difficult. Elucidating the connectivity of the locomotor networks has relied on the 
classical techniques of relating electrical properties and physiology to anatomical 
studies and descriptions of cell types. With the advent of genetic manipulation, 
involving recombinase technology and gene expression studies, our understanding of 
the spinal cord network has been greatly enhanced.   
 
1.2 Spinal cord structure 
 
Understanding the anatomical arrangement of the spinal cord network is integral to our 
understanding of the function of the spinal cord in both health and disease. Spinal cord 
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anatomy has therefore been studied at all levels in great detail using the rodent, rat and 
mouse. 
 
The cells of the mammalian spinal cord have been classified into numerical laminae, 
from dorsal to ventral, according to the cytoarchitectonic description first devised from 
transverse sections of cat spinal cord (Rexed, 1954). The dorsal horn of the rodent 
lumbar spinal cord accounts for laminae I to VI. Neurons in the dorsal laminae receive 
inputs from cutaneous sensory and proprioceptive afferents. Laminae VII to IX 
comprise the ventral horn and these neurons receive inputs from descending, ascending, 
propriospinal, and sensory neurons. Neurons in the lumbar spinal cord integrate sensory 
and motor commands. The surfaces of the laminae are located parallel to the dorsal 
(posterior) and ventral (anterior) surfaces of the spinal cord. The spinal vasculature 
consists of a single ventral spinal artery and two dorsal spinal arteries that branch into 
vertebral arteries. 
 
Investigation of spinal cord network function is aided by the understanding of the 
individual cell types and their spatial arrangement within the spinal segments. In order 
to help interpret the potential function of nitrergic neurons located in specific regions of 
the spinal cord – one of the main aims of the present study – a brief spatial and 
functional description of the ten laminae follows: 
 
Lamina I, also known as the marginal layer, is a thin layer often appearing continuous 
with the white matter, covering the top of the dorsal horn. The layer contains small, 
fusiform neurons that project to the lateral and dorsal funiculi and are involved in 
processing of reflex input. 
 
Lamina II corresponds to substantia gelatinosa Rolandi, and is divided into an inner 
(medial) and outer (lateral) zone. Lamina II contains neurons expressing opioid 
receptors involved in sensory processing, particularly pain.  
 
Lamina III, also referred to as the superficial nucleus proprius, contains small cells 
involved in sensory processing. 
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Laminae I to III are located parallel to the dorsal surface and extend over the edge of the 
dorsal surface.  
 
Lamina IV was formerly referred to as the base of the nucleus proprius and comprises 
small, medium and large cells involved in sensory reflex pathways. In the lower 
thoracic and upper lumbar cord, the medial zone is interrupted by Clarke’s column.  
 
Lamina V was formerly referred to as the neck of the dorsal horn and is the thickest 
layer of the dorsal horn. Neurons located in this lamina receive primary afferent input 
from the dorsal roots of lower spinal cord and project to the dorsolateral funiculus. The 
lateral zone corresponds to the formation reticularis, while the medial aspect is 
interrupted by Clarke’s column. 
 
Lamina VI is only visible in the intumescences or enlargements (cervical and lumbar), 
with indistinct borders. It is thickest in the medial zone, narrowing towards the midline 
and again towards the lateral edge. Lamina VI forms the curved base of the dorsal horn. 
Relative to the medial section, neurons in the lateral zone are large but scarce, while in 
the medial zone, neurons are small and tightly packed. 
 
Lamina VII is the largest lamina located in the centre of the grey matter, also referred 
to as the zona intermedia. Neurons in lamina VII are regular in size and distribution. In 
the enlargements, the lateral motor nuclei (IX) are accommodated more laterally and 
dorsally than in the rest of the cord with lamina VII cells medial to the lamina IX pools. 
Autonomic neurons of the sympathetic system are located in the intermediolateral layer 
(IML) and intercalated nucleus (ICN), located within lamina VII.  
 
Neurons in laminae V to VII project predominantly to the ventral and lateral funiculi on 
the ipsilateral side of the cord. Mechanoreceptive, nociceptive and Ia spindle afferents 
project to the neurons in these laminae. The lamina VII interneurons project to the inter- 
and intra-segmental homolateral motor nuclei. The neurons in the IML and ICN 
integrate and relay sympathetic preganglionic reflexes. 
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Lamina VIII is restricted to the medial half of the ventral horn. Neurons are 
heterogeneous in appearance and size and project into the contralateral grey and 
contralateral ventral funiculi. Lamina VIII propriospinal interneurons are involved in 
the inter- and intra-segmental control of contralateral motor reflexes.  
 
Lamina IX contains the medial and large lateral motor neuron groups. Both α- and γ- 
motor neurons are located in IX. 
 
Lamina X, also referred to as the substantia grisea centralis or substantia gelatinosa 
centralis, is the area around the central canal and marks the midline of the cord. The 
central canal is a remnant of the embryonic ventricular system and is continuous with 
the fourth cranial ventricle. Lamina X neurons are typically small and irregularly 
distributed and receive visceral and somatic afferents.  
 
 
1.3 Identification of spinal locomotor-related neurons  
 
The final lamina location and phenotype of developing neurons is determined by both 
the expression of morphogens and activity-dependent mechanisms (Jessell, 2000, Ben-
Ari and Spitzer, 2010). During embryonic development, neurons develop and 
differentiate from the ventricular zone of the neural tube epithelium. Expressed along an 
opposing concentration gradient, the signalling proteins (morphogens), Sonic hedgehog 
(Shh), bone morphogenic proteins (BMP 4,6,7), and growth differentiation factor 7 
(GDF7), are secreted from the notochord floor plate ventral to the neural tube (Shh) and 
the roof plate (BMP4, 6, 7 and GDF7), respectively (Jessell, 2000). Combinatorial 
expression patterns of transcription factors, induced by varying morphogen 
concentrations, determine the phenotypic fate of neurons differentiating along Shh/BMP 
morphogenic gradients. At embryonic day 11 (E11), eleven progenitor domains have 
developed and will go on to generate different classes of neurons.  
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Progenitor domains pd1 to pd6 give rise to the sensory neurons of the dorsal horn, dI1-
dI6 interneurons, the four progenitor domains p0 to p3 give rise to the ventral 
interneurons V0 to V3, and the pMN progenitor domain differentiates into the lateral, 
medial and visceral motor neurons (Jessell, 2000, Goulding, 2009). Identification of the 
ventral neuron classes by transcription factor expression, alongside traditional 
physiological techniques, has accelerated the functional delineation of neurons involved 
in locomotor output. However, the spinal circuitry is complex and interneuron classes 
are themselves heterogeneous, further increasing the complexity of relating 
transcription factor phenotype to physiological function.  
 
Nevertheless, progress continues to be made in assigning functions to the transcription 
factor-led identification of neuronal classes and subclasses during development. Recent 
advances in genetic manipulation, such as Cre-Lox recombination to conditionally 
influence gene expression, have added high-resolution information about the identity 
and contribution to network function at the cellular component level (Lobe and Nagy, 
1998). Selective ablation of transcription factor specific neuron classes has provided an 
unprecedented acceleration in understanding the functional components of the 
locomotor network and their interconnectivity.  
 
The V0 class of interneurons is defined by expression of the transcription factor 
developing brain homoebox1 (Dbx1; p0). The V0 class of neurons comprises two 
identified subclasses. The largest subclass is the V0D neurons, which account for 70% 
of all V0 neurons; they are GABA/glycinergic and project to contralateral motor 
neurons (Lanuza et al., 2004). V0 interneurons are critically linked with the 
maintenance of L/R alternation, in a speed dependent manner. Dbx1 mutant mice do not 
have the capacity to produce normal L/R alternating output and instead exhibit L/R 
synchronous locomotor output (Lanuza et al., 2004). The remaining 30% are V0V 
(even-skipped homeobox gene, Evx1/2
+
) neurons, to which the cholinergic and 
glutamatergic Pitx2 (pituitary homeobox2-expressing) V0C and V0G subclasses belong. 
The cholinergic Pitx2 neurons, which represent just 5% of the total V0 population, 
originate from a small population of neurons located adjacent to the central canal and 
have been described as the source of the modulatory C-bouton inputs onto motor 
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neurons (Zagoraiou et al., 2009). These neurons are particularly interesting as they are 
intimately involved in the modulation of motor neuron and therefore locomotor output. 
C-boutons increase the excitability of motor neurons by reducing the action potential 
after hyperpolarization (AHP), possibly via direct actions on calcium dependent 
potassium channels (IKCa), and they are synaptically opposed to muscarinic receptors 
(m2) and voltage-dependent delayed rectifier K+ channels (Kdr; Kv2.1), (Wilson et al., 
2005, Miles et al., 2007, Zagoraiou et al., 2009). 
 
The V1 interneurons are the major ipsilateral inhibitory input to motor neurons in the 
lumbar spinal cord (Mentis et al., 2005). Originating from the V1 class of interneurons, 
the Ia inhibitory interneurons and Renshaw Cells are defined by the EN1 (engrailed-1; 
p1) transcription factor. These neurons represent just 25-30% of the total neuronal 
complement that constitute the V1 interneurons (Gosgnach et al., 2006). Silencing of 
V1 interneurons leads to increases in the step-cycle period during fictive locomotion, 
suggesting these neurons play an important role in coordinating locomotor output 
(Gosgnach et al., 2006, Wilson et al., 2010). However, they are not the sole source of 
inhibition to motor neurons during locomotion. 
 
These two distinct subclasses of neurons, the Ia inhibitory neurons and Renshaw Cells, 
originate from the same progenitor domain and yet have very distinct projection targets 
and receptive fields. Activity-dependent maturation of the network synergistic with 
genetic programming has been postulated to be the mechanism by which these two 
classes develop differential projection patterns (Siembab et al., 2010).   
 
V2 interneurons are marked by Lhx2 (LIM homeobox2; p2) expression during 
development. Two subclasses of V2 interneurons have been identified. V2a – 
glutamatergic neurons expressing the post-mitotic transcription factors Sox14 and 
Chx10 (SRY-related HMG-box 14 and ceh-10 homeo domain containing homolog) and 
the V2b inhibitory interneurons (GABA/glycinergic) expressing the post-mitotic 
GATA2/3 transcription factors (GATA binding protein) (Butt et al., 2005). The 
contribution of V2b neurons to locomotor output has not yet been explored. However, 
the V2a interneurons have been shown to have a role in maintenance of L/R alternation 
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and project to contralateral V0V interneurons and motor neurons (Lanuza et al., 2004). 
Ablation of V2a interneurons in the mouse results in a speed-dependent gait change. 
Locomotion is not affected under normal conditions, but does result in a change of gait 
from walking to hopping at high treadmill speeds (Crone et al., 2009, Zhong et al., 
2010). Ablation of the excitatory V2a-expressing Chx10 subclass of interneurons does 
not affect locomotion at normal speeds but does result in an abnormal gait change to 
hopping at high treadmill speeds. These neurons therefore appear to form an integral 
part of the locomotor network (Crone et al., 2008, Crone et al., 2009, Zhong et al., 
2010). 
 
Less progress has been made in deciphering the distinct role of V3 interneurons, which 
express single-minded homolog 1 (Sim1) during development and appear to be 
exclusively excitatory interneurons. V3 Sim1-expressing interneurons are excitatory and 
mostly commissural, involved in the precise timing of L/R alternation, and their 
selective removal increases the variability in L/R alternation (Zhang et al., 2008). 
 
The neurons that express Hb9 (homeobox9; pMN) during development give rise to the 
excitatory interneurons (Hb9
+
/VGLUT2
+
) located in lamina VIII that are potentially 
involved in rhythm generation (Wilson et al., 2005). Selective ablation of the 
glutamatergic Hb9 expressing neurons has not been attempted, as Hb9 is expressed in 
both motor neurons and interneurons. However, characterisation of the Hb9 neurons 
continues, as they exhibit properties that suggest they may form an integral part of the 
rhythm generator (Wilson et al., 2005, Kwan et al., 2009).  
 
Spinal motor neurons (pMN, Islet1, Islet2, Hb9) develop into either visceral or somatic 
neurons projecting via the spinal nerves to visceral targets and skeletal muscle fibres 
(αMN, extrafusal and γ, intrafusal respectively). Descending and sensory inputs, as well 
as commands from the CPG, are transmitted by the motor neurons to the relevant 
effector muscles (Figure 1.2). Thus, motor neurons have been termed the final common 
pathway for integrated information from the central nervous system (CNS) to target 
muscles. Figure 1.1 provides a schematic overview of the last order interneurons and 
their inputs to motor neurons.  
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Figure 1.1. Simplified schematic of last order interneuron inputs to a single motor neuron. Motor neurons 
are the final common pathway for information from the CNS to target muscles. Motor neurons receive 
descending and sensory inputs represented by dashed black lines. The colour scheme is as follow; red 
indicates excitatory neurons, blue indicates inhibitory neurons and neuromodulatory neurons are depicted 
as green. The solid lines monosynaptic inputs and the dashed vertical line represents the midline. 
Diagram taken from (Brownstone and Bui, 2010), with permission © Elsevier Science BV. 
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1.4 The spinal locomotor network 
 
As stated previously, the spinal cord is capable of generating locomotor output in the 
absence of supraspinal inputs. In the rodent, forelimb and hind limb locomotor networks 
are located in the cervical and lumbar spinal cord. The spinal cord generates 
spontaneous and coordinated locomotor output and motor function in mice begins 
before birth during embryonic development.  
 
At embryonic day 12 (E12) in the rodent, 5HT receptors can be activated, before 
descending serotonergic inputs have reached the lumbar spinal cord, and simple 
synchronous rhythmic output can be induced. A more complicated pattern of output can 
be induced by 5HT at E14 and this may mark a key point in development, since by E15 
the activity develops an element of left-right alternation. By E18, left-right alternating 
rhythmic output is established and this pattern is maintained after birth (Branchereau et 
al., 2000, Yvert et al., 2004). 
 
Prenatal spontaneous activity in rodents has been attributed to the fact that during 
embryonic development, the neurotransmitter GABA produces excitatory, giant 
depolarising potentials mediated by the NKCC1 transporter. This was first shown in 
hippocampal cells and has since been described in numerous studies of the developing 
spinal cord network (Ben-Ari et al., 1989, O'Donovan et al., 1998, Vinay and Jean-
Xavier, 2008, Gonzalez-Islas et al., 2009, Gonzalez-Islas et al., 2010, Spitzer, 2010). 
Highly rhythmic, spontaneous activity occurs in the developing spinal cord at E11.5 – 
E14.5 and is mediated by nicotinic acetylcholine receptors (nAChR) and electrical 
coupling. It is likely that this activity is a result of excitatory, cholinergic inputs from 
motor neurons onto each other and onto GABAergic interneurons (Hanson and 
Landmesser, 2003). 
 
The isolated neonatal rodent spinal cord provides a functional and scalable network for 
the study of locomotor activity generated by the brainstem-spinal cord and spinal cord 
(Smith and Feldman, 1987, Kudo and Yamada, 1987). By birth, propriospinal networks 
have reached functional maturity; for instance, coupling of locomotor activity in the 
Chapter 1 
11 
 
fore and hind limb circuits has been described (Gordon and Whelan, 2006a, Gordon and 
Whelan, 2006b) but has been postulated to be less complex than in the mature network 
(Whelan et al., 2000). 
 
In the neonatal mouse, forelimb locomotor-like activity can be initiated by electrical 
stimulation in the cervical spinal cord (Gordon et al., 2008), and, in separate brainstem-
spinal cord studies in both the mouse and the rat, pharmacologically-activated cervical 
and lumbar networks interact to produce coordinated locomotor-like activity (Ballion et 
al., 2001, Juvin et al., 2005). This interaction in concert with bulbospinal descending 
excitatory drive contributes to activation and maintenance of locomotor activity 
(Zaporozhets et al., 2006, Zaporozhets et al., 2011). 
 
Locomotor output can be evoked by a number of mechanisms in the isolated lumbar 
spinal cord of the neonatal mouse. As previously mentioned, some spontaneous 
rhythmic motor output has been noted at P0-2 (Bonnot et al., 1998). Electrical 
stimulation of the cauda equina, sural or other afferent nerves produces locomotor 
output sufficient for study, whilst electrical stimulation of ventral roots initiates 
glutamatergic-mediated synchronous activity (Whelan et al., 2000, Bonnot et al., 2002a, 
Bonnot et al., 2009). The isolated spinal cord with hind limbs attached validates the 
isolated spinal cord preparation but illustrates that the induced innervation of hind limb 
muscles produces functionally relevant locomotor output. The hind limb attached 
preparation provides corroborative evidence that the upper segments (L1-3) and lower 
segments (L5- L6) predominantly innervate the hind limb flexor and extensor muscles, 
respectively (Whelan et al., 2000, Hayes et al., 2009).  
 
Systematic reduction of the rodent spinal cord involving the separation of the 
symmetrical halves or hemi-segments (sagittal separation, down the midline), segmental 
lesions and removals (transverse sectioning, from rostral to caudal ends), and removal 
of laminae (such as the dorsal horn) to gain access to specific areas in the ventral horn 
(coronal or horizontal sectioning), have provided anatomical evidence of the location of 
regions crucial to locomotor rhythmogenesis.  
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Lesion studies have shown the location of regions of rhythmogenic importance in the 
neonatal rat. These studies show that the ability to generate hind limb locomotor-related 
activity is distributed throughout the lumbar spinal cord segments, but with greater 
rhythmogenic potential in the rostral lumbar segments (Kiehn and Kjaerulff, 1996). In 
the same study, it was shown that CPG elements are located medially, ventral to the 
central canal and in all lumbar segments (L1-L6). Indeed, the rostral segments of the 
thoracolumbar spinal cord appear to be more rhythmogenic during pharmacological 
activation of fictive locomotion than caudal segments, and L2/L3 appear to be 
especially critical for rhythm generation in the neonatal rat (Bertrand and Cazalets, 
2002). 
 
Each hemi-segment contains sufficient circuitry to generate spontaneous rhythmic 
locomotor output while an intact segment is necessary for the generation of left-right 
alternating output. Combining lesions with the pharmacological block of glycinergic 
and GABAergic inhibition, it has been shown that, between P5 – 10 in the neonatal rat, 
a single ventral horn is sufficient to produce the excitatory drive responsible for 
ipsilateral burst output, and that commissural input from contralateral half-centres of at 
least two segments are required to maintain left-right alternation (Bracci et al., 1996). In 
fact, complete removal of endogenous glutamatergic signalling within the spinal cord, 
using a VGLUT2 knock-out mouse, shows that, in the absence of endogenous 
glutamatergic excitation, the locomotor network can still generate locomotor-like output 
(Talpalar et al., 2011). In a recent study, inhibitory driven locomotor output was 
initiated and maintained by excitatory neurotransmitters and was completely ablated by 
picrotoxin and strychnine, inhibitors of GABAA and glycine receptors (Talpalar et al., 
2011). 
 
Understanding of the mammalian locomotor network has been and continues to be 
influenced by the significant contribution of research conducted in other vertebrate 
systems, such as the Xenopus laevis tadpole, the adult lamprey Lampetra 
fluviatilis/Petromyzon marinus and the zebra fish Danio rerio, which all share similar 
locomotor network connectivity. The tadpole has a complement of about ten identified 
neuron classes in the pre-metamorphic stages of development, and with a relatively 
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small network of well-characterised neurons it provides an ideal system for 
understanding the organisation of simple neural networks (Li et al., 2001, Roberts et al., 
2010). Fictive locomotion at between 10-20Hz can be induced by electrical stimulation 
or sensory stimuli, such as light dimming, to produce bouts of swimming for 
manipulation and study.  
 
The half-centre model can be explained particularly clearly in the tadpole and lamprey 
locomotor networks where descending inputs originating from reticulospinal neurons 
activate the locomotor CPG and the motor neurons are segmentally organized and 
innervate axial muscles to produce undulatory swimming. Following the transcription 
factor-led identification of rodent neuronal phenotypes, homologs have been identified 
in the tadpole. Descending interneurons in the tadpole are equivalent to the rodent V2a, 
V3 and Hb9 neuron classes, while the ascending GABAergic interneurons of the 
tadpole integrate mechanosensory inputs (equivalent to the V1 En1 and V2b 
interneurons) (Kiehn, 2011). Excitatory glutamatergic interneurons project to 
commissural glycinergic interneurons. Commissural glycinergic inhibitory interneurons 
(the equivalent to dl6 and V0V Dbx1, Evx1/2
-
 in the rodent) provide reciprocal 
inhibition to motor neurons on the contralateral side and also project to ipsilaterally 
projecting inhibitory neurons (Goulding, 2009, Roberts et al., 2010, Kiehn, 2011). 
 
 
1.5 Initiation, maintenance and modulation of locomotion  
 
As the neuronal components of the locomotor CPG and their interconnectivity are 
elucidated, it is also vital to understand how ‘neuromodulation’ of intrinsic neuronal 
properties and synaptic connectivity within the CPG can affect network output. 
 
The descending pathway that initiates locomotion in the intact brain-spinal cord is 
supraspinal in origin. Locomotor drive potentials (LDP) caused by stimulation of the 
mesencephalic locomotor region (MLR) in the dorsal midbrain can induce locomotion 
in the spinal locomotor network (Noga et al., 2003). Fictive locomotion in the present 
study is described as the generation of rhythmic motor output from the isolated spinal 
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cord in the absence of the effector muscles and actual movement, and can be induced by 
pharmacological or electrical stimulation.  
 
Fibres projecting to the spinal cord from the forebrain, cerebellum, raphe nuclei, and 
locus coeruleus innervate the locomotor network, though other descending projections 
are also involved in the modulation of this network. Descending excitatory fibres 
contribute to both the initiation and modulation of spinal locomotor output, for example, 
the glutamatergic reticulospinal neurons (located in the brainstem), which project to the 
spinal cord (Rekling et al., 2000). The block of glutamatergic descending input to the 
spinal cord by NMDA antagonists during electrical stimulation of the MLR inhibits 
fictive locomotion (Douglas et al., 1993). In addition to supraspinal glutamatergic 
inputs, noradrenergic (NA) fibres also project to the spinal cord from the locus 
coeruleus (Gabbay and Lev-Tov, 2004) and descending serotonergic fibers from the 
raphe nuclei are involved in the development and maturation of the spinal locomotor 
network (Vinay et al., 2000, Garraway and Hochman, 2001, Pearlstein et al., 2005). 
Descending dopaminergic inputs contribute to locomotor output but are not reticular in 
origin and originate from the A11 area of the hypothalamus (Clemens et al., 2006).  
 
Exogenous neuroactive compounds can initiate and maintain fictive locomotor output in 
the rodent spinal cord in the absence of descending inputs. Neuroactive compounds, 
particularly monoamines, are thought to mimic the natural excitatory descending inputs 
from the brainstem that regulate network activity in the spinal locomotor network. The 
pharmacological activation of the CPG has been studied extensively; of particular 
interest has been the initiation of fictive locomotion by serotonin (5HT). Descending 
raphe inputs are generally severed in the isolated preparation, requiring the addition of 
serotonin by bath application to activate the locomotor network. 5HT7 and 5HT2 
receptors have been identified as critical for eliciting alternating locomotor activity 
(Branchereau et al., 2000, Nishimaru et al., 2000, Madriaga et al., 2004, Liu and Jordan, 
2005, Liu et al., 2009, Dunbar et al., 2010). The locomotor activity evoked by 5HT7 
and 5HT2 agonists has also been shown to interact with dopaminergic receptors D1/2 
(Madriaga et al., 2004), and rostrocaudal excitability gradients have been uncovered in 
the neonatal mouse using combinations of monoamines including 5HT/DA (Christie 
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and Whelan, 2005) and combinations of N-Methyl-D-aspartic acid (NMDA), 5HT and 
dopamine (DA) (Cazalets et al., 1992, Beato et al., 1997, Jiang et al., 1999, Whelan et 
al., 2000, Bonnot et al., 2002a). NMDA alone can also induce locomotor activity (Kudo 
and Yamada, 1987), although it is not clear whether NMDA receptor activation is an 
absolute requirement during fictive locomotion (Beato et al., 1997, Nishimaru et al., 
2000, Cowley et al., 2005). 
 
Other neuropeptides generate or regulate locomotor networks; for example, 
noradrenaline (NA) has been shown to be involved in maintenance of 5HT/NMDA-
induced locomotor activity (Kiehn et al., 1999, Gabbay and Lev-Tov, 2004). In a study 
to investigate eleven neuroactive peptides, four were shown to elicit uncoordinated 
output whilst all eleven were shown either to induce or modulate NMDA-induced 
locomotion in the neonatal rat (Barriere et al., 2005). 
 
 
Figure 1.2. Schematic representation of rhythmic, alternating motor output generated by antagonistic 
motor pools. Schematic showing how rhythmic, alternating motor output generated by antagonistic motor 
pools (A) can be altered in amplitude (i), frequency (ii), or both (iii), depending on whether a given 
modulator acts at the level of the motoneurons (Bi), the CPG (Bii), or a combination of the two (Biii).  
Diagram adapted from the original, with kind permission of the authors  (Miles and Sillar, 2011). 
     
 
1.5.1 Modulation of locomotion 
 
Neurotransmitters from the descending sources already described or local sources (local 
neuronal network and glia) are involved in the ionotropic transmission that directly 
facilitates neural communication between higher centres, CPG interneurons and motor 
neurons to drive locomotor activity (Figure 1.2). Neuromodulation, on the other hand, is 
defined as the modulatory changes as a result of metabotropic actions of 
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neurotransmitters that influence the response of neurons to ionotropic transmission. 
Neuromodulation has become an increasingly important aspect of the study of 
locomotor networks; particularly as the actions of metabotropic processes are 
continually revealed to play a role in the homeostatic function of locomotor-related 
neurons and influencing behavioural states. As such, these pathways are also of 
significant interest in pathophysiological conditions, where homeostasis appears to be 
disrupted, for instance, in ALS where motor neurons receive an elevated level of 
excitatory inputs which are thought to subsequently contribute to cell death (Heckman 
et al., 2009, Quinlan et al., 2011).  
 
Ion channels located in the neuronal membrane determine the intrinsic properties of 
neurons at rest and during activity. Thus intrinsic properties can vary from cell to cell 
according to specific expression patterns and ion channel densities, in concert with 
modulation of ion channel properties by neurotransmitters. The intrinsic properties of 
individual neurons are a complex orchestration of interactions between cation channel 
conductance (i.e. INa+, IK+ and ICa2+). Categorical and functional studies of ion channels 
provide important information about the nature of cell communication. A large body of 
work exists detailing individual ion channel families and their role in cellular 
communication, a comprehensive summary of which is outside the scope of this thesis. 
There are many books and review articles collating and detailing this information 
(Takahashi and Berger, 1990, Takahashi, 1990, Catterall, 2000, Goldin et al., 2000, 
Rekling et al., 2000, Hille, 2001, Jentsch et al., 2002, Gutman et al., 2005, Ulbricht, 
2005). 
 
Neuromodulation specifically refers to the metabotropic pathways that modulate 
neuronal output. Most neurotransmitters can have both ionotropic and metabotropic 
effects. For instance, glutamate, already discussed as a fast-acting neurotransmitter via 
NMDA/Kainate/AMPA receptors, can also modulate the excitability of neurons via 
metabotropic receptor linked secondary messenger cascades. Metabotropic glutamate 
receptors (mGluR) are G-protein coupled receptors and modulate the intrinsic 
excitability of motor neurons (Rekling et al., 2000). There are three groups (Group I to 
III), with a total of eight types (mGluR1–8). Directly involved in modulating motor 
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neurons are the Group I mGluRs (mGluR1 and mGluR5) which activate Protein kinase 
C (PKC) directly and indirectly by increasing cytosolic Ca
2+
. Additionally they activate 
Protein kinase A (PKA) by increasing cAMP (Kim et al., 2008). This mGluR activity is 
not necessary for maintenance of rhythmic locomotion, but is involved in setting the 
rhythm (Taccola et al., 2003). mGluR1 activation initiates second messenger cascades 
that modulate locomotor output notably by decreasing motor neuron excitability by both 
presynaptic and postsynaptic mechanisms while increasing the frequency of locomotor 
output (Iwagaki and Miles, 2011). In the lamprey, the activation of mGluR1 also 
increases both the short and long term frequency of locomotor output (Kyriakatos and 
El Manira, 2007).  
 
The 5HT (serotonin) receptor family consists of fifteen receptor subtypes: 5HT3 is a 
ligand-gated ion channel and the remainder are G-protein coupled receptors. 5HT 
enhances, amongst other things, the low voltage Ca
2+
 (LVA) and high voltage L-type 
Ca
2+
 channels (HVA) that underlie plateau potentials and the hyperpolarization-
activated inward current, Ih (Li and Bennett, 2007). Serotonergic modulation of spinal 
neurons occurs principally via 5HT1, 5HT2 and 5HT7 receptors; the latter two facilitate 
excitation and the first appears to mediate inhibition, possibly at the action potential 
initiation site (Dunbar et al., 2010). Serotonin depolarises the resting membrane 
potential and increases the input resistance of spinal motor neurons. It has also been 
shown to induce oscillations in locomotor-related interneurons (Carlin et al., 2006), to 
modulate bi-stability (plateau potentials) in motor neurons (Kiehn and Eken, 1998) and 
to co-localise with Substance P and Thyrotropin releasing hormone (TRH) 
(Rekling et al., 2000). 
 
Another neuromodulatory pathway involves dopamine. Coupled to Adenylyl cyclase, 
D1 dopamine receptors activate, and D2 inhibit, this second messenger cascade in 
locomotor-related neurons. Dopamine receptors are also expressed in the membranes of 
Renshaw cells where their activation leads to an increase in excitability (Rekling et al., 
2000).  Spinal Hb9 interneurons and motor neurons express dopamine receptors but 
their role and the full extent to which they modulate the spinal locomotor circuitry are 
not yet fully understood (Han et al., 2007). 
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The main neurotransmitters involved in rhythm generating networks are conserved 
across the species most actively studied in relation to motor control, particularly in 
rodents – the focus of this study – and in the lamprey, zebrafish, and tadpole. In the 
hatchling tadpole, swimming at stage 37 is modulated by descending aminergic fibers 
from the raphe (serotonin) and locus coeruleus (noradrenaline). Serotonin released from 
raphe projections to the spinal cord facilitates maturation of the swimming pattern 
between stage 37, when motor neurons fire once per cycle, and stage 42, when the 
motor neurons are able to fire repetitively during locomotor activity (Sillar et al., 1995). 
Activation of NMDA receptors in the presence of 5HT causes membrane oscillations in 
commissural interneurons suggesting an activity-dependent modulation of locomotor 
output (Sillar et al., 1998, McLean and Sillar, 2002). Evidence from the tadpole has 
shown that non-NMDA excitatory amino acids activate the locomotor network as a 
result of descending input from the brainstem (Sillar et al., 1992). NA has been shown 
to inhibit locomotor output slowing the motor pattern and facilitating glycinergic 
inhibition and NO has been shown to modulate this NA-mediated effect (McLean and 
Sillar, 2004). 
 
Similarities between the basic components of the mammalian and non-mammalian 
vertebrates and the description of a NO-mediated modulation during fictive locomotion 
warrant this brief mention of tadpole swimming here. For an excellent discussion of the 
generation and modulation of tadpole swimming, the following review is recommended 
(Roberts et al., 2010).  
 
 
1.5.2 NO-mediated modulation of locomotor networks 
 
NO is an important modulator in both invertebrate and non-mammalian vertebrate 
species but the likely role of NO in mammalian locomotion has yet to be described. 
However, suggestion of the likely role of NO in the mammalian spinal cord network 
may be drawn from the established roles of NO in the locomotor networks of other 
species. 
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NO has been shown to modulate locomotor circuits in a broad range of marine 
invertebrates including Clione limacina and Lymnaea stagnalis (Palumbo, 2005). 
Clione limacina (winged, gelatinous pelagic molluscs also known as sea angels) are 
opportunistic predators that feed on shelled molluscs. On detecting suitable prey, they 
accelerate swimming, produce rhythmic buccal movements, and the feeding orifice 
displays an “explosive extrusion of buccal cones”, leading to the marine equivalent of 
eating a fine meal (Moroz et al., 2000). NO modulates the neural networks that activate 
motor neurons and interneurons that coordinate these behaviours via cGMP, and 
reduces their excitability, by cGMP-independent hyperpolarization of the interneurons 
involved in lip closure. Similarly, NO is involved in regulating the speed circuits 
involved in feeding in the pond snail Lymnaea stagnalis, and a modulatory relationship 
between NO and 5HT at motor neuron synapses has been established (Elofsson et al., 
1993, Moroz et al., 1993, Straub et al., 2007). The simplicity and ease of use of the 
invertebrate nervous system makes it an attractive model for locomotor studies, though, 
unfortunately, direct translational capacity between invertebrate and higher mammals is 
difficult, due to the differences in the fundamental design of the CNS of higher 
mammals. However, findings in invertebrate systems provide clues for potential 
mechanisms in vertebrate models. 
 
NO has been established as a neuromodulator in non-mammalian vertebrate models of 
locomotion. In the tadpole and lamprey, nitric oxide synthase (NOS) positive 
reticulospinal neurons in the caudal hindbrain are thought to be the source of NO-
mediated modulation of swim circuits. In the tadpole, NO slows swimming frequency 
and reduces swimming episode duration, by facilitating both glycinergic and 
GABAergic transmission via presynaptic mechanisms (McLean and Sillar, 2001, 
McLean and Sillar, 2000). The GABAergic effects of NO are a result of direct NO 
effects, whilst glycinergic-mediated increases in cycle period are a result of 
metamodulation, where NO modulates the activity of another downstream modulator, 
NA. This meta-modulatory hierarchy is evidence that neuromodulation can result from 
potentially complex interactions between neurotransmitters as well as from direct 
modulation of intrinsic cellular properties. NO also modulates the intrinsic properties of 
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postsynaptic neurons by depolarising the membrane potential and increasing membrane 
input resistance in the tadpole but not in the lamprey (McLean and Sillar, 2004, 
Kyriakatos et al., 2009). In contrast to NO effects in the tadpole, NO increases lamprey 
swim frequency by reducing mid-cycle inhibition and facilitating on-cycle excitation 
(Kyriakatos et al., 2009). Interestingly, NO is also involved in spinal mGluR1-mediated 
long-term plasticity, though a mechanism for this action is not currently known. 
Altogether, this convincing evidence from the non-mammalian vertebrates suggests that 
a role for NO in the mammalian locomotor network is highly probable.  
 
We do know that in the rodent respiratory circuit, NO inhibits inspiratory drive received 
by hypoglossal motor neurons, by cGMP-dependent mechanisms (Montero et al., 2008, 
Saywell et al., 2010). Furthermore, NO enhances excitatory transmission during 
inspiratory phase transition controlled by neurons in the brainstem (Pierrefiche et al., 
2007)and long-term facilitation of XII motor neuron output, in concert with NA 
(Saywell et al., 2010). During hypoxia, NO also inhibits inspiratory drive by modulation 
of KATP channels (Mironov and Langohr, 2007). 
 
Another example of a role for NO in motor systems of mammals is provided by studies 
of the trigeminal nucleus, which coordinates complex oral motor tasks. NO produced by 
pre-trigeminal and pre-hypoglossal motor neurons in the cat has been shown to decrease 
glutamatergic signalling to trigeminal motor neurons (Pose et al., 2011, Pose et al., 
2005). 
 
However, there is an absence of research into the effects of NO in mammalian spinal 
locomotor networks. Research currently being undertaken in our laboratory has used 
immunohistochemistry and fluorescence labelling to locate neurons that produce NO in 
the spinal cord ventral horn (Fig. 1.2). This thesis is an investigation into the likelihood 
that NO is involved in the regulation of mouse hind limb locomotion. 
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1.6 Nitric oxide signalling 
  
Research into the identity, causes and effects of NO has been the focus of numerous 
groups over the last thirty years. Whilst effectors and consequences of NO production 
were identified from the early 1960s onwards, NO was identified as an endogenous 
modulator of vascular smooth muscle in the late 1980s. NO was identified as the 
endothelial derived relaxing factor by four independent research groups (Murad, 1986, 
Palmer et al., 1987, Ignarro et al., 1987, Palmer et al., 1988). The Nobel Prize was 
awarded for “for their discovery concerning NO as a signalling molecule in the 
cardiovascular system” to Robert Furchgott, Louis Ignarro and Ferid Murad in 1998. 
NO continues to be studied in a variety of model organisms with at least one clear role 
for NO defined in the periphery and emerging roles in the CNS. However, the actions of 
NO have been relatively understudied in the networks that generate and maintain 
locomotion. In order to understand the possible roles of NO in mammalian locomotor 
networks the production of NO must be considered. A simplified summary of NO 
signalling accompanies the following detailed text (Fig. 1.1). 
 
1.6.1 Nitric oxide synthase structure and function 
 
NO is produced biologically by the enzyme NOS of the oxidoreductase enzyme family 
(EC 1.14.13.39). The mammalian NOS family constitutes three isozymes with 
molecular weights of between 125-155kDa and with more than 60% homology 
(Moncada et al., 1991, Dawson et al., 1991, Knowles and Moncada, 1994). The 
neuronal (nNOS or NOS-1) and endothelial (eNOS or NOS-3) NOS are constitutively 
expressed and require calcium for normal function whilst the inducible form (iNOS or 
NOS-2) is calcium independent and expressed by activated macrophages, neutrophils 
and microglia in response to immune stimulation. While the inducible form is expressed 
specifically at times of inflammation and immune challenge, the constitutively 
expressed isoforms are distributed throughout the body, particularly in the vasculature 
(eNOS) and the CNS (nNOS).  
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The NOS enzyme is a homodimer and requires several cofactors to produce NO: 
calmodulin (CaM) nNOS/eNOS; flavin adenine dinucleotide (FAD); flavin 
mononucleotide (FMN); haem; NADPH (Nicotinamide adenine dinucleotide 
phosphate); and tetrahydrobiopterin (BH4). All three isozymes have a reductase domain 
consisting of a NADPH binding site, flavin cofactors FAD and FMN, and an oxygenase 
domain consisting of a haem and BH4 binding site. The constitutive forms contain an 
autoinhibitory sequence between the FMN and CaM binding site that acts as a hinge, 
separating the reductase and oxygenase domains until the enzyme is activated by CaM.  
 
Figure 1.3. Simplified schematic of NO production and signalling via sGC/cGMP. NOS is activated by 
calcium influx through NMDA receptors. NOS catalyses the reaction between l-arginine and O2 to 
produce citrulline and NO. NO binds to soluble guanylate cyclase (sGC) initiating cGMP production and 
with subsequent downstream effects. NO is free to diffuse in a retrograde manner to the presynaptic cell 
and participate in the same range of reactions. 
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Figure 1.4. Representative images of nitrergic neurons located in lamina X of the mouse spinal cord.  
Representative images from the postnatal mouse spinal cord reveal nNOS immunostaining A and DAF 
2DA fluorescence (indicating the presence of NO) B in the mouse lumbar spinal cord. (Images courtesy 
of Dr Lissa Herron).   
 
Adjacent to the N-terminal haem, nNOS is linked to membrane ion channels via the 
molecular adaptor molecule, PDZ (PSD95 Dlg1 zo-1), that interacts with postsynaptic 
density-95 (PSD95). The discovery that nNOS is an NADPH-diaphorase enzyme (Hope 
et al., 1991) resulted in a large number of studies, mapping the localization of NO 
producing cells. The distribution of NO producing cells in the spinal cord is discussed 
in Chapter 2. All three isoforms generate NO and citrulline by the NADPH dependent 
oxygenation of l-arginine.   
 
1.6.2 Nitric oxide synthesis 
 
The biological production of NO was the first biochemical pathway discovered to 
synthesize a gas. The calcium dependent forms of the enzyme are activated by an 
increase in intracellular Ca
2+
 levels, via glutamate binding to NMDA receptors or 
voltage dependent calcium channels with the subsequent formation of the 
Ca
2+
/calmodulin complex (Moncada et al., 1991). Each Ca
2+
/calmodulin complex 
recruits tetrahydrobiopterin, forming a stable tetramer and activating the enzyme 
complex. The NOS reductase domain transfers a hydride to FAD from NADPH forming 
NADP+ and FADH2 followed by a sequence of 1e- transfers from FADH2 to FMN. 
CaM removes the spatial inhibition imposed by the autoinhibitory site, bringing 
 B A 
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together the FMNH2 and the oxygenase domain haem allowing the transfer of electrons. 
CaM activates O2 resulting in the oxygenation of l-arginine; this N-hydroxy-l-arginine 
binds to the haem at the active site. BH4 accepts an electron from the Fe-NO complex, 
liberating NO and citrulline (Feng and Tollin, 2009, Daff, 2010). Cellular signaling 
cascades regulate NO production. Protein kinase C (PKC) phosphorylates the enzyme, 
modestly increasing activity, whilst CaM kinase II phosphorylation results in a decrease 
in activity (Nakane et al., 1991).  
 
L-citrulline is the by-product of NO production and is recycled by argininosuccinate 
synthetase (AS) and argininosuccinate lyase (AL) to arginine. This recycling has been 
studied in glial cells in the context of inducible NO production but not in the context of 
the constitutively expressed isoforms or in the locomotor network (Wiesinger, 2001, 
Mori and Gotoh, 2000). A recent study carried out using the rat phrenic nerve, hemi-
diaphragm preparation, suggests that citrulline may also cause inhibition of [3H] 
acetylcholine release by activating adenosine receptors (Barroso et al., 2007, Timoteo et 
al., 2008). 
 
NO is free to diffuse, unrestricted, through the cytoplasm and across cell membranes to 
a target receptor, in an autocrine, paracrine or retrograde manner. L- arginine is the only 
physiological substrate involved in NO synthesis and analogues of the amino acid are 
potent inhibitors of the NOS enzyme.  
 
1.6.3 The NO/sGC/cGMP signalling pathway in the CNS 
 
NO is a free radical, diatomic gas with a plethora of physiological and 
pathophysiological effects. NO has been described as both a direct modulator of cellular 
function and a retrograde transmitter; that is, a molecule that is released from the 
postsynaptic neuron diffuses to the presynaptic bouton where it activates a specific 
receptor and alters synaptic transmission (Regehr et al., 2009).  As a direct modulatory 
agent and a retrograde messenger, NO is able to modulate synaptic function through 
coupling to enzymes, direct modification of proteins by s-nitrosation, and initiation of 
signalling cascades.  
Chapter 1 
25 
 
 
The receptor for NO is soluble guanylate cyclase (sGC; EC 4.6.1.2), which produces 
cyclic guanosine 3’, 5’- monophosphate (cGMP) from guanosine 5’ triphosphate (GTP) 
(Bredt and Snyder, 1989, Bredt and Snyder, 1992, Snyder and Bredt, 1992). Soluble 
guanylate cyclase is a heterodimeric haemoprotein comprising two subunits, α1/α2 and 
β1/β2, and is a member of the nucleotide cyclase family exhibiting a degree of 
similarity in structure to adenylyl cyclase. The α and β protein subunits are between 70 
to 82 kDa in size and are highly related (Koesling et al., 1988, Nakane et al., 1988). The 
β subunit N-terminus contains the haem/NO/oxygen-binding (H-NOX) domain, and the 
catalytic domain, consisting of both α and β subunit components, is located at the C-
terminus. The N-terminus haem selectively combines with NO, inducing a 
conformational change that activates the catalytic domain, which converts GTP to 
cGMP.  The mechanism of sGC activation and action is the subject of numerous studies 
and has yet to be described definitively (Winger et al., 2007, Fernhoff et al., 2009, 
Garthwaite, 2010).  
 
The predominant isoform of the NO sensitive soluble guanylate cyclase molecule in the 
vasculature is α1β1 in the CNS α2β1 (Russwurm et al., 2001, Friebe and Koesling, 2003). 
Much of the research into the location of NOS and cGMP has been in relation to pain 
processing and immune stimulation (Murphy, 2000, Friebe et al., 2007, Baltrons et al., 
2008). Indeed, a significant amount of research into the distribution of sGC and cGMP 
in the ventral lumbar spinal cord is needed to understand fully the role of NO-mediated 
processes in mammalian locomotion. 
 
In the absence of detailed information on the role of NO in the lumbar spinal cord 
specifically, interesting suggestions for the role of NO/sGC/cGMP-mediated signalling 
can be gleaned from the involvement of NO in nociception. Immunohistochemical 
studies have confirmed that the sGC β1 subunit is present specifically in spinal cord 
tissue though expression patterns in L4 and L5 of the ventral horn were not reported 
(Ding and Weinberg, 2006). In this study, it was postulated that NO acts as a paracrine 
agent during nociceptive processing as nNOS and sGC did not co-localize in the same 
neurons. Validating a paracrine role for NO, nNOS positive neurons were found to 
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appose neurons containing sGC. sGC β1 immunohistochemistry indicates that sGC is 
primarily located in neurons in the dorsal horn and around the central canal (Schmidtko 
et al., 2008). Knock-out of the sGC β1 subunit in the mouse has revealed that NO/cGMP 
signalling is essential for life. The sGC β1 knock-out was lethal for 60% of mice within 
the first 2 days of birth. Knock-outs were 40% smaller than wild types, hypertensive, 
absolutely unable to prevent platelet aggregation and were found to have severe 
dysfunctional gut peristalsis. The inability to coordinate relaxation and contraction of 
the gut leads to death at weaning when fibre becomes a major component of the diet 
(Friebe et al., 2007). 
 
In the cervical spinal cord, large cholinergic, cGMP-reactive boutons have been 
visualised near ventral motor neurons (Vles et al., 2000). Another investigation by the 
same authors has shown, using NO donors and an sGC agonist, that NO-mediated 
increases in cGMP are predominantly found in the dorsal horn and the ventral laminae 
(VII - X) (de Vente et al., 2006). Though the motor neurons were devoid of cGMP 
reactivity in this study, cGMP co-localised with a population of vesicular glutamate 
transporter (VGLUT2) and some vesicular acetylcholine transporter (vACHT) reactive 
neurons in laminae (VII- X), and isolated cGMP-positive boutons in lamina VIII and 
IX, regions that contain the locomotor-related neuronal circuits. Furthermore, in situ 
hybridization showed that ventral motor neurons and interneurons express 
phosphodiesterase (PDE) 2, 5 and 9, all involved in the breakdown of cGMP. A similar 
study in the lumbar ventral horn would help to address the lack of knowledge relating to 
NO/sGC/cGMP involvement in mammalian locomotion, though findings in the dorsal 
horn are again encouraging of a putative role for NO in the lumbar hind limb locomotor 
network. 
 
The level of sGC activity is dependent on the concentration of NO and the active site 
haem. A haem-independent binding site is also thought to be involved in full activation 
of the enzyme. In the absence of NO, sGC exhibits a basal level of activity. When NO 
binds to the haem moiety, cGMP production is increased, and in the presence of non-
haem modification, sGC enters a highly activated, but reversible state that persists in the 
presence of excess NO (Winger et al., 2007, Fernhoff et al., 2009). Adenosine 
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triphosphate (ATP) reduces sGC sensitivity to NO whilst still allowing it to bind to the 
enzyme, possibly to act as a barrier to serendipitous activation of the enzyme or to 
provide a cellular sink of NO (Garthwaite, 2010, Roy et al., 2008). 
 
NO potency in activation of cerebellar and vascular sGC (α1β1) is greater than that 
observed in tissue homogenates (Bellamy et al., 2000), suggesting that NO activation of 
sGC may be tissue- and thus subunit-specific. The NO activation of sGC is responsible 
for activating cGMP-mediated pathways such as cGMP-dependent protein kinase and 
cGMP-regulated phosphodiesterase, and cyclic-nucleotide gated ion channels (Dawson 
et al., 1998, Denninger and Marletta, 1999, Francis et al., 2010).  
 
NO-mediated effects have been alluded to in the preceding sections detailing the 
structure and function of the locomotor network and NO metabolism. With no clear role 
ascribed to NO in the rodent locomotor network, suggestions of the possible effects 
exerted by NO in the spinal network can be drawn from the range of NO-mediated 
effects in the CNS. In the rat cerebellum, hyperpolarization-activated cyclic nucleotide-
gated ion channels (HCN) are modulated by NO-mediated cGMP production (Wilson 
and Garthwaite, 2010). In the ventral spinal cord, HCN channels have been identified in 
areas associated with the locomotor network (Milligan et al., 2006), though a definitive 
role for NO-mediated modulation of cyclic nucleotide-gated ion channels in spinal cord 
locomotor networks, and in particular motor neurons, is still to be fully elucidated 
(Sirois et al., 2002, Biel et al., 2009).  
 
NO has been described as a retrograde transmitter in long term potentiation (LTP) in the 
hippocampus (Boulton et al., 1995, Ko and Kelly, 1999) and involved in long term 
depression (LTD) of adaptive motor learning coordinated by the cerebellum 
(Yanagihara and Kondo, 1996). NO also facilitates GABAergic transmission in the 
hypothalamic paraventricular nucleus of the rat by a cGMP-dependent mechanism (Li et 
al., 2004).  
 
NO has also been shown to inhibit cytochrome c in the mitochondrial respiratory chain 
(Brown and Cooper, 1994, Brown and Borutaite, 2007). In the CNS, NO has been 
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shown to disrupt synaptic transmission in hippocampal cells, by inhibition of 
mitochondria and the subsequent release of adenosine (Bon and Garthwaite, 2001). 
 
NO activates Ba
2+ 
sensitive leak K
+ 
channels causing hyperpolarisation in cholinergic 
basal forebrain neurons. This effect can be mimicked by the PKG agonist 8BrcGMP 
(Kang et al., 2007, Toyoda et al., 2008). At the Calyx of Held, a giant synapse in the 
mammalian auditory complex NO is produced after glutamate receptor stimulation and 
inhibits the actions of KV3 ion channels. Further investigation of the NO activity 
dependent effects at this synapse has shown that NO mediates the suppression of KV3 
and the simultaneous switch to KV2 ion channels to control action potential firing at 
high frequencies (Steinert et al., 2008, Steinert et al., 2011).  
 
Interestingly, in the pond snail Helisoma trivolvis, NO depolarises the membrane 
potential and increases firing rates of B5 neurons in the buccal ganglion before 
eventually causing the same neurons to fall silent. These effects are mediated by NO 
inhibition of calcium-activated and apamin-sensitive potassium channels (Artinian et 
al., 2010). 
  
These studies indicate that NO has a wide range of roles in both vertebrates and 
invertebrates CNS, increasing the likelihood of a role for NO in the mammalian spinal 
cord locomotor network. 
 
 
1.6.4 cGMP-dependent protein kinases 
 
PKGI α/β and II are NO/cGMP signal transducers. In addition to involvement in PKG 
stimulation, cGMP is also thought to regulate cAMP-dependent protein kinases 
(Hofmann et al., 2009). NO stimulation of sGC facilitates the production of cGMP, 
which binds to PKGI at two allosteric sites resulting in increasing phosphotransferase 
activity. PKGI α is located predominantly in the cerebellum and medulla while the 
PKG1β isoform is located predominantly in the hypothalamus, cortex, hippocampus and 
olfactory bulb. PKG1 mediates a wide variety of reactions including the facilitation of 
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vascular smooth muscle relaxation, platelet disaggregation and the neuronal voltage-
gated K+ channels Kv3.1 and Kv3.2 via serine-threonine phosphatase (Moreno et al., 
2001, Schmidt et al., 1992). 
 
PKGII is found throughout the mammalian brain, but its expression in the spinal cord, 
and therefore relationship to locomotion, has been less well studied (Hofmann et al., 
2009). PKGII null mice exhibit reduced bone development and increased behavioural 
disorder phenotype defined by increased anxiety and excessive ethanol consumption 
(Pfeifer et al., 1996, Werner et al., 2004). More recently, the NO/sGC/cGMP/PKGII 
pathway has been reported to modulate mouse HCN2 channel activity(Hammelmann et 
al., 2011). 
 
 
1.6.5 cGMP metabolism 
 
cGMP levels will also be affected primarily by phosphodiesterase (PDE) breakdown 
and to a lesser extent trafficking out of the cell by ATP-dependent multidrug resistant 
proteins (Jedlitschky et al., 2000). cGMP is broken down by cyclic nucleotide PDEs. 
Prolonging the life of cGMP and increasing the duration and magnitude of its related 
downstream effects make PDEs ideal therapeutic targets (Boswell-Smith et al., 2006). 
The pharmacological success stories of PDE5 inhibitors sildenafil and tadalafil (Viagra 
and Cialis), and PDE3 inhibitor cilostazol, used to treat hypertension, erectile 
dysfunction, and acute heart failure respectively, are well documented. The role of these 
and other PDEs have been studied extensively in the neuronal and peripheral vascular 
system and to some extent in the immune system. In the CNS, PDE5 ameliorates 
autoimmune encephalomyelitis in the mouse model of Multiple Sclerosis (Pifarre et al., 
2011) and inhibition of cGMP metabolism by PDE9 leads to enhancement of learning 
and memory in the rat hippocampus (van Zundert et al., 2008, Wunder et al., 2005).  
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1.7 NO forms reactive nitrogen species 
 
1.7.1 Nitrosative stress 
 
NO can participate in a number of thermodynamically favourable, chemical reactions 
that modify cellular activity independent of the NO/sGC/cGMP pathway.  These 
reactions are classified as occurring under either oxidative or nitrosative stress and 
result from an increased level of NO in the cellular environment, with nitrosative stress 
the predicted result at the highest concentrations of NO. Whilst it may seem extraneous 
to consider the chemistry of NO under physiological conditions, the confirmation that 
these reactions can occur during normal cellular function, and the added complication 
that manipulation of the NO system routinely involves other reactive pharmacological 
agents, give validation to their consideration.  
 
The auto-oxidation of NO in the reaction with oxygen forms nitrogen dioxide according 
to the reaction: 
 
                    [1] 
 
In an environment where an excess of NO persists, nitrogen dioxide reacts with 
dinitrogen trioxide as follows:   
 
          
-
                                            [2] 
 
Dinitrogen trioxide reacts with water to produce nitrite as follows: 
 
                
-
           [3] 
 
Though oxidative reactions can occur, at high levels of NO the balance is predicted to 
shift towards nitrosative stress.  In conditions of nitrosative stress, NO can react with 
superoxide to produce peroxynitrite: 
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-
       -       [4] 
 
Peroxynitrite can react with NO to produce both dinitrogen trioxide and nitrite: 
        
    -                 
-
    [5] 
 
And in the presence of carbon dioxide peroxynitrite reacts with NO to produce 
dinitrogen trioxide and nitrogen dioxide: 
 
    -                  [6] 
 
In the absence of L-arginine, NO synthase will produce superoxide. Superoxide 
dismutase has a lower affinity for NO than the superoxide radical and as a consequence, 
traces of NO can produce peroxynitrite. Peroxynitrite participates in lipid peroxidation 
and thiol modification with potentially mutagenic consequences. It has been shown that 
nitrate glutathione (GSH) and phenolic compounds such as tyrosine and peroxynitrite 
can uncouple NO synthase by oxidizing BH4. Dinitrogen trioxide (equations 2, 5 and 6) 
is also a potent nitrating agent, and nitrite, like NO, is endogenously produced and a 
potent free radical (Kuzkaya et al., 2005, Radi, 2004). This reactive radical chemistry is 
a facet of NO metabolism and is normally counteracted by antioxidant levels. 
Haemoglobin is a potent scavenger of NO, nitrite and peroxynitrite, whilst 
physiological plasma levels of urate and ascorbic acid scavenge peroxynitrite (Griffiths 
et al., 2003, Kuzkaya et al., 2005). 
 
The diverse range of reactions, leading to both protective and apoptotic states, can be 
accounted for by the signalling pathways and direct stimulation of cellular targets by 
NO and the indirect, chemical reactions that involve nitrosation. Typically, S-nitrosation 
requires higher concentrations (≈1μM) of NO than does activation of sGC (≈1-30nM) 
and it has been suggested that thiol modification takes place more readily in 
pathophysiological states (Thomas et al., 2008). However, evidence of a wide range of 
physiologically relevant nitrosation modifications has been described.  
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Cysteine has been identified as the amino acid residue that is most often the target of s-
modification (Lipton et al., 1993). S-nitrosation has been shown to modify the activity 
of ion channels, in particular the NMDA receptor, suggesting an activity dependent role 
for NO synthase activity. The NMDA receptor is intimately linked with NOS through 
the PDZ domain of PSD95. Cys399 of the NMDA receptor NR2 subunit is s-nitrosated 
and NO dependent activity is reduced (Stamler et al., 1992, Choi et al., 2000). NO 
dependent s-nitrosation and subsequent activation of nociceptive, acid-sensing ion 
channels (ASIC) increases the open probability, but not the maximum conductance, of 
these channels (Cadiou et al., 2007). Similarly, ryanodine receptors (RyR3) can be s-
nitrosated (Sun et al., 2001), and in isolated aortic smooth muscle, s- nitrosation (also 
referred to as s-nitrosylation) has been shown to desensitise sGC, leading to a negative 
feedback loop in which NO inactivates sGC and desensitises the receptor to further 
stimulation by NO (Sayed et al., 2007). Nitrosation of proteins is the second main 
pathway by which NO can exert its effects and the breadth of these studies involving 
endogenous and pathophysiological s-nitrosation indicates that this mechanism is 
important in both normal and abnormal function. 
 
 
1.7.2 Nitrosative stress in ALS 
 
It has been postulated that NO in involved in the progression of a number of 
neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimers’ disease (AD) 
and ALS (Smith et al., 2001, Raoul et al., 2006).  
 
ALS in particular is relevant to the present study, which seeks to investigate the 
distribution and function of NO in the mammalian spinal locomotor networks. NO has 
been implicated in ALS, an adult-onset disease characterised by the progressive loss of 
somatic motor neurons, leading to rapid muscle wasting, paralysis and death typically 
within 3-4 years of diagnosis (Chapter 2, Section 2.1.4). NO may facilitate disease 
progression, through mechanisms that involve nitrosative stress   
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However, NO has a variety of physiological effects in the CNS, and the role of NO in 
ALS is not clear. For instance, as a modulator of neural output, NO on the one hand 
maintains vascular tension and reduces the impact of oxidative stress (Wingler et al., 
2011) while on the other hand contributes to programmed cell death by nitrosative stress 
(Boillee et al., 2006). In ALS, NO dependent production of peroxynitrite leads to 
caspase-mediated cell death (Martin et al., 2005, Raoul et al., 2006, Locatelli et al., 
2007, Martin et al., 2007) and is also thought to be involved in axon retraction and 
synaptic stripping (Sunico et al., 2005, Sunico et al., 2010, Moreno-López et al., 2011, 
Sunico et al., 2011). 
 
However, the distribution of NO producing neurons and the chronological contribution 
of NO to ALS remain unclear and are likely a product of the neuronal environment. It is 
also likely that NO signalling acts in concert with other mechanisms in the progression 
of ALS.  Most studies investigating the causes and progression of ALS have not 
considered a change in NOS expression as part of the disease mechanism and a study of 
the distribution of NOS in the spinal cord of the mouse model of ALS has yet to be 
carried out.  
 
 
1.8 Scope of this investigation 
 
It is clear that NO is a modulator of neuronal function in the locomotor networks of 
both invertebrate and vertebrate species. NO is an important modulator in the vertebrate 
locomotor network, illustrated by its role in tadpole and lamprey swimming. NO also 
has a wide range of effect in other networks of the CNS but a role for NO-mediated 
transmission or modulation in the mammalian locomotor network has yet to be 
described. In order to better understand the role of NO in the mammalian spinal 
locomotor network, the present study aims to identify the sources of NO in the lumbar 
spinal cord, assess the effect of NO on whole network locomotor-related output and 
investigate the potential modulation of neuronal properties by NO that contribute to the 
regulation of locomotor output.  
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In Chapter 2, I will describe the spatial and temporal distribution of NOS positive 
neurons in the lumbar spinal cord over a developmentally relevant period, using the 
NADPH diaphorase histochemical reaction in wild type CD1 mice. Additionally I will 
describe the distribution of NOS positive neurons in the lumbar spinal cord of the 
SOD
G93A
 transgenic mouse. The contribution of NO to the regulation of rhythmic fictive 
locomotion recorded from in vitro isolated spinal cord preparations and the pathways 
involved in any effects will be described in Chapter 3. Finally, in Chapter 4, using 
quiescent slice preparations, the effects of NO on the intrinsic properties of lumbar 
spinal neurons will be assessed. 
 
Together these chapters aim to investigate the role of NO-mediated modulation in the 
mammalian hind limb spinal locomotor network. 
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Chapter 2: Spatiotemporal distribution of NADPH Diaphorase 
containing neurons in the lumbar spinal cord of the neonatal mouse. 
 
 
2.1 Introduction 
 
2.1.1 Background 
 
While the brain and spinal cord constitute a single organ, historically, delineation of the 
structure and function of the CNS has centred on the cortices. From the mid-eighteenth 
century, efforts to understand the structure and function of the spinal cord were largely 
at the level of gross structure, akin to the studies of the cortices of the brain. At the turn 
of the twentieth century, studies investigating the structure of the spinal cord were 
heavily influenced by the revolutionary histological work and theories of Golgi and 
Ramon y Cajal, neuroanatomists for whom synaptological studies and their findings 
were the best strategy for the study of the spinal cord.  
 
By the middle of the twentieth century, research into the structure of the spinal cord 
found a middle ground between the studies at the gross and synaptic level, when Bror 
Rexed, incorporating newly available knowledge of prominent cell columns, published 
his research investigating the structure of the cat spinal cord. His hypothesis that the 
spinal cord, like the brain is “generally…built up of a number of cell layers, regions or 
nuclei, which are adequately characterized by the shape, arrangement and connections 
of their constituent cells” marked a turning point in the study of spinal cord neurons in 
specific, anatomically characterised areas (Rexed, 1954). His canonical delineation and 
methodical categorisation of the cells of the spinal cord has been shown to be broadly 
consistent across species and remains a reference for anatomical studies sixty years after 
its first publication (Watson, 2009). 
 
The spinal cord matter can be described at the gross level as consisting of two distinct 
substances, white and grey matter. White matter consists of myelinated axon tracts, 
while the grey matter consists of soma, dendrites and both myelinated and unmyelinated 
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axons. The grey matter is composed of nine cell layers (laminae I to IX) and the area 
around the central canal (lamina X). The ventral horn, comprising laminae VII – IX, is 
associated with motor control. Locomotor-related interneurons are located in laminae 
VII, VIII, IX and X while the motor nuclei are found in lamina IX. The projection 
patterns and transcription factor identity of the neurons were detailed in Chapter 1 
(Section 1.2).  
 
Conventionally described as segmented, the spinal cord consists of two halves or hemi-
segments and each half has a dorsal or afferent nerve and a complimentary ventral 
nerve, through which axons respectively return from and project to the periphery. The 
rodent spinal cord comprises thirty-eight segments: cervical, C1 – C8; thoracic, Th1 – 
Th13; lumbar, L1 – L6; sacral, S1 – S4; and coccygeal, Co1 – Co3. The present study is 
concerned specifically with the spinal hind limb locomotor-related ventral interneurons 
(laminae VII, VIII, IX and X) and the motor neurons in the medial and lateral motor 
pools (lamina IX) located in the lumbar spinal cord. 
 
Determining the location of nitrergic neurons in the mammalian spinal cord is integral 
to our understanding of the role of NO during development and disease. The following 
section details what is known of the distribution of nitrergic neurons in the spinal cord 
and the roles of NO in spinal cord development together with the putative role of NO in 
the fatal neurodegenerative disease, ALS. 
 
 
2.1.2 Expression of nitric oxide synthase in the spinal cord 
 
Since NOS was identified as an NADPH-dependent enzyme in the brain, the NADPH 
diaphorase histochemical reaction has become a selective marker for NOS reactivity 
throughout the CNS (Dawson et al., 1991, Hope et al., 1991). Tetrazolium salts can act 
as substrates for the NADPH-dependent reaction catalysed by NOS, producing an 
insoluble visible, blue/purple formazan. The reaction is particularly useful as the 
NADPH diaphorase reactivity of the NOS enzyme is resistant to formaldehyde fixation. 
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The terms NOS positive and NADPH diaphorase reactive are used here 
interchangeably.  
 
NADPH diaphorase activity has been described in the spinal cord of a large number of 
vertebrates and invertebrates. Extensive spatiotemporal studies have been conducted in 
the brain and spinal cord of the anuran amphibian, Xenopus laevis. In the spinal cord, 
NADPH diaphorase reactivity increases between developmental stages 29, at the onset 
of early locomotor activity, and stage 47, when limb buds appear (McLean and Sillar, 
2001). A subsequent study during the early stages of metamorphosis (stages 47 to 66) 
showed that NADPH diaphorase reactivity peaks at the time of emergence of the limbs 
(although it is not co-localised with motor pools in developing limb circuits), before 
declining (Ramanathan et al., 2006). 
 
In the adult rat, the greatest NADPH diaphorase reactivity is observed in the dorsal 
horn, specifically the superficial layer (I and II), consistent with the large body of 
research detailing the role of NO in sensory processing (Cury et al., 2011, Murphy, 
2000, Schmidtko et al., 2009). Reactivity in the intermediolateral layer (IML) is closely 
related to the vasculature, and in the ventral horn some scattered weak reactivity is seen 
amongst the motor neurons. Neurons exhibiting reactivity around the central canal are 
uniformly distributed with axons extending across the midline of the grey matter (Dun 
et al., 1993, Spike et al., 1993, Valtschanoff et al., 1992). 
 
A comparative study of the rat, mouse, cat, and squirrel monkey showed that, across 
species, the distribution of NADPH diaphorase reactivity in the spinal cord is broadly 
similar (Dun et al., 1993). All species showed reactivity in the superficial dorsal horn, 
IML, ventral horn, and central canal. However, fewer reactive neurons were recorded 
around the central canal in the cat and squirrel monkey, with the squirrel monkey 
recording the least reactivity in lamina X of all the species tested. NADPH diaphorase 
reactivity was notably absent from the motor neuron population in all of the species 
examined. However, in the rabbit, upregulation of NOS expression in ventral horn 
motor neurons has been observed after induced ischemia in the rabbit (Schreiberová et 
al., 2006). This highlights the possibility that NOS expression can be state specific. 
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Transient expression of NOS in populations devoid of NOS at certain stages of 
development or pathophysiology is possible. Similarities to the non-human expression 
patterns described were recorded in a small study of the developing human spinal cord; 
between 42 to 98 days post conception, NADPH diaphorase neurons appear in the 
dorsal and ventral horns and migrate to the deeper dorsal horn, IML and Lamina X 
(Foster and Phelps, 2000). 
 
NO production has been linked to NMDA receptor signalling in nociception and 
therefore it is thought that NO production is activity-dependent (Maihofner et al., 2000, 
Xu et al., 2007). An increase in NO production during development in the rat spinal 
cord has been supported by the observation that the molecular scaffolding molecule 
PSD95 and nNOS co-localise in rat lumbar neurons. Neurons showing co-localisation 
increase in number from birth to P14, followed by a decline, suggesting that NO may 
have a predominant role in spinal cord development and a lesser role in normal network 
function (Gao et al., 2008). However, the exact developmental and network interactions 
of NO are not known. 
 
NADPH diaphorase reactivity in the mouse lumbar spinal cord has been examined in 
relation to neurons involved in nociception (de Vente et al., 2006, Schmidtko et al., 
2009, Todd, 2010). Over the developmental period P5-P30, the NADPH diaphorase 
reactivity pattern was described in the superficial dorsal horn neurons of lumbar 
sections L3-L6 to investigate the potential mediation of nociception by NO. NADPH 
reactive neurons increased in number over the period, peaking at P20 before declining, 
and the number of reactive neurons increased in response to NMDA, confirming 
activity-dependent activation of NOS, as would be expected after nerve injury (Xu et al., 
2006).  
 
Immunohistochemistry has revealed the neurotransmitter phenotype of neurons 
possessing NADPH diaphorase reactivity, providing insight into the excitatory or 
inhibitory characteristics of these neurons. In the rat, mouse, cat, and squirrel monkey, 
there is some co-localisation of NADPH diaphorase reactivity with choline 
acetyltransferase (ChAT) in the IML of lamina VII and lamina X (Dun et al., 1993). 
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Motor neurons of the ventral horn are cholinergic but not NOS positive (Dun et al., 
1993). Furthermore, NADPH diaphorase reactive neurons can be 
GABAergic/glycinergic, in addition to showing cholinergic immunoreactivity. In the 
superficial dorsal horn (laminae I and II), NADPH diaphorase reactivity was restricted 
to neurons that are either glycinergic or GABAergic. In the deeper dorsal horn neurons 
(lamina III), NADPH diaphorase reactivity was found in neurons with either GABA- 
and glycinergic or GABAergic and cholinergic neurotransmitter phenotypes (Spike et 
al., 1993). Higher resolution studies using confocal microscopy have revealed that, in 
fact, nNOS is also expressed by a significant proportion of excitatory interneurons in 
the same laminae I and II populations that also express protein kinase C (PKC) 
(Sardella et al., 2011). 
 
Cholinergic transmission, mediated by C-bouton synapses on motor neurons, is an 
important modulator of motor neuron excitability; however, 99% of C-boutons have 
been shown to be devoid of NOS immunoreactivity (Miles et al., 2007, Zagoraiou et al., 
2009), precluding a role for direct involvement of NO in this motor neuron gain control 
system. However, ChAT reactive terminals that are NOS positive have been described 
in close proximity to motor neurons (Miles et al., 2007). Furthermore, the C-boutons 
that excite motor neurons originate from V0C interneurons that are located around the 
central canal (lamina VII) and the medial zone of lamina VII (Zagoraiou et al., 2009) 
and therefore by the close proximity of NOS expressing neurons to the V0C population, 
NO may directly (autocrine) or indirectly (paracrine) influence locomotor behaviour.  
 
The spatiotemporal distribution of NOS-producing neurons has been previously 
described in the tadpole brainstem and spinal cord (McLean and Sillar, 2000, Lopez and 
Gonzalez, 2002). The endogenous production and exogenous application of NO 
modulates locomotor activity in the tadpole by facilitating glycinergic transmission 
(McLean and Sillar, 2000, McLean and Sillar, 2002). This evidence from a non-
mammalian model organism not only shows that NO is located in neurons that regulate 
locomotor output but that NO explicitly modulates locomotor activity. Given the 
similarities between core spinal locomotor mechanisms in the non-mammalian 
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vertebrate and in mammals, these studies strongly suggest that NO may modulate 
mammalian locomotor output. 
 
Despite the evidence that NO is produced by neurons in the mammalian ventral horn, 
the expression and function of NO in the locomotor network have not been studied in 
great detail.  In particular, little is known about the expression pattern and role of NO 
during postnatal development of the spinal locomotor networks as they mature. 
A preliminary study of NADPH diaphorase reactivity was performed in the lumbar 
spinal cord of the neonatal mouse (Collett, 2007). A comparison of lumbar segments L2 
and L3 at P1, P5, and P14 showed an increase in the total number of NADPH 
diaphorase reactive neurons. The present study aims to advance these preliminary 
findings by investigating NOS expression, at greater detail by examining expression 
within individual laminae, during postnatal development in the wider L1-L5 neonatal 
lumbar mouse spinal cord.  Detailed knowledge of the expression patterns of NOS in 
the developing spinal cord is critical in progressing our current understanding of the role 
of NO in the development of spinal motor systems and the potential physiological roles 
of NO in the control of movement.  
 
 
2.1.3 Roles of nitric oxide in spinal cord development 
 
NO has been shown to have both morphogenic and axonogenic properties. The main 
receptor for NO is soluble guanylate cyclase, which catalyses the production of cGMP 
from GTP, initiating changes to cellular properties through PKG. NO signalling through 
cGMP-dependent mechanisms potentiates the Sonic hedgehog protein (Shh) -mediated 
induction of ventral cell-types in chick neural explants (Robertson et al., 2001). The 
physiological radical/antioxidant balance between NO and folic acid controls cell 
proliferation and cell death in chick neural tube development; high levels of NO 
promote pre-mitotic proliferative effects and increase neural tube closure defects. In 
contrast, in the absence of NO, mitosis is potentiated. Inhibition of the morphogen, bone 
morphogenic protein 4 (BMP4), induces NO mediated apoptosis leading to neural tube 
defects (Plachta et al., 2003, Weil et al., 2003, Traister et al., 2004). 
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A variety of studies suggest that NO has diverse roles later on in development. In the 
chick embryo, NO causes a reduction in motor neuron dendritic tree arborisation via the 
cGMP/PKG pathway (Xiong et al., 2007). Similar results were observed in the zebra 
fish embryo where inhibition of NO production causes an increase in axon collaterals 
(Bradley et al., 2010). In the chick embryo, symmetrical ryanodine receptor calcium 
induced calcium (RCIC) release is involved in directional polarity of growth cones. 
Through cGMP-dependent mechanisms, NO reverses the attraction or repulsion of the 
growth cone towards or against cell adhesion molecule substrates (Murray et al., 2009, 
Tojima et al., 2009). 
 
However, in contrast to studies in the chick, NO production in the rat causes growth 
cone collapse and axon retraction by thiol modification of microtubule associated 
protein 1B determining primary dendrite length (Stroissnigg et al., 2007). Similarly, NO 
reversibly inhibits neurite growth in dorsal root ganglion nerves by thiol-modification 
(Hess et al., 1993). In contrast, NO promotes 2
nd
, 3
rd
 and 4
th
 order dendrite arborisation 
but appears to have no effect on primary dendrite length in the mouse (Inglis et al., 
1998).  
 
These contrasting developmental effects of NO are evidence that much work remains to 
be done in elucidating the tissue-specific, species-specific and mechanistic roles of NO 
during development. An integral part of understanding the role of NO in the mammalian 
locomotor network will involve describing the expression of NOS in the developing 
lumbar spinal cord. 
 
 
2.1.4 Nitric oxide in Amyotrophic lateral sclerosis (ALS) 
 
NO has been implicated in neurodegenerative diseases such as Multiple Sclerosis (MS), 
Alzheimers’ disease (AD) and ALS (Smith et al., 1997, Smith et al., 2001, Raoul et al., 
2006). Of these, ALS is most relevant to the present study as NO has previously been 
implicated in the progression of ALS. ALS is an adult-onset disease characterised by 
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the progressive loss of somatic motor neurons, which consequently leads to rapid 
muscle wasting, paralysis and death, predominantly from respiratory failure (typically 
within 3-4 years of diagnosis). The majority of ALS cases are sporadic (SALS), while 
~10% of all cases are familial (FALS) with 20% of FALS cases a result of mutations in 
the superoxide dismutase 1 (SOD1) gene. The most studied murine models of ALS 
express mutant human Cu/Zn superoxide dismutase 1 transgenes, particularly the 
SOD
G93A
 mutation (Boillee et al., 2006, Van Den Bosch, 2011).  
 
The mechanisms involved in the onset and progression of ALS are poorly understood 
though motor neuron death has been linked to glutamate-mediated excitotoxicity. 
Riluzole is the only current treatment for ALS; a persistent sodium and calcium channel 
blocker, known to inhibit presynaptic release of glutamate, and thereby it is presumed to 
act by reducing putative aberrant excitatory input to motor neurons (Wang et al., 2004, 
Lamanauskas and Nistri, 2008). Riluzole has been used to treat the disease since 1994, 
with limited success, increasing life expectancy by just 3-4 months; thus, the study of 
the mechanisms involved in disease cause and progression are the subject of intense 
research (Bensimon et al., 1994, Aggarwal and Cudkowicz, 2008).   
 
Though oxidative and nitrosative stress are not the sole cause of ALS progression, wild-
type motor neurons in culture are less susceptible than cultured SOD
G93A
 mice motor 
neurons to NO-mediated programmed cell death (Raoul et al., 2006). In SOD
G93A
 mice, 
upregulation of nNOS and subsequent peroxynitrite production leads to FAS activation 
and cell death mediated by caspase-8 (Martin et al., 2005, Raoul et al., 2006, Locatelli 
et al., 2007, Martin et al., 2007). There is also evidence that NOS is upregulated in 
motor neurons in adult SOD1
mutant 
mice at early pre-symptomatic (<24 weeks) and 
during symptomatic (>32 weeks) stages of the disease (Sasaki et al., 2002). A role for 
NO in ALS has also been postulated due to the observation that the NO/sGC/cGMP 
pathway and subsequent activation of RhoA/Rho kinase (ROCK) leads to axon 
retraction from their target muscles (Moreno-López et al., 2011). NO has also been 
implicated in synaptic stripping, which involves the elimination of synapses with motor 
neurons, by cGMP dependent and cGMP-independent mechanisms (Sunico et al., 2005, 
Sunico et al., 2010, Sunico et al., 2011).  
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An increase in the excitability of motor neurons has been shown in cultured motor 
neurons and during development in SOD1
mutant
 mice, over the period P1 to P12 (Kuo et 
al., 2004, Kuo et al., 2005, Heckman et al., 2009). Changes in motor neuron excitability 
during this period of development provide the impetus to investigate whether NO 
production may be upregulated during the same period in SOD1
mutant
 compared to wild 
type mice. Investigating NOS expression during the period when the changes in 
excitability occur will provide an indication of whether NO signalling is involved in 
these changes.  
 
Despite the significant interest in the potential contribution of NO to ALS, little is 
known about the expression of NOS in postnatal SOD1
mutant
 mice. Though the majority 
of research is focussed on the development of the ALS phenotype from pre-
symptomatic stages onwards, information regarding the changes that occur during 
development is relatively scarce. 
 
 
2.1.5 Scope of this study  
 
This chapter aims to describe the spatiotemporal distribution of neurons in the lumbar 
spinal cord of the mouse that exhibit NADPH diaphorase, and thus NO, reactivity over 
the first twelve postnatal days of development, when mice develop the ability to bear 
weight and walk. 
 
NO is an important mediator of developmental processes and function of the spinal cord 
circuitry. In the mouse lumbar spinal cord, the expression of NOS, which is a NADPH 
diaphorase enzyme, has been studied in relation to sensory processing with little 
attention given to the potential role of NO in the locomotor network. At birth, the 
neonatal locomotor network continues to develop and locomotion consists of gradually 
improving attempts to coordinate limbs. Maturity of the locomotor network occurs at 
P10 in BALB/c mice and rats, indicated by the ability to move with the ventral surface 
supported on all four limbs (Clarac et al., 1998, Jiang et al., 1999). It is well known that 
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the lumbar spinal cord contains the CPG that coordinates hind limb locomotion. This 
provides the impetus for the investigation of NADPH diaphorase reactivity in the 
neonatal mouse spinal cord during this period, which is developmentally relevant to the 
study of locomotor networks. 
 
It is not known whether NOS expression differs during postnatal development in 
SOD1
mutant
 compared to SOD1
WT
animals. Thus, a preliminary investigation was made 
to assess NADPH diaphorase reactivity in a small group of SOD1 
G93A
mice, as changes 
in NOS expression and therefore NO signalling may contribute to the pathogenesis of 
ALS. 
 
 
2.2 Materials and Methods 
 
2.2.1 Tissue collection and preparation  
 
All experiments were performed in accordance with the United Kingdom Animals 
(Scientific Procedures) Act 1986. CD-1 wild-type (CD-1WT) mice were obtained from 
Charles River Laboratories (Scotland, UK).  The mice were bred under conditions of a 
12-h light/dark cycle in individual ventilated cages at a constant temperature of 22°C 
and 56% humidity with free unrestricted access to food and water. Following cervical 
dislocation, decapitation, evisceration and vertebrectomy, spinal cord sections from mid 
cervical to upper sacral region were isolated in a chamber containing gassed artificial 
cerebral spinal fluid (aCSF; equilibrated with 95% oxygen, 5% carbon dioxide, ~4ºC). 
Spinal cord tissue was removed from mice between the ages of postnatal day (P)1-12 
and placed in 4% paraformaldehyde overnight. Following fixation, the lumbar segments 
L1-L5 were cryoprotected in 30% sucrose overnight. Each lumbar segment was then cut 
using a cryostat (Bright lnstrument Co Ltd, Cambs., UK) at -21
o
C, into 10-15μm 
transverse sections. The sections were placed on SuperFrost poly-L-lysine coated slides 
and left to dry at room temperature for between 60 and 90 minutes. The sections were 
washed with 0.1M phosphate buffered saline (PBS, pH7.4) in preparation for the 
nicotinamide adenine dinucleotide phosphate diaphorase staining procedure. At P12, 
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SOD1
G93A
 and wild-type (SOD1 WT) littermate control animals were dissected and 
fixed as per CD-1WT protocol. The litter analysed comprised SOD1
G93A
  (n = 4) and 
wild-type (SOD1 WT) littermate control animals (L1, L3, L4 and L5, n = 3 and L2, n = 
2). The notation SOD1 WT is used to describe wild type littermates. 
 
Transgenic mice expressing the G93A mutation in the human SOD1 gene were utilised 
in a subset of experiments. Expression of the SOD1
G93A
 transgene was detected using 
polymerase chain reaction of DNA from tail clippings. DNA was extracted and 
polymerase chain reaction (PCR) was performed using the RED Extract-N-Amp Tissue 
PCR Kit (Sigma-Aldrich) as per the manufacturer’s instructions.   
 
The following primers were used: 
SOD1 forward primer 5’-CAT CAG CCC TAA TCC ATC TGA-3’  
SOD1 reverse primer 5’-CGC GAC TAA CAA TCA AAG TGA-3’  
Internal control forward primer 5’-CTA GGC CAC AGA ATT GAA AGA TCT-3’  
Internal control reverse primer 5’-GTA GGT GGA AAT TCT AGC ATC ATC C-3’ 
 
Thermal cycling was performed on a PCR machine (PCR sprint thermal cycler, Thermo 
Fisher Scientific, Massachusetts, USA). PCR products were run on a 1.5% agarose gel 
alongside a 1kb DNA ladder for analysis. Tail clipping, PCR and gel-analysis were 
performed by Noboru Iwagaki (Iwagaki, 2011).  
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Figure 2.1. NADPH diaphorase reactivity in the neonatal spinal cord of the mouse. A. Derivation of 
Rexed’s laminae used to assign location to reactive neurons during cell count (P5L1, NADPH stain). B, 
Haematoxylin and Eosin and D, DAPI nuclear stain confirm that the discrete number of reactive neurons 
were not a consequence of fixing protocol and staining procedures. DAPI histomount was used to 
coverslip NADPH tissue, C, and images were taken simultaneously comfirming the integrity of the tissue 
and staining prodecure. Annotations: cc – central canal, D – dorsal, DF – dorsal funiculus, LF – lateral 
funiculus,  V – ventral, VF – ventral funiculus, IML – intermediolateral layer, VII – lamina VII, VIII – 
lamina VIII, IX – lamina IX, X – lamina X. Scale bars = 200µm, A and B; 20µm, C and D. 
(Haematoxylin and Eosin, courtesy of Jill McVee). 
 
 
2.2.2 Nicotinamide adenine dinucleotide phosphate diaphorase (NADPH) 
staining procedure 
 
The NADPH diaphorase histochemical staining procedure was based on the method 
previously described (Xu et al., 2006). The slide-mounted sections were incubated for 
110 minutes at 37
oC in 0.1M PBS (pH 7.4) containing 1mg/ml β-NADPH, 0.13 mg/ml 
NBT and 0.3% Triton-X100. The reaction was terminated by washing the slides with 
PBS and distilled water, and slides were then left to dry overnight at room temperature. 
The dry sections were cleared in xylene and coverslipped using dibutyl phthalate in 
xylene (DPX). Hemotoxylin and Eosin staining and NADPH diaphorase with 
fluorescent DAPI (histomount) were used in a small sample group of sections to 
confirm tissue viability (Fig 2.1). 
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2.2.3 Image collection and analysis 
 
The animals were divided into four age groups: Group 1 – P1 to 3; Group 2 – P4 to 6; 
Group 3 – P7 to 9; and Group 4 – P10 to 12. Whole section digital images were 
captured using a 7.1 Megapixel camera (Canon A620) mounted on a Zeiss Axiolab 
optical microscope. High power images at specific laminar locations were collected 
under brightfield and fluorescent illumination using a Hamamatsu ORCA ER camera 
(Hamamatsu Corp., GmbH) mounted on a Zeiss Axioplan 2 microscope (Carl Zeiss 
Ltd., UK) with x40 and x63 objectives, collected and optimised using Zeiss Axiovision 
software (Axiovision Release 4.8.1., Carl Zeiss Ltd., UK). All images were imported 
into GNU Image Manipulation Program for contrast/colour manipulation and figure 
assembly was performed in the Inkscape graphics package (Inkscape and GIMP; Free 
Software Foundation, MA, USA). 
 
Section outlines were made using the grey matter boundary and cell plots created with 
reference to Rexed’s laminae (Rexed, 1954) (Fig. 2.1). Cells in the dorsal horn are 
predominantly involved in sensory processing and thus were not assigned to individual 
lamina, instead, laminae I-VI were pooled. Cells were counted in five separate sections 
of the same spinal segment in each animal and assigned a laminar position. In each age 
group, the mean number of cells in each lamina for six separate animals was recorded 
using Excel (version 2010, Microsoft Corp.). 
 
The NADPH diaphorase technique is non-specific for NOS isoforms and therefore 
labels blood vessels which express endothelial NOS as well as neurons which express 
nNOS. Positive staining of neurons was defined as staining intensity equal to or greater 
than that of the blood vessels and distinct from background stain. Neurons exhibited 
staining of the soma with an absence of staining in what is presumed to be the nucleus.  
Some light reactivity was observed around cells in the ventral horn; this was not 
included in the cell counts.  
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2.2.4 Statistics  
 
Data are presented as mean ± SEM. Segmental and age group data were analysed by 
two-way ANOVA with Bonferroni multiple comparisons post-hoc test unless stated 
otherwise. P < 0.05 was considered statistically significant (see Table 2.3, 2.6). All 
statistical data were calculated using GraphPad Prism software (Graphpad, La Jolla, 
CA). 
 
 
2.3 Results 
 
2.3.1 NADPH diaphorase reactivity in CD-1 wild-type mice 
 
NADPH Diaphorase reactivity was recorded in several areas within the grey matter of 
the lumbar spinal cord, including: the superficial and deeper laminae of the dorsal horn; 
the intermediolateral column (IML), intercalated nucleus (ICN) and lumbar dorsal 
commissural nucleus of lamina VII (regions in the upper lumbar spinal cord containing 
sympathetic preganglionic neurons); the remainder of lamina VII; and lamina X, the 
area encompassing the central canal.  Fewer reactive neurons were found scattered in 
lamina VIII and the medial and lateral motor columns (lamina IX). NADPH diaphorase 
reactivity was measured in four groups by age: Group 1 – P1 to 3; Group 2 – P4 to 6; 
Group 3 – P7 to 9; and Group 4 – P10 to 12. NADPH diaphorase reactivity was 
recorded in the lumbar spinal cord of six animals in each age group. 
 
As mentioned previously, the NADPH diaphorase reaction is non-specific for NOS 
isoforms and consequently, vascular staining was visible at all levels of the lumbar 
spinal cord in both white and grey matter. Typically, NADPH diaphorase reactivity was 
confined to the cytoplasm of neurons containing the enzyme. In the superficial dorsal 
horn, reactivity appeared continuous throughout the soma, likely due to the combination 
of small cell size and limited imaging resolution.  
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Dorsal Horn (Lamina I – VI) 
The laminae of the dorsal horn contained the largest population of NADPH diaphorase 
reactive neurons, which accounted for between 19±3 and 68±5% of all reactive neurons 
across segments L1-L5 of Groups 1-4 (Table 2.2). A representative selection of dorsal 
horn neurons was measured and varied in size from approximately 10 to 15µm (Fig. 
2.2B and Fig. 2.8B). Along the rostral-caudal axis this dorsal population of NADPH 
diaphorase reactive neurons was greatest at the caudal levels. (Figs. 2.3, 2.5, 2.7, 2.9 A-
E, 2.10B provide a schematic summary of the group and lamina distribution.)  
 
Over the developmental period studied, NADPH diaphorase reactive neurons in the 
dorsal horn increased in number (1.5-fold increase between Group 1 and 2, 1.3-fold 
increase between Group 2 and 3; Table 2.1), with the greatest increase in number at 
Group 4 (3-fold increase between Group 3 and 4; Table 2.1). The greatest mean increase 
at all levels of the lumbar spinal cord occurred in the L1 segment between Group 1 and 
Group 4 (10-fold increase; Table 2.1; Fig. 2.10A). 
 
Lamina VII   
Neurons in lamina VII form the third largest population of NADPH diaphorase reactive 
neurons in spinal grey matter across the age groups and spinal segments analysed. 
Reactivity in the intercalated nucleus (ICN), where visible, was predominantly restricted 
to fibre tracts and, therefore, was not treated as distinct per se from the wider lamina VII 
area. If neurons showed reactivity and appeared to be in the approximate region of the 
ICN, they were included in the wider lamina VII count. NADPH diaphorase reactive 
neurons in lamina VII were irregularly distributed throughout the lamina, and did not 
appear to form specific nuclei. A mixture of neurons was observed in all segments, with 
approximate sizes of between 10-30 µm in diameter (Figs. 2.6E, 2.8E). The largest 
populations of stained neurons within lamina VII were located in the rostral segments 
(L1-L3) with lower levels in L4 and L5 (Fig. 2.10C).  
 
The proportion of NADPH diaphorase reactive neurons which were found within 
lamina VII increases from as low as 12±1% up to a maximum of 27±3% (P3L2 and 
P12L3 respectively; Fig.2.3 and Fig.2.9; Table 2.2) over the period P3 to P12. NADPH 
Chapter 2 
50 
 
diaphorase reactivity increased in lamina VII throughout the developmental period 
studied in all segments (Figs. 2.10C, 2.3, 2.5, 2.7 and 2.9, A-E). The total number of 
NADPH diaphorase reactive neurons in lamina VII increased from Group 1 to Group 4 
by approximately 70% (Tables 2.1).  
 
The sympathetic preganglionic neurons of the intermediolateral layer (IML) exhibited 
NADPH diaphorase reactivity. These neurons formed clusters in the upper lumbar 
segments (L1 – L3) and were often observed in dense plexuses of neurons closely 
associated with what appeared to be blood vessels (Fig. 2.6A and C). The level of 
NADPH diaphorase activity in the IML remained relatively consistent during 
development, with a peak at L2 in Group 3 (Fig. 2.2; Table 2.1).  
 
Lamina VIII 
Light NADPH diaphorase staining was noted infrequently in lamina VIII with less than 
one neuron recorded per group. The few neurons that were positively stained tended to 
be located in the rostral segments, with approximate sizes of between 10-20 µm in 
diameter (Tables 2.1 and 2.2).  
 
Lamina IX 
A small number of neurons were NADPH diaphorase reactive in lamina IX 
(approximately one per segment). These neurons were found mostly in the rostral 
segments and the largest proportion of these neurons was noted in Group 1 (Tables 2.1 
and 2.2). Light punctate staining in the areas around the approximate location of the 
motor pools, which appeared different in texture and intensity from staining seen in the 
other laminae, was noted across all segments and age groups (compare Fig. 2.11B, C, 
and D).  Typically, this staining occurred in regions associated with both the medial and 
lateral motor pools (Fig. 2.11 A; x63, Fig. 2.11B). 
 
Lamina X 
Neurons in lamina X form the second largest population of NADPH diaphorase reactive 
neurons in spinal grey matter. Labelled neurons were approximately 15 to 30µm in 
diameter (Fig. 2.6D and Fig. 2.8D), with the largest neurons appearing in Group 4. The 
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projections from labelled neurons appeared to extend along both the dorsolateral and 
medioventral axes. The proportion of NADPH diaphorase reactive neurons in lamina X 
in each segment remained relatively constant across the developmental period analysed, 
except in Group 4 where dorsal horn neurons dominate and lamina X neurons contribute 
15±2 to 25±2% of the total Group 4 population, as opposed to 35±2 to 42±4% in Group 
1 (Table 2.2). It was not always possible to separate the neurons of the lumbar dorsal 
commissural nucleus from those recorded in lamina X on the basis of NADPH 
reactivity alone and therefore, no distinction was made between the two groups. 
 
Across all age groups, there are more NADPH diaphorase reactive neurons within 
lamina X of the rostral segments (L1, L2 and L3) than the caudal segments (L4 and L5). 
In each age group, the lamina X population peaks at L2/L3, with the least neurons 
recorded in L4 segments (Figs. 2.10A, 2.3, 2.5, 2.7 and 2.9, A-E).  
 
2.3.2 NADPH diaphorase reactivity in SOD1 wild-type and SOD1G93A mouse 
 
NO has been implicated in a number of neurodegenerative diseases including ALS. 
There is evidence that NOS is upregulated in motor neurons in adult SOD1
mutant 
mice at 
early presymptomatic (<24 weeks) and during symptomatic (>32 weeks) stages of the 
disease (Sasaki et al., 2002). However, little is known about the expression of NOS in 
the postnatal SOD1
mutant,
 thus, a preliminary investigation was made to assess NADPH 
diaphorase reactivity in the SOD1 
G93A
 mouse model of ALS. 
 
NADPH diaphorase reactivity was recorded in the grey matter of the lumbar spinal cord 
of both SOD1
G93A
 mice and wild type littermates at P12. The pattern of reactivity in 
both SOD1 WT and SOD1 G93A mice was consistent with that observed in CD-1WT 
mice. No difference in the total number of NADPH diaphorase reactive neurons was 
noted between SOD1 WT and CD-1WT mice (two-way ANOVA with Bonferroni 
multiple comparison post-hoc test). However, the total number of NADPH diaphorase 
reactive neurons was significantly lower in the P12 SOD1
G93A
 when compared to the 
SOD1 WT mice (Student’s t-test, P<0.05). 
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Dorsal Horn (Lamina I – VI) 
The laminae of the dorsal horn contain the largest population of NADPH diaphorase 
reactive neurons (Table 2.6). Reactive neurons in both SOD1 WT and SOD1
G93A
 
sections did not appear to differ in size from CD-1WT neurons. NADPH diaphorase 
reactive neurons constitute a similar percentage of the total population of reactive 
neurons in the dorsal horn of both SOD1 WT and SOD1
G93A
 mice (approximately 60% 
of the total segmental population; Table 2.6). However, there were less reactive neurons 
overall in the rostral segments L1 and L2 of SOD1
G93A
, when compared to SOD1 WT 
mice. The total number of reactive neurons in SOD1 WT mice was 68±1 in L1 and 
79±2 in L2 compared to 53±1 in L1 and 49±1 in L2 of SOD1
G93A
 mice (Table 2.5). 
 
The number of reactive neurons increased in the cord along the rostral-caudal axis with 
the largest population recorded in the caudal levels of both SOD1 WT and SOD1
G93A
 
mice (Fig. 2.12A; Table 2.5.).  
 
Lamina VII 
NADPH diaphorase reactive neurons were again distributed throughout lamina VII with 
a trend towards the largest population being located within the first three rostral 
segments of the spinal cord. NADPH diaphorase reactive neurons comprised a similar 
percentage of the total population of reactive neurons in lamina VII of both SOD1 WT 
and SOD1
G93A
 mice, except in L2 where a higher proportion of the total reactive 
population were found in lamina VII of SOD1
G93A
 mice compared to SOD1 WT mice 
(approximately 25% of the total segmental population in the SOD1
G93A
 and 
approximately 17% in the wild type; Table 2.6). However, there were less reactive 
neurons in L1 and L2 of the SOD1
G93A
, when compared to the SOD1 WT. The total 
number of reactive neurons in the SOD1
G93A
 mouse was 23±1 in L1 compared to 30±1 
in L1 of the wild type littermates (Table 2.5; Fig. 2.13C). 
 
The sympathetic preganglionic neurons were again observed as clusters in the IML of 
upper lumbar segments (L1-L2 only) (Fig. 2.11A). Interestingly, the level of NADPH 
diaphorase reactivity in the IML was approximately 16-fold lower in SOD1
G93A
 than in 
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SOD1 WT, particularly at L2 (P<0.05, Mann-Whitney test, SOD1
G93A
, n=4 and WT, 
n=2; Fig. 2.12A and B, Fig. 2.12D; Table 2.5).   
 
Lamina VIII and IX  
Very few neurons were NADPH diaphorase reactive in laminae VIII and IX (less than 
one per segment). The lamina VIII neurons were found mostly in the rostral segments of 
the SOD1 WT. In lamina X, only one reactive neuron was recorded in the SOD1 WT 
while none were recorded in the SOD
G93A
 (Tables 2.5). Light punctate staining in the 
areas around the approximate location of the motor pools was noted occasionally in 
both SOD1 WT and SOD
G93A
 sections.  
 
Lamina X 
The population of NADPH diaphorase reactive neurons in lamina X remained relatively 
constant along the rostral-caudal axis and no difference was noted between the SOD1 
WT and SOD1
G93A
 groups (Table 2.5 and 2.6). The neurons of the lumbar dorsal 
commissural nucleus were recorded in the cell count for lamina X as described in the 
CD-1WT. NADPH diaphorase reactive neurons constitute a similar percentage of the 
total population of reactive neurons in lamina X of both SOD1 WT and SOD1
G93A
, with 
the exception of L5. In L5 the SOD1
G93A
 had a lower proportion of the total reactive 
population compared to the SOD1 WT (approximately 16% of the total segmental 
population in the SOD1G93A and approximately 21% in the wild type; Table 2.6). The 
total number of reactive neurons in the SOD1
G93A
 mouse was 17±1 in L5 compared to 
23±1 in L5 of the wild type littermates (Table 2.5; Fig. 2.13B). NADPH diaphorase 
reactive neurons comprised a similar percentage of the total population of reactive 
neurons in L2 of both SOD1 WT and SOD1G93A but the total number of reactive 
neurons in the SOD1
G93A
 mouse was lower in L2 compared to the wild type littermates 
(17±1 and 27±1, respectively; Table 2.5).  
 
In both SOD1 WT and SOD1G93A, the pattern of NADPH diaphorase reactive neurons 
closely resembled that of the CD1 WT mouse. There were overall less NADPH 
diaphorase reactive neurons in the SOD1G93A compared to the SOD1 WT mouse, in 
all the laminae described and particularly in the rostral regions (L1 and L2).  
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Figure 2.2. Transverse section taken at P3L1 demonstrates NADPH diaphorase reactivity in lumbar 
spinal cord. A. Discrete populations of neurons stain throughout the spinal cord section, stained neurons 
are visible in the dorsal Ai, intermediolateral layer Aii and lamina X (LX) Aiii. High magnification (x40) 
brightfield images of typical neurons in the dorsal horn with dorsoventral projections B, Ai., sympathetic 
preganglionic neurons in the intermediolateral layer project laterally and are closely associated with the 
vasculature C, Aii and neurons in LX with both dorsoventral and lateral projections. Staining appears to 
be restricted to the cytoplasm in all lamina expect those of the superficial dorsal horn which appear to 
stain in both nucleus and cytoplasm.  D, Aiii. Vascular staining is visible, throughout the section (black 
arrowheads). Annotations: cc – central canal, d – dorsal, DF – dorsal funiculus, LF – lateral funiculus,  v 
– ventral, VF – ventral funiculus, VMF – ventral median fissure. Scale bars = 200µm, A; 50µm, B, C and 
D. 
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Figure 2.3. Schematic diagram of NADPH diaphorase activity in the mouse spinal cord at P1-3 taken 
from spinal segments lumbar (L)1-5. Ai-Ei. Approximate positions of positively stained neurons are 
indicated by black filled circles.  Each lumbar segment represents 5 transverse segments from 1 mouse 
and each filled circle represents one neuron. d and v indicate dorsal and ventral orientation. Diagrams are 
not to scale. Aii-Eii. Graphs showing the total number of positively stained neurons in LX, LVII, D and 
the total in LVII which include the SPN cells of the IML (TVII for L1-3 only). Data are mean ±SEM, 
n=6. 
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Figure 2.4. Transverse section taken at P5L1 demonstrates NADPH diaphorase reactivity in lumbar 
spinal cord. A. Discrete populations of neurons stain throughout the spinal cord section, stained neurons 
are visible in the dorsal Ai, intermediolateral layer Aii and lamina X (LX) Aiii. High magnification (x40) 
brightfield images of typical neurons in the dorsal horn with dorsoventral projections B, Ai., sympathetic 
preganglionic neurons in the intermediolateral layer project laterally and are closely associated with the 
vasculature C, Aii and neurons in LX with both dorsoventral and lateral projections. Staining appears to 
be restricted to the cytoplasm in all lamina expect those of the superficial dorsal horn which appear to 
stain in both nucleus and cytoplasm.  D, Aiii. Vascular staining is visible, throughout the section (black 
arrowheads). Annotations: cc – central canal, d – dorsal, DF – dorsal funiculus, LF – lateral funiculus,  v 
– ventral, VF – ventral funiculus, VMF – ventral median fissure. Scale bars = 200µm, A; 50µm, B, C and 
D. 
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Figure 2.5. Schematic diagram of NADPH diaphorase activity in the mouse spinal cord at P4-6 taken 
from spinal segments lumbar (L)1-5. Ai-Ei. Approximate positions of positively stained neurons are 
indicated by black filled circles.  Each lumbar segment represents 5 transverse segments from 1 mouse 
and each filled circle represents one neuron. d and v indicate dorsal and ventral orientation. Diagrams are 
not to scale. Aii-Eii. Graphs showing the total number of positively stained neurons in LX, LVII, D and 
the total in LVII which include the SPN cells of the IML (TVII for L1-3 only). Data are mean ±SEM, 
n=6. 
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Figure 2.6. Transverse section taken at P7L1 demonstrates NADPH diaphorase reactivity in lumbar 
spinal cord. A. Discrete populations of neurons stain throughout the spinal cord section, stained neurons 
are visible in the dorsal Ai, intermediolateral layer Aii lamina X (LX) Aiii and lamina VII Aiv. High 
magnification (x40) brightfield images of typical neurons in the dorsal horn with dorsoventral projections 
B, Ai., sympathetic preganglionic neurons in the intermediolateral layer project laterally and are closely 
associated with the vasculature C, Aii and neurons in LX with both dorsoventral and lateral projections. 
Neurons in lamina VII are loosely distributed throughout the layer E, Aiv. Staining appears to be 
restricted to the cytoplasm in all lamina expect those of the superficial dorsal horn which appear to stain 
in both nucleus and cytoplasm.  D, Aiii., Vascular staining is visible, throughout the section (black 
arrowheads). Annotations: cc – central canal, d – dorsal, DF – dorsal funiculus, LF – lateral funiculus,  v 
– ventral, VF – ventral funiculus, VMF – ventral median fissure. Scale bars = 200µm, A; 50µm, B, C and 
D. 
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Figure 2.7. Schematic diagram of NADPH diaphorase activity in the mouse spinal cord at P7-9 taken 
from spinal segments lumbar (L)1-5. Ai-Ei. Approximate positions of positively stained neurons are 
indicated by black filled circles.  Each lumbar segment represents 5 transverse segments from 1 mouse 
and each filled circle represents one neuron. d and v indicate dorsal and ventral orientation. Diagrams are 
not to scale. Aii-Eii. Graphs showing the total number of positively stained neurons in LX, LVII, D and 
the total in LVII which include the SPN cells of the IML (TVII for L1-3 only). Data are mean ±SEM, 
n=6. 
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Figure 2.8. Transverse section taken at P12L1 demonstrates NADPH diaphorase reactivity in lumbar 
spinal cord. A. Discrete populations of neurons stain throughout the spinal cord section, stained neurons 
are visible in the dorsal Ai, intermediolateral layer Aii lamina X (LX) Aiii and lamina VII Aiv. High 
magnification (x40) brightfield images of typical neurons in the dorsal horn B, Ai., sympathetic 
preganglionic neurons in the intermediolateral layer project laterally C, Aii, neurons in LX D, Aiii, and 
lamina VII E, Aiv. Vascular staining is visible, throughout the section (black arrowheads). Annotations: 
cc – central canal, d – dorsal, DF – dorsal funiculus, LF – lateral funiculus,  v – ventral, VF – ventral 
funiculus, VMF – ventral median fissure. Scale bars = 200µm, A; 50µm, B, C and D. 
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Figure 2.9. Schematic diagram of NADPH diaphorase activity in the mouse spinal cord at P10-12 taken 
from spinal segments lumbar (L)1-5. Ai-Ei. Approximate positions of positively stained neurons are 
indicated by black filled circles.  Each lumbar segment represents 5 transverse segments from 1 mouse 
and each filled circle represents one neuron. d and v indicate dorsal and ventral orientation. Diagrams are 
not to scale. Aii-Eii. Graphs showing the total number of positively stained neurons in LX, LVII, D and 
the total in LVII which include the SPN cells of the IML (TVII for L1-3 only). Data are mean ±SEM, 
n=6. 
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Figure 2.10. The spatiotemporal distribution of NADPH diaphorase reactive neurons in the lumbar spinal 
cord of the neonatal mouse from P1 – P12. The mean number of NADPH diaphorase reactive neurons in 
lumbar segments L1 to L5 of the A dorsal horn, B lamina X, C lamina VII and D IML of lamina VII (n=6 
per group; see Table 2.3 and 2.4 for significance). Data are mean ± SEM. 
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Figure 2.11. Transverse section taken at P3L5 demonstrates light NADPH diaphorase reactivity in 
lumbar spinal cord. A. Areas of light reactivity in the medial and lateral motor columns (lamina IX, 
position indicated by dashed circles). High magnification (x63) images show that this light reactivity is 
qualitatively different B, from typical somatic labelling as illustrated in D. Desaturated and inverted 
images highlight the qualitative difference in staining between soma/blood vessels and staining found 
around the soma C, D. Blood vessels are indicated by arrowheads. Annotations: cc – central canal, d – 
dorsal, DF – dorsal funiculus, LF – lateral funiculus, v – ventral, VF – ventral funiculus, VMF – ventral 
median fissure. Scale bars = 20μm, B, C and D. A not to scale. 
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Figure 2.12. Transverse section taken at P12L2 demonstrates NADPH diaphorase reactivity in SOD
WT
 
and SOD
G93A
 lamina VII intermediolateral layer. The pattern of reactivity in A, SOD
WT
 and B, SOD
G93A
 
tissue closely resembles that demonstrated previously in CD1WT. Discrete populations of neurons stain 
throughout the spinal cord section, including the vasculature. Blood vessels are indicated by black 
arrowheads. The pattern of NADPH diaphorase reactivity of neurons in the IML of Ai, SOD
WT
 differs 
from the IML of Bi, SOD
G93A
 where fewer neurons or an absence of staining was observed.  Annotations: 
cc – central canal, d – dorsal, DF – dorsal funiculus, LF – lateral funiculus, v – ventral, VF – ventral 
funiculus, VMF – ventral median fissure. Scale bars = 200µm, B, C and D. 
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Figure 2.13. The spatiotemporal distribution of NADPH diaphorase reactive neurons in the lumbar spinal 
cord of the juvenile SOD
WT
 and SOD
G93A
 mouse at P12. The mean number of NADPH diaphorase 
reactive neurons in lumbar segments L1 to L5 of the A dorsal horn, B lamina X, C lamina VII and D IML 
of lamina VII (n=6 per group). The total number of NADPH diaphorase reactive neurons was 
significantly lower in SOD
G93A
 when compared to SOD
WT
 (P<0.05, 2-way ANOVA). The number of 
NADPH diaphorase reactive neurons was significantly lower in L2 IML SOD
G93A
 when compared to L2 
IML SOD
WT
 (P<0.05, Mann-Whitney test). Data are mean ± SEM. 
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Table 2.1 Segmental and laminar distribution of NADPH diaphorase reactive neurons in each segment
1
 of the developing 
neonatal mouse lumbar spinal cord. 
Group Segment  Total ±SEM LVII ±SEM LVIII ±SEM LIX ±SEM LX ±SEM IML ±SEM D ±SEM 
1 L1 37.8 12.9 5.7 0.4 2.2 0.2 0.3 0.1 13.3 0.3 9.3 0.3 7.0 0.4 
1 L2 60.7 16.0 7.0 0.2 0.3 0.1 0.5 0.1 24.3 0.5 5.7 0.4 22.8 0.4 
1 L3 46.3 10.8 6.5 0.2 0.7 0.1 0.2 - 19.3 0.4 3.0 0.2 16.7 0.4 
1 L4 18.5 8.5 3.8 0.2 0.7 0.1 - - 7.0 0.3 - - 7.0 0.4 
1 L5  43.3 9.8 6.3 0.3 0.2 - - - 16.3 0.3 - - 20.5 0.6 
2 L1 49.7 21.3 9.7 0.5 1.5 0.2 1.0 0.1 18.8 0.7 3.5 0.4 15.2 0.8 
2 L2 76.8 19.1 15.7 0.4 1.3 0.1 0.3 - 22.8 0.3 2.7 0.2 34.0 0.8 
2 L3 58.5 13.3 10.8 0.3 1.0 0.1 - - 20.8 0.4 6.0 0.5 19.8 0.4 
2 L4 27.0 11.7 6.3 0.3 - - - - 8.7 0.4 - - 12.0 0.5 
2 L5  39.2 10.5 7.2 0.3 - - - - 16.3 0.4 - - 15.7 0.5 
3 L1 81.7 26.3 14.2 0.6 1.0 0.1 0.5 0.1 31.2 0.7 13.2 0.5 21.7 0.7 
3 L2 117.8 29.3 25.8 0.5 0.7 0.1 - - 36.2 0.7 20.7 0.6 34.5 0.6 
3 L3 61.3 13.9 16.8 0.4 - - - - 18.5 0.3 2.7 0.3 23.3 0.5 
3 L4 52.7 12.6 12.8 0.5 - - - - 19.3 0.4 - - 20.5 0.5 
3 L5  51.2 10.7 13.8 0.4 - - 0.2 - 18.2 0.4 - - 19.0 0.6 
4 L1 144.5 29.6 26.7 0.5 4.2 0.2 0.7 0.1 28.5 0.5 13.8 0.4 70.7 1.0 
4 L2 95.8 18.4 19.0 0.5 - - - - 24.2 0.3 5.2 0.3 47.5 0.6 
4 L3 112.5 26.0 30.7 0.7 0.5 0.1 0.2 - 17.7 0.3 0.8 0.1 62.7 1.1 
4 L4 82.5 15.8 17.5 0.5 - - 0.2 - 12.5 0.3 0.2 - 52.2 0.9 
4 L5  104.0 24.0 14.3 0.5 - - - - 18.5 0.4 - - 71.2 1.1 
1 Calculated as the average number of NADPH diaphorase reactive neurons in a lamina in 5 sections taken from one segment. 
Each segment is an average of 6 mice. Data mean ± SEM. 
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Table 2.2 Percentage
1
 laminar distribution of NADPH diaphorase reactive neurons in each segment of the neonatal 
mouse lumbar spinal cord. 
Group Segment LVII ±SEM LVIII ±SEM LIX ±SEM LX ±SEM IML ±SEM D ±SEM 
1 L1 15.0 3.1 5.7 1.6 0.9 0.8 35.2 2.3 24.7 2.3 18.5 3.1 
1 L2 11.5 1.3 0.5 0.6 0.8 0.6 40.1 3.1 9.3 2.5 37.6 2.5 
1 L3 14.0 1.9 1.4 0.9 0.4 - 41.7 3.7 6.5 1.9 36.0 3.7 
1 L4 20.7 2.4 3.6 1.2 - - 37.8 3.5 - - 37.8 4.7 
1 L5 14.6 3.1 0.4 - - - 37.7 3.1 - - 47.3 6.1 
2 L1 19.5 2.3 3.0 0.9 2.0 0.5 37.9 3.3 7.0 1.9 30.5 3.8 
2 L2 20.4 2.1 1.7 0.5 0.4 - 29.7 1.6 3.5 1.0 44.3 4.2 
2 L3 18.5 2.3 1.7 0.8 - - 35.6 3.0 10.3 3.8 33.9 3.0 
2 L4 23.5 2.6 - - - - 32.1 3.4 - - 44.4 4.3 
2 L5 18.3 2.9 - - - - 41.7 3.8 - - 40.0 4.8 
3 L1 17.3 2.1 1.2 0.4 0.6 0.4 38.2 2.5 16.1 1.8 26.5 2.5 
3 L2 21.9 1.7 0.6 0.3 - - 30.7 2.4 17.5 2.0 29.3 2.0 
3 L3 27.4 2.9 - - - - 30.2 2.2 4.3 2.2 38.0 3.6 
3 L4 24.4 4.0 - - - - 36.7 3.2 - - 38.9 4.0 
3 L5 27.0 3.7 - - 0.3 - 35.5 3.7 - - 37.1 5.6 
4 L1 18.5 1.7 2.9 0.7 0.5 0.3 19.7 1.7 9.6 1.4 48.9 3.4 
4 L2 19.8 2.7 - - - - 25.2 1.6 5.4 1.6 49.6 3.3 
4 L3 27.3 2.7 0.4 0.4 0.1 - 15.7 1.2 0.7 0.4 55.7 4.2 
4 L4 21.2 3.2 - - 0.2 - 15.2 1.9 0.2 - 63.2 5.7 
4 L5 14 2 - - - - 18 2 - - 68 5 
1 
Percentage distribution calculated as the average number of NADPH diaphorase reactive neurons in a lamina divided 
by the average total number of reactive neurons in that segment. Data mean ± SEM 
 
 
Chapter 2 
68 
 
Table 2.3 summary matrix for statistical comparison
1   
of the 
main reactive lamina by segment. 
Group Segment  LVII vs. LX LVII vs. D LX vs. D 
1 L1 **** ns **** 
1 L2 **** **** ns 
1 L3 **** **** **** 
1 L4 **** **** ns 
1 L5  **** **** **** 
2 L1 **** **** **** 
2 L2 **** **** **** 
2 L3 **** **** ns 
2 L4 * **** *** 
2 L5  **** **** ns 
3 L1 **** **** **** 
3 L2 **** **** ns 
3 L3 ns **** **** 
3 L4 **** **** ns 
3 L5  **** **** ns 
4 L1 ns **** **** 
4 L2 **** **** **** 
4 L3 **** **** **** 
4 L4 **** **** **** 
4 L5  *** **** **** 
1 
Two-way ANOVA followed by Bonferroni Multiple 
comparison post-test  
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Table 2.4  Summary matrix for statistical comparison
1
 of the main reactive lamina by group 
Segment Lamina Gp1 vs. Gp2 Gp1 vs. Gp3 Gp1 vs. Gp4 Gp2 vs. Gp3 Gp2 vs. Gp4 Gp3 vs. Gp4 
L1 X  **** **** **** **** **** ns 
L1 VII  *** **** **** *** **** **** 
L1 IML **** *** **** **** **** ns 
L1 Dorsal **** **** **** **** **** **** 
L2 X  ns **** ns **** ns **** 
L2 VII  **** **** **** **** ** **** 
L2 IML ** **** ns **** ns **** 
L2 Dorsal **** **** **** ns **** **** 
L3 X  **** ns ns **** **** ns 
L3 VII  **** **** **** *** **** **** 
L3 IML *** ns * *** **** * 
L3 Dorsal **** **** **** ns **** **** 
L4 X  * **** **** **** **** **** 
L4 VII  * **** **** **** **** **** 
L4 IML n/a n/a n/a n/a n/a n/a 
L4 Dorsal **** **** **** **** **** **** 
L5  X  ns * **** * **** ns 
L5  VII  ns **** **** **** **** ns 
L5  IML n/a n/a n/a n/a n/a n/a 
L5  Dorsal **** * **** **** **** **** 
1 
Two-way ANOVA followed by Bonferroni Multiple comparison post-test  
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Table 2.5.  Segmental and laminar distribution of NADPH diaphorase reactive neurons in each segment
1
 of the SOD1WT and SOD
G93A
 
mouse lumbar spinal cord 
Group Segment Total  ±SEM LVII ±SEM LVIII ±SEM LIX ±SEM LX ±SEM IML ±SEM D ±SEM 
SOD L1 111 19.2 23 0.6 0 0.2 - - 27 0.5 9 0.5 53 1.1 
SOD L2 88 14.9 22 0.5 - - - - 17 0.3 1 0.0 49 1.0 
SOD L3 74 13.4 17 0.5 1 0.0 - - 12 0.4 - - 45 0.9 
SOD L4 100 20.5 19 0.7 - - - - 19 0.5 - - 62 1.4 
SOD L5 107 16.5 11 0.5 1 0.0 - - 17 0.3 - - 78 1.4 
WT L1 147 26.7 30 0.6 2 0.3 0 0.1 31 0.9 15 0.7 68 1.0 
WT L2 149 56.0 26 0.7 2 0.0 - - 27 0.7 16 0.8 79 2.3 
WT L3 81 12.4 18 0.4 - - - - 15 0.5 - - 46 1.1 
WT L4 93 22.0 14 0.6 - - - - 17 0.3 - - 62 1.5 
WT L5 109 15.1 9 0.4 1 0.5 - - 23 0.5 - - 76 1.5 
1
 Calculated as the average number of NADPH diaphorase reactive neurons in a lamina in 5 sections taken from one segment. Each segment is 
an average of 6 mice. Data mean ± SEM. 
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Table 2.6. Percentage
1
 laminar distribution of NADPH diaphorase reactive neurons in each segment of the SOD1WT and 
SOD
G93A
 mouse lumbar spinal cord 
Group Segment LVII ±SEM LVIII ±SEM LIX ±SEM LX ±SEM IML ±SEM D ±SEM 
SOD L1 20.7 3.1 0.0 1.0 - - 23.8 2.4 7.9 2.5 47.4 5.7 
SOD L2 24.9 3.4 - 
 
- - 18.7 2.0 1.4 0.0 55.0 6.8 
SOD L3 23.0 3.5 0.7 0.0 - - 15.9 2.8 - - 60.5 6.7 
SOD L4 19.0 3.2 - - - - 18.8 2.4 - - 62.2 7.0 
SOD L5 10.1 3.3 0.7 0.0 - - 16.0 2.0 - - 73.2 8.6 
WT L1 20.5 2.3 1.4 1.0 0.2 - 20.9 3.2 10.5 2.7 46.6 3.6 
WT L2 17.2 1.2 1.0 0.0 - - 17.8 1.2 10.8 1.4 53.2 4.1 
WT L3 22.3 3.4 - - - - 19.0 3.8 - - 57.4 8.5 
WT L4 15.4 2.7 - - - - 18.3 1.6 - - 66.3 6.7 
WT L5 8.3 2.5 0.9 3.3 - - 21.4 3.6 - - 69.4 9.9 
1 
Percentage distribution calculated as the average number of NADPH diaphorase reactive neurons in a lamina divided by 
the average total number of reactive neurons in that segment. 
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2.4 Discussion  
 
NOS is a NADPH diaphorase enzyme, requiring NADPH to reduce L-arginine by a 
series of electron transfers to produce L-citrulline and NO (Hope et al., 1991). 
Diaphorase reactivity is formaldehyde-resistant and therefore ideal for post-fixation 
studies of spinal tissue. Substitution of L-arginine by a tetrazolium salt leads to the 
irreversible conversion of the substrate to a visible blue formazan. The reaction is non-
specific, and thus all isoforms of the enzyme will exhibit reactivity, notably in the 
vasculature. In this chapter, the distribution of NO producing neurons is described in the 
CD1 wild-type mouse lumbar spinal cord over the postnatal period P1-P12 using the 
NADPH diaphorase histochemical reaction. The present study not only describes the 
distribution of NADPH diaphorase in the lumbar spinal cord of the neonatal mouse but 
also describes this distribution in higher temporal resolution than any of the 
aforementioned investigations. Additionally, in the present study, the distribution of NO 
producing (NADPH diaphorase reactive) neurons was described in the lumbar spinal 
cord of the SOD1
G93A
 mouse model of human ALS at P12.  
 
 
2.4.1 Spatiotemporal distribution of NADPH diaphorase reactivity in the CD1 
WT 
 
The distribution of NADPH diaphorase has been described previously in the spinal cord 
of the tadpole (McLean and Sillar, 2001, Ramanathan et al., 2006), mouse, cat, and 
squirrel monkey (Dun et al., 1993, Spike et al., 1993, Valtschanoff et al., 1992), rabbit 
(Schreiberová et al., 2006) and embryonic human (Foster and Phelps, 2000). Although 
NADPH diaphorase reactivity has been described in the hatchling tadpole, adult 
mammal and embryonic human, no such investigation has been conducted in the lumbar 
spinal cord of the neonatal mouse. 
 
NADPH reactivity in the present study closely resembled that detailed in other studies 
with the majority of reactivity occurring in the dorsal horn, where NO signalling is 
involved in activity-dependent sensory processing in the dorsal horn (Maihofner et al., 
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2000, Xu et al., 2006). However, the role of NADPH diaphorase reactive neurons in the 
ventral horn is less clear. The present study describes the distribution of NADPH 
diaphorase reactivity in the lumbar spinal cord to assess the possibility that NO may 
regulate, directly by autocrine or indirectly by paracrine mechanisms, the neurons in the 
locomotor network.  
 
NADPH diaphorase reactivity was recorded in discrete areas of the ventral horn: lamina 
VII clustered in the IML and scattered across wider lamina VII; lamina X, around the 
central canal; and in very small numbers in laminae VIII and IX. Light staining was 
observed, predominantly in lamina IX, in the vicinity of the motor nuclei, but was not 
included in the tally of reactive neurons. Similarly, light staining has previously been 
observed in a preliminary investigation of NADPH diaphorase reactivity in L3-L5 
(Collett, 2007). 
 
Over the developmental period P1 to P12, the total number of NADPH diaphorase 
reactive neurons increased significantly in the lumbar spinal cord. Overall, the dorsal 
horn exhibited the largest population of reactive neurons, both by segment and by 
group. As the neuronal population in the dorsal horn is involved in sensory processing, 
and therefore outside the remit of the present study, the dorsal horn laminae were not 
individually described. However, the distribution of NADPH diaphorase in the present 
study was similar to that described in a previous study involving NADPH diaphorase 
producing neurons in the dorsal horn (Xu et al., 2006). 
 
The NADPH diaphorase reactive neurons in lamina VII increased during development 
from P1 to P12, particularly in the rostral segments (L1 to L3). The number of NADPH 
diaphorase reactive neurons peaked in the rostral segments, particularly L2, of Group 3. 
The reason for this peak in the population in Group 3 is not clear from the anatomy 
alone. However, mice become functionally motor-mature around P8-P10 (Jiang et al., 
1999) and it is possible that NOS expression and NO production are involved in 
maturation of the network in the days before the ability to bear weight and walk 
(anterior surface raised above ground) fully develops. NO is also expressed transiently 
during development but a definitive reason for transient expression is not always clear; 
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for instance, a small group of presumed somatic motor neurons in the cervical spinal 
cord, the location of the forelimb locomotor network, are transiently NADPH 
diaphorase positive in the embryonic rat (E15) spinal cord (Wetts et al., 1995). The peak 
in NOS expression in the present study, during a developmentally relevant period, 
warrants further investigation and would be an ideal time point at which to perform 
whole cell physiology to determine the effect of removal of endogenous NO on 
locomotor-related interneurons and the function of the whole locomotor circuit. 
 
The rostral segments of the lumbar neonatal mouse spinal cord have greater 
rhythmogenic capacity compared to the more caudal segments (Bonnot et al., 2002b). 
The finding that expression of NOS is greater in the rostral segments, particularly prior 
to the most locomotor-relevant developmental stage, warrants further investigation to 
determine if NO is involved in locomotor network maturation and function. NADPH 
diaphorase reactive neurons in lamina X were more populous in the rostral segments 
(L1 to L3) as opposed to the caudal segments (L4 and L5). Lamina X neurons remained 
a consistent proportion of the total NADPH diaphorase reactive neurons in the lumbar 
spinal cord, except at P12 when the dorsal horn reactive population was highest. The 
consistent expression of NOS in neural populations within the sphere of influence of the 
locomotor-related interneurons increases the likelihood that NO may modulate the local 
CPG network.  
 
Although it is not possible to visually identify locomotor-related interneurons in the 
present study, it is possible to speculate about which interneuron populations may 
produce (or at least are situated within the sphere of influence of) cells producing NO.  
Transcription factor-led identification of locomotor interneurons has provided a clearer 
connectivity pattern within the locomotor network by allowing the expression of 
fluorescent markers in selected neuronal subgroup and thus allowing selective and 
targeted study of their properties and connection patterns (Jessell, 2000, Goulding, 
2009). A subset of interneurons, in laminae X, VII and VIII, are NOS positive but are 
not involved in cholinergic transmission to motor neurons (Miles et al., 2007). It is 
possible that Hb9 interneurons, involved in the maintenance of locomotor output, may 
themselves be modulated by NO or produce NO that modulates the output of motor 
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neurons (Brownstone and Wilson, 2008). Similarly, NO producing neurons in wider 
lamina VII, as well as those in the IML, could act as producers of paracrine NO, 
modulating neurons in the near vicinity.  
 
Other neurons that could express NOS, or that could be affected by neurons in the 
vicinity which produce NO, include the V2b (Gata2/3) inhibitory interneurons that are 
located in lamina VII along with the V1 derived inhibitory Renshaw cells and Ia 
inhibitory interneurons (Alvarez and Fyffe, 2007). V0 (Dbx1) inhibitory interneurons 
are located in lamina VIII and are essential for normal alternating locomotion n 
(Lanuza et al., 2004). The scarcity of NADPH diaphorase reactive neurons in lamina 
VIII does not discount potential modulation of these interneurons by NO as they are 
located within the sphere of influence of NO-producing populations near the central 
canal and in lamina VII. 
 
The sympathetic preganglionic autonomic neurons (SPN) are located in the IML and are 
known to integrate descending autonomic signals. Although these neurons are not 
directly involved in hind limb locomotor output, they are within signalling distance of 
the locomotor interneurons and, therefore, NO produced by the SPN could potentially 
affect locomotor output (Heise, 2004). 
 
Although NADPH diaphorase histochemical reactivity in this study does not directly 
prove NO regulation of locomotor-related neurons, its presence implies that an active 
role in locomotion is possible, given the location of NOS positive neurons in the ventral 
horn amongst the locomotor-related interneurons and motor neuron nuclei. These data 
confirm the potential for NO to modulate a wide range of neurons involved in 
locomotor activity and further validate the aims of the present study to investigate the 
modulatory effects of NO on fictive locomotor output.  
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2.4.2 Distribution of NADPH diaphorase reactivity in the SOD1G93Amouse model 
of human ALS 
 
The distribution of NO-producing neurons was described in the lumbar spinal cord of 
the mouse model of human ALS SOD1
G93A
 and SOD1 wild-type littermates at P12. 
ALS is a fatal neurodegenerative disease leading to the loss of somatic motor neurons. 
Although mutations in the SOD1 gene are found consistently in FALS, the effect of 
SOD1 mutation on disease onset and progression is not known. The SOD1
G93A
 
transgenic mouse expresses the human mutant form of the SOD1 gene and develops 
ALS-like symptoms, which are widely accepted to follow the course of human ALS 
(Van Den Bosch, 2011). It is thought that the SOD1 mutation leads to a toxic gain of 
function and that disease progression is multifactorial, including aberrant excitatory 
transmission, oxidative stress and mitochondrial malfunction (Barber and Shaw, 2007, 
Boillee et al., 2006). Electrophysiological data have provided direct evidence of 
intrinsic changes to motor neuron excitability in early SOD1
G93A
development (Jiang et 
al., 2009, Kuo et al., 2004, Kuo et al., 2005, Pambo-Pambo et al., 2009, van Zundert et 
al., 2008). However, few anatomical studies have been carried out at early postnatal 
stages, as the focus remains on mostly pre -, early onset, late onset and end stage/post-
mortem stages of the disease. Whether NO plays a role in ALS development is not 
known.  
 
In the present study, the pattern of NADPH diaphorase reactivity in the SOD1
G93A
 and 
SOD1 wild-type lumbar spinal cord of littermates at P12 was similar to that shown in 
other species and closely resembled the distribution pattern in CD1 WT mice. 
Reactivity was recorded in the ventral horn; lamina VII in the IML and wider lamina 
VII; lamina X, around the central canal; and occasionally in laminae VIII and IX. Light 
staining was observed in lamina IX, in the vicinity of the motor nuclei, but again was 
not included in the tally of reactive neurons. The majority of reactive neurons were 
located in the dorsal horn, with bias towards the rostral segments. Similarly, the pattern 
and number of reactive neurons closely resembled that of the CD1 WT in both 
SOD1
G93A
 and SOD1 wild type, with the majority of reactive neurons in laminae VII 
and X located in the rostral segment. However, the reactive neuron population in the 
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IML of lamina VII was considerably diminished in the SOD1
G93A
 compared to the 
SOD1 wild type. 
 
During the symptomatic stage of ALS, the loss of integrity in blood vessel endothelium 
in the spinal cord has been detected in SOD1
G93A
 mice, resulting in hemosiderin 
deposits near motor neurons and possibly contributing to their deaths (Zhong et al., 
2008). Loss of neurons in the IML has been demonstrated in the thoracic segments (T2 
to T9) in a study at the end-stage of the disease when some ALS patients require 
artificial ventilation (Iwanaga et al., 1997). Furthermore, aberrant sympathetic 
hyperactivity has been reported during symptomatic ALS (Oey et al., 2002). A 
reduction in nitrergic transmission resulting from the loss of NOS production could 
explain a reduction in resting vagal tone. However, the studies of the SPN and 
sympathetic outflow are largely centred on the thoracic spinal cord. In the absence of 
detailed information about changes to the NOS positive neurons in the lumbar IML 
during ALS, it is not clear what contribution to these effects is mediated by the loss or 
presence of NO.  
 
The reason for this dramatic difference between NOS expression in the IML of SOD1
WT
 
and SOD1
G93A
 mice is unprecedented. It is not clear whether NOS is no longer 
expressed or whether the absence of reactivity signals the loss of neurons altogether and 
this finding merits further study. 
 
 
2.5 Conclusion 
 
These results show that there are discrete sources of NO in the mammalian lumbar 
spinal cord. During the first twelve postnatal days, the number of NO-producing 
neurons increased and peaked between P7-P9, the period preceding hind limb network 
maturation. It is feasible that NO is involved in locomotor network activity, given the 
proximity of NADPH diaphorase neurons to the laminae in which locomotor related 
interneurons are located.  
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Defining the transcription factor and neurotransmitter phenotype of the NOS-positive 
neurons will give clearer indications of the nature of NO-mediated signalling; that is, 
whether it is involved in reciprocal or ipsilateral, excitation or inhibition. Additional 
studies in thick slice (~100μm) and/or longitudinal section will provide further detail of 
projection patterns not visible in the thin slices used in this study.  
 
For the first time, a reduction in the number of sympathetic preganglionic neurons has 
been recorded at P12 in the mouse model of human ALS, SOD1
G93A
, but not SOD1
WT
 
wild type littermates. It is not immediately clear whether this has any direct bearing on 
locomotor function or is related purely to autonomic transmission. Additional study and 
verification of this result by increasing the range and sample size will confirm the 
significance of the reduction observed in these experiments. Whole cord physiology in 
the SOD1
G93A 
mice using inhibitors and donors of NO may also reveal the implications 
(if any) of a potential deficit in NO production.  
 
In this chapter I have established the presence of NO-producing neurons in the mouse 
lumbar spinal cord. A logical extension to these results is to manipulate the levels of 
NO during fictive locomotion to define an active role for NO in the locomotor network. 
To this aim, the following chapter describes the results obtained from the manipulation 
of NO levels during lumbar locomotor network activity.     
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Chapter 3: Nitric oxide-mediated modulation of locomotor–rhythm 
generating networks in the isolated in vitro neonatal mouse spinal cord 
 
3.1 Introduction 
 
3.1.1 Background 
 
The isolated spinal cord retains the capacity to generate a variety of spontaneous and/or 
rhythmic coordinated locomotor behaviours, such as swimming, scratching, and 
walking. These movements are modulated in a variety of natural environmental 
circumstances, for example, during the transition from a walk to a gallop or to generate 
escape swimming in response to stress.  
 
In 1911, Thomas Graham Brown showed that the spinal cord contains sufficient 
circuitry to generate and maintain locomotion in the absence of supraspinal and sensory 
inputs. In this pivotal study, he postulated that proprioceptive inputs have a regulatory 
and not an intrinsic role in movement, that movement produced in the absence of 
afferents shared great similarity with movement when afferents remained intact, and 
that “The rhythmic sequence of the act of progression is consequently determined by 
phasic changes innate in the local centre” (Brown, 1914, Brown, 1911). Brown also 
proposed the half-centre model to describe the organisation of the ‘innate local centres’ 
within the spinal cord, now known as CPGs (Grillner, 2011), which control locomotion.  
In the half-centre model, each half-centre consists of excitatory interneurons that 
innervate motor neurons controlling flexor and extensor muscles, or muscles of the left 
and right sides of the body, which are innervated by roots originating from the same 
spinal segment e.g. L2 ipsilateral and contralateral roots. The excitatory interneurons 
within the two half-centres are prevented from synchronous activation by inhibitory 
interneurons (Renshaw, commissural or other ipsilateral inhibitory interneuron 
populations) in a process termed reciprocal inhibition. This synaptic organisation leads 
to an alternating pattern of output from motor neurons equivalent to that seen in the 
intact animal. However, this simple half-centre model does not account for the wide 
range of precisely controlled movements generated by the spinal cord, and thus, the 
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modified half-centre model, that accommodates increasing levels of excitatory and 
inhibitory sets of interneurons, currently dominates the theoretical debate on the control 
of locomotion (McCrea and Rybak, 2008). The two-layer half-centre model involves, 
firstly, the rhythm generator (RG) that is responsible for the timing of locomotor output, 
analogous to a pacemaker or clock. It is multiple orders above the last order 
interneurons that synapse directly onto motor neurons. The second layer of this model is 
the pattern generator (PG), consisting of last order interneurons, that synapse directly 
onto motor neurons, relaying intensity and temporal signals from the RG/rest of the 
network (McCrea and Rybak, 2008, Kiehn, 2011). The location and identity of the RG 
neurons remains a matter of great debate and research. In experiments where 
pharmacological or electrical stimulation perturbs the output from the in vitro locomotor 
network, effects on the output and thus the RG and PG can be inferred. 
 
 
3.1.2 Modulation of rhythmic locomotor activity 
 
In the absence of descending innervation, activation of the spinal locomotor network 
can be initiated by electrical stimulation, amines such as 5HT/DA (Christie and Whelan, 
2005), combinations of N-Methyl-D-aspartic acid (NMDA), 5HT and dopamine (DA) 
(Beato et al., 1997, Bonnot et al., 2002a, Cazalets et al., 1992, Jiang et al., 1999, Whelan 
et al., 2000), as well as a wide range of endogenously produced peptides (Barriere et al., 
2005). A rostrocaudal gradient exists in the hind-limb spinal cord circuitry, with greater 
rhythmogenic capacity located within the rostral (L1 – 3) than in the more caudal (L4 – 
6) segments of the lumbar spinal cord (Chapter 1). Rhythmic locomotor activity is 
known to be modulated by activation of metabotropic G-protein-coupled receptors and 
biogenic amines (LeBeau et al., 2005). A relatively recent addition to this list of 
modulators is NO. 
 
The role of NO as a neuromodulator of spinal locomotor networks has been established 
in vertebrate models of locomotion. In Xenopus laevis tadpoles, NO potentiates 
glycinergic mid-cycle inhibition and increases the frequency of GABAergic IPSPs 
(inhibitory postsynaptic potential), reducing swim episode duration and increasing cycle 
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period (McLean and Sillar, 2000, McLean and Sillar, 2002). In addition to this evidence 
of a direct inhibitory action, it has also been shown that NO modulation of 
noradrenaline release increases mid-cycle inhibition, slowing tadpole swimming 
frequency (McLean and Sillar, 2004). These inhibitory effects appear to be species 
specific as NO has the opposite, excitatory effect in Rana temporaria embryos (McLean 
et al., 2001) and in the lamprey (Kyriakatos et al., 2009). 
 
In the adult lamprey Lampetra fluviatilis/Petromyzon marinus, mGluR1 activation 
during locomotion recruits both NO and endocannabinoid pathways (Kyriakatos and El 
Manira, 2007). An NO-dependent increase and long term potentiation of locomotor 
burst frequency occur as a result of a decrease in presynaptic release of glycine and, 
therefore, mid-cycle inhibition (Kyriakatos et al., 2009).  
 
The distribution of neurons that express NOS in the locale of the locomotor circuitry, 
and therefore potentially represent the source of neuromodulatory NO, has been shown 
using immunohistochemistry and NADPH diaphorase activity in the tadpole and 
lamprey. In the tadpole, a population of reticulospinal neurons and their processes 
exhibit NADPH diaphorase reactivity and are potentially involved in modulation of 
descending locomotor commands (McLean and Sillar, 2001). Whilst NADPH 
diaphorase reactivity is largely absent from tadpole motor neurons, motor neurons in the 
lamprey express NOS, and both tadpole and lamprey motor neurons are modulated by 
NO (Kyriakatos et al., 2009, Ramanathan et al., 2006). In the present study, I have 
already described NADPH diaphorase reactivity in the ventral horn of the mouse spinal 
cord (Chapter 2) and shown that although NO reactivity is absent from the motor pools 
there are sources of NO within the sphere of influence of the motor pools. These NOS 
positive neurons increase in number during postnatal development and may be a source 
of NO involved in the modulation of locomotor activity. 
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3.1.3 Nitric oxide production and signalling pathways  
 
Since the initial discovery that NO is endothelial-derived relaxating factor, the role of 
NO as a neurotransmitter and morphogen has been well established in a range of organs 
of both vertebrates and invertebrates. Three isoforms of the NO synthetic enzyme NOS 
are located throughout the CNS and both eNOS and nNOS are constitutively expressed 
(Knowles and Moncada, 1994). The primary cellular target for NO is the soluble form 
of guanylate cyclase (sGC), which catalyses the production of cyclic guanosine 
monophosphate (cGMP) from guanosine triphosphate (GTP) (Bellamy et al., 2002, 
Cary et al., 2006, Fernhoff et al., 2009, Zhao et al., 2000). cGMP then goes on to 
activate the protein kinase G signalling cascade (PKG) which is involved in a number of 
downstream effects, such as phosphorylation and protein synthesis (Wang and 
Robinson, 1997). cGMP can also directly activate cyclic nucleotide gated ion channels 
(CNGC) such as the HCN channels in the hippocampus (Wilson and Garthwaite, 2010, 
Neitz et al., 2011). In addition to signalling via cGMP-dependent pathways, NO 
signalling can also be mediated via highly reactive NO-derived radical products, such as 
peroxynitrite, which are formed by nitrosative and oxidative mechanisms and can react 
with lipids and proteins. Such reactions typically involve the addition of a nitroso (-NO) 
functional group to proteins, particularly thiols of cysteine residues (i.e. -SH) by a 
process termed s-nitrosation (Stamler et al., 1992{Jaffrey, 2001 #220)}. It has been 
theorized that direct effects of NO (such as sGC activation) occur at low, physiological 
concentrations, whilst indirect radical reactions (nitrosative/oxidative stress) occur at 
high pathophysiological concentrations of NO, particularly when iNOS is activated 
(Redford et al., 1997, Smith et al., 2001, Hofseth et al., 2003, Duncan and Heales, 2005) 
.  
 
 
3.1.4 Scope and importance of this study 
 
Despite clear evidence of the importance of NO-mediated signalling in the control of 
the locomotor CPG in tadpole and lamprey swim circuits; the role of NO-mediated 
signalling in the mammalian locomotor CPG has yet to be investigated. Studies in the 
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mammalian respiratory network suggest NO is involved in activity-dependent 
modulation in concert with other neurotransmitters (Saywell et al., 2010). In light of this 
evidence, a role for NO in the control of mammalian hind limb lumbar spinal circuitry is 
likely. In the present study, sources of NO have been described in the developing 
mammalian lumbar spinal cord. The NO producing neurons are located in close 
proximity to the neurons involved in coordinating movement, around the central canal 
(lamina X) and the wider lamina VII, and thus, may potentially modulate locomotor 
output.  
 
This chapter details the investigation of the role of NO in the mammalian locomotor 
circuit and the possible contribution of the NO/sGC/cGMP pathway to its effects, using 
pharmacologically induced fictive locomotion in the isolated spinal cord (Jiang et al., 
1999) and the disinhibited isolated spinal cord preparation (Bracci et al., 1996). This 
involved manipulation of induced fictive locomotion by application of NO donors and 
the inhibition or removal of endogenous sources of NO, as well as modulators of the 
NO/sGC pathway.  
 
These results represent the first investigation into the possibility that NO is involved in 
the modulation of mammalian locomotion. Identifying and clarifying a role for NO in 
mammalian locomotion will enhance our basic understanding of the functional circuitry 
involved in the generation and maintenance of movement, and consequently provide 
additional knowledge for consideration in dysfunctional and damaged circuits as a result 
of spinal cord trauma and neurodegenerative disease. 
 
 
3.2 Materials and Methods 
 
3.2.1 Tissue collection and preparation   
 
All experiments were performed in accordance with the United Kingdom Animals 
(Scientific Procedures) Act 1986. C57BL6 wild-type mice were obtained from Charles 
River Laboratories (Scotland, UK).  The mice were bred under conditions of a 12-h 
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light/dark cycle in individual ventilated cages at a constant temperature of 22°C and 
56% humidity with free unrestricted access to food and water. Following cervical 
dislocation, decapitation, evisceration and vertebrectomy, spinal cord tissue from mid 
cervical to upper sacral region was isolated in a chamber containing artificial cerebral 
spinal fluid (aCSF; equilibrated with 95% oxygen, 5% carbon dioxide, ~4ºC). All 
procedures were carried out at room temperature (RT) (18-22°C). Neonatal mice aged 
postnatal day (P) 1-3 were used for the experiments detailed in this chapter.  
 
Spinal cords were isolated from the mid-thoracic to mid-sacral regions and fixed with 
fine steel pins, ventral side up, to a sylgard-lined dissection chamber containing 
artificial cerebral spinal fluid (aCSF) equilibrated with 95% O2/5% CO2 (Jiang et al., 
1999, Miles et al., 2007, Iwagaki and Miles, 2011). The pia mater was removed and the 
dorsal roots trimmed before the cord was moved to the recording chamber; a sylgard-
lined custom-built Perspex chamber perfused with aCSF (equilibrated with 95% O2/5% 
CO2) at a rate of between 5-8 mL min
-1
. The spinal cord was again fixed ventral surface 
up with fine steel pins. 
 
 
3.2.2 Induction and recording of fictive rhythmic locomotion 
 
Fictive rhythmic locomotion is characterised by rhythmic bursts of locomotor-related 
output which alternate between pairs of ventral roots originating from the same lumbar 
segment i.e. left-hand side/right-hand side (L/R) L2 (Fig. 3.2A, B rL2/lL2 and r∫L2/ 
l∫L2). Bursts of locomotor-related output also alternate between ipsilateral ventral roots 
which predominantly innervate flexor and extensor roots i.e. RHS L2/L5 (Fig.3.2A, B 
rL2/rL5 and r∫L2/r∫L5). The ventral root activity recorded at L2 is consistent with hind-
limb flexor activity and activity recorded at L5 is consistent with hind-limb extensor 
activity as previously described (Kjaerulff and Kiehn, 1996, Bonnot et al., 2002b).  
 
L/R ventral root activity was recorded by placing glass suction electrodes over L1, L2 
or L3 roots (see Fig.3.2A, solid blue electrode). In experiments where flexor/extensor 
ventral root activity was compared, a third glass suction electrode was placed over an 
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ipsilateral L5 root (see Fig.3.2A, dotted blue electrode). Signals were amplified, filtered 
(30-3000Hz) and raw signals rectified and integrated (Qjin Design, ON, Canada). Raw 
and integrated signals were acquired at 1kHz using a Digidata 1440A A/D board and 
AxoScope software (version 7.0, Molecular Devices, Sunnyvale, CA). 
  
Locomotor output (see Fig. 3.2B) was induced by bath application via the perfusate of 
5µM N-methyl-d-aspartate (NMDA) and 10µM 5-hydroxytryptamine hydrochloride 
(5HT) and the pattern of alternating rhythmic output was allowed to develop for 
between 50-60 minutes on average before the addition of pharmacological agents used 
to investigate the roles of NO-mediated signalling in the control of locomotor output. 
Pharmacological agents affecting NO-mediated signalling were applied for 30 or 45 
minutes after which time they were removed by gradual elimination from the perfusate. 
Pharmacologically induced fictive locomotion (5HT and NMDA) varied in frequency 
between 0.22 and 0.39Hz across different preparations (Fig. 3.1). Disinhibited fictive 
locomotion was induced by applying 10μM 5HT and 5μM NMDA in combination with 
1μM strychnine and 10μM bicuculline. Disinhibited fictive locomotor activity was 
characterised by synchronous bursts of activity across all ventral roots. The disinhibited 
rhythm was much slower than the rhythm observed when inhibition remained intact, 
with frequencies varying between 0.09 and 0.07Hz (Fig. 3.1). 
 
Recordings were defined as control condition when fictive rhythmic output was induced 
using 5HT and NMDA only (see Fig. 3.2A and B, Fig. 3.3A and B, control), except in 
the disinhibited preparation (see Fig. 3.6A and B, control) where the control solution 
contained strychnine and bicuculline in addition to 5HT and NMDA. Drug condition 
designates rhythmic output during the addition of pharmacological agents to the 
perfusate (for example see Fig. 3.3A and B, DEA NO) for a period of 30 or 45 minutes. 
Drug condition perfusate was systematically replaced by control solution containing 
5HT and NMDA only, except in the disinhibited preparation (see Fig. 3.6A and B, 
washout) where the control solution also contained strychnine and bicuculline, and this 
was designated as wash or washout.  
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3.2.3 Analysis 
 
Data (raw for amplitude, and integrated and smoothed for temporal) were analysed 
offline using Dataview software (version 6.3.2. courtesy of Dr W J Heitler, University 
of St Andrews).  
The in vitro rhythmic preparation provides several quantitative parameters for analysis 
(see Fig. 3.1D). Those relevant to this study are: 
 
Frequency – the onset-to-onset frequency of burst output from nerve roots, interpreted 
as the temporal signal received by motor neurons from the locomotor network CPG 
and/or its components (see Fig. 3.2Di); 
 
Amplitude – the peak-to-peak burst amplitude from nerve roots, interpreted as the 
output from motor neurons transmitted via the nerve root to the effector muscle (see 
Fig. 3.2D ii); 
 
Inter-burst amplitude – the mean inter-burst amplitude from nerve roots, interpreted as 
tonic, non-synchronous motor neuron activity (see Fig.3.2D iii); 
 
Left/right and extensor/flexor alternation – the timing (phase) of burst onset between 
left/right ventral roots originating from the same segment (e.g. LHS/RHS L2) and 
between ipsilateral, flexor/extensor roots (e.g. RHS L2/L5; Fig.3.2D iv and v 
respectively; Section 3.2.2). 
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Figure 3.1. Frequency distribution of the frequency of pharmacologically induced fictive locomotion. 
Fictive locomotion was induced using 5µM NMDA and 10µM 5HT. Alternating rhythmic output was 
established over 50 – 60 minutes before recording output. Fictive locomotor output varied in frequency 
between 0.22 and 0.39Hz across different preparations. Disinhibited fictive locomotion was induced using 
10μM 5HT and 5μM NMDA in combination with 1μM strychnine and 10μM bicuculline. Disinhibited 
locomotor-related output varied in frequency between 0.09 and 0.07Hz.  
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Figure 3.2. Experimental setup used to investigate pharmacologically induced fictive rhythmic locomotor 
output from the isolated mouse spinal cord. A, C Raw and B, D rectified/integrated traces of 5μM NMDA 
and 10μM 5HT induced fictive locomotion recorded from L2/flexor and L5/extensor ventral roots. C Raw 
and D, rectified/integrated traces of disinhibited synchronous fictive output induced by addition of 1μM 
strychnine and 10μM glycine to perfusate containing 5μM NMDA and 10μM 5HT. E Illustration of 
isolated lumbar spinal cord preparation showing suction electrodes attached to L2 ventral roots (solid 
outline) and one L5 root (dotted outline). Diagram adapted from original courtesy of Dr G.B Miles. F 
Measurement parameters of alternating fictive locomotion include; i burst frequency, ii burst amplitude, 
iii inter-burst amplitude, and iv left/right and extensor flexor alternation. 
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Data were averaged in 1-minute bins, and normalised by dividing with mean control 
values (10 minutes). Graphs and time plots were constructed using GraphPad Prism 
software (Graphpad, La Jolla, CA). Images of raw and integrated traces were imported 
into GNU Image Manipulation Program (Free Software Foundation Inc., Boston, MA) 
from Dataview for formatting, and figure assembly was performed in the Inkscape 
graphics package (Free Software Foundation Inc., Boston, MA). 
 
The integrity of the phase relationship between left/right and flexor/extensor ventral 
root bursting during control and DEA NO application (n=3) were described using 
circular statistics (Kjaerulff and Kiehn, 1996, Bonnot et al., 2002a). Burst events (15-
20) in both control conditions and during application of DEA NO were analysed and 
phase data calculated using Dataview. These phase data were used to compute circular 
descriptive statistics and circular plots in StatistiXL (version 1.8, 2007). The mean 
phase coordinate was calculated as previously described (Kjaerulff and Kiehn, 1996). 
 
Coordinates plotted on the circular plot represent the burst phase, defined as the onset of 
ventral root activity on the left versus the right side of the spinal cord, as a number 
between 0 and 1 (on the graph the coordinate 0 represents both 0 and 1). Phase values 
clustered around 0 indicate synchronous burst output between compared roots and 
clustering around 0.5 indicates alternation of burst output between compared roots. 
Individual data points plotted around the circle comparing segmentally aligned, 
contralateral, flexor-related roots represent the onset of individual locomotor bursts 
recorded from L2 ventral roots on the right hand side. Data points plotted around the 
circle comparing L2- versus L5-related ipsilateral roots represent the onset of individual 
locomotor bursts recorded from L5 ventral roots. 
 
The phase values for a single representative experiment were plotted with vectors 
originating from the centre of the circle indicating the mean phase for all experiments in 
which activity was recorded from both L2 and L5 ventral roots. The vector length 
indicates the concentration of data points around the mean.  
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3.2.4 Statistics 
 
Statistical significance between control versus drug condition and wash or multiple drug 
conditions was tested using either the one way analysis of variance, with Dunnett post 
test or repeated measures analysis of variance, with Bonferroni post test (ANOVA; 
GraphPad Prism software, Graphpad, La Jolla, CA). Statistical significance is indicated 
by asterisk as follows; * = P<0.05, ** = P<0.01, *** = P<0.001, **** = P<0.0001.  The 
strength of phase coupling was tested by Rayleigh’s test for uniformity using StatistiXL 
(version 1.8, 2007). Changes are expressed as a percentage of control. Significance was 
defined as P < 0.05.  All values are expressed as mean ± SEM. 
 
3.2.5 Solutions and reagents 
 
3.2.5.1 Solutions 
 
Artificial cerebral spinal fluid (aCSF) 
The aCSF composition: 127mM NaCl; 3mM KCl; 2mM CaCl2; 1mM MgCl2; 26mM 
NaHCO3; 1.25mM NaH2PO4; and 10mM glucose. 
 
3.2.5.2 Reagents 
Reagents used in the present study have been summarised in Table 3.1. 
 
Reagents obtained from Sigma-Aldrich Company Ltd., Dorset, UK were: 
N-methyl-d-aspartate (NMDA) – agonist of NMDA-type ionotropic glutamate receptors 
which are activated during fictive locomotion (Schmidt et al., 1998, Cowley et al., 
2005); 
 
5-hydroxytryptamine hydrochloride (5HT) – monoamine neurotransmitter. 5HT2 and 
5HT7 receptors have been shown to be involved in the initiation of fictive locomotion 
(Smith and Feldman, 1987, Kudo and Yamada, 1987, Liu and Jordan, 2005, Ung et al., 
2008); 
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2-Phenyl-4, 4, 5, 5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO) – imidazoline 
scavenger shown to ablate NO mediated vasodilatory effects observed in rabbit aorta 
between 75-95% at 100-300μM, within the range of concentrations used in the present 
study (Akaike et al., 1993, Pfeiffer et al., 1997);  
 
(5S)-5-[(6R)-6,8-dihydro-8-oxofuro[3,4-e]-1,3-benzodioxol-6-yl]-5,6,7,8-tetrahydro-
6,6-dimethyl-1,3-dioxolo[4,5-g]isoquinolinium iodide (bicuculline) – GABAA receptor 
antagonist; 
 
(−)-Strychnine – alkaloid glycine receptor antagonist; 
 
N5-(nitroamidino)-L-2,5-diaminopentanoic acid (L-NNA) – an inhibitor of the NOS 
isozymes with a specificity for nNOS > eNOS > iNOS (Ki = 15nM, bovine; 39nM, 
human; 4.4µM, murine) (Griffith and Kilbourn, 1996);  
 
8-bromoguanosine 3′, 5′-cyclic monophosphate sodium salt (8BrcGMP) – membrane 
permeable PKG agonist.  
 
Reagents obtained from Ascent Scientific Ltd., Bristol, UK were:  
1H-[1, 2, 4] oxadiazolo [4, 3-a] quinoxalin-1-one (ODQ) – sGC inhibitor (Boulton et 
al., 1995); 
N-nitro-L-arginine methyl ester hydrochloride (L-NAME) – a methyl ester of L-NNA 
which requires a hydrolysis step to produce L-NNA with similar kinetics (Griffith and 
Kilbourn, 1996). 
 
Reagents obtained from Fluorochem Ltd., Derbyshire, UK were:  
2-(N,N-diethyl amino)-diazenolate-2-oxide diethyl ammonium salt (DEA NO) – a NO 
donor, with a half-life of approximately 16 minutes at 22
o
C (Keefer et al., 1996); 
 
2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide potassium salt 
(cPTIO) – a lipophobic imidazoline scavenger of NO shown to ablate NO mediated 
vasodilatory effects observed in rabbit aorta between 75-95% at 100-300μM, within the 
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range of concentrations used in the present study (Akaike et al., 1993, Pfeiffer et al., 
1997).  
 
Table 3.1 Reference summary of pharmacological agents used to manipulate NO concentration in the in vitro 
isolated spinal cord preparation. 
Abbreviation Synonym CAS MW Mode of 
action 
Selectivity References 
DEA NO 2-(N,N-Diethylamino)-
diazenolate-2-
oxide.Diethylammoniu
m salt 
56329-
27-2 
206.2 NO donor 1.5 moles of NO 
produced at RT;               
half-life 16 
minutes 
(Keefer et al., 1996) 
PTIO 2-Phenyl-4,4,5,5-
tetramethylimidazoline-
1-oxyl 3-oxide  
18390-
00-6  
233.3 NO 
scavenger 
selective, 
reversible;                                    
IC50 of 
0.11±0.03 mM 
(Akaike et al., 1993,  
Pfeiffer et al., 1997) 
cPTIO 2-(4-Carboxyphenyl)-
4,4,5,5-
tetramethylimidazoline-
1-oxyl-3-oxide 
potassium salt 2-(4-
Carboxyphenyl)-4,5-
dihydro-4,4,5,5-
tetramethyl-1H-
imidazol-1-yloxy-3-
oxide potassium salt  
148819
-94-7 
315.4 NO 
scavenger 
selective, 
reversible;              
19.71±- 4.23pM 
(Pfeiffer et al., 1997, 
Wanikiat et al., 1997,  
Akaike et al., 1993) 
ODQ 1H-[1,2,4]oxadiazolo[4,
3-a]quinoxalin-1-one 
41443-
28-1 
187.2 sGC 
inhibitor 
selective 
irreversible;               
IC50 ~20nM 
(Garthwaite et al., 1995) 
8BrcGMP 8-Bromoguanosine 
3′,5′-cyclic 
monophosphate sodium 
salt 
51116-
01-9 
423.2 PKGI 
agonist 
selective, 
reversible;                
IC50=8±0.03 nM  
(Choi and Farley, 1998,  
Lee et al., 1997,  
Francis et al., 2010) 
L-NNA N5-(Nitroamidino)-L-
2,5-diaminopentanoic 
acid  
2149-
70-4  
219.2 NOS 
inhibitor 
non- specific;                         
eNOS 
IC50=3.1±0.4μM 
(Griffith and Kilbourn, 1996) 
L-NAME Nω-Nitro-L-arginine 
methyl ester 
hydrochloride 
51298-
62-5  
269.7 NOS 
inhibitor 
non- specific;                         
eNOS 
IC50=3.1±0.4μM 
(Griffith and Kilbourn, 1996, 
Rees et al., 1990) 
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3.3 Results 
 
3.3.1 Modulation of fictive locomotion by exogenous nitric oxide 
 
To investigate the potential role of NO-mediated signalling in the control of the spinal 
locomotor circuitry, the NO donor DEA NO, which will increase exogenous levels of 
NO, was applied to isolated spinal cord preparations in which fictive locomotion had 
been pharmacologically induced. Fictive locomotion was induced and maintained by 
activation of the spinal cord locomotor network using a combination of 10μM 5HT and 
5μM NMDA by bath application via the circulating, oxygenated perfusate (Materials 
and Methods, Section 3.2.2.). Once output had stabilised (qualitative evaluation), 
approximately 60 minutes after application of 5HT and NMDA, 50μM (Fig. 3.3A and 
B), 100μM, 200μM or 400μM DEA NO was added to the perfusate for a period of 45 
minutes. Rhythmic locomotor-related output was recorded from ventral roots via 
suction electrodes and the effects of DEA NO measured with any changes expressed as 
a percentage of control. 
 
The frequency of bursts of locomotor-related activity recorded from ventral roots 
consistently and significantly decreased (Fig.3.3A, B, C and E), compared to control 
during the application DEA NO at concentrations of 50μM (P<0.05; -15±4%, n=7), 
100μM (P<0.05; -5±3%, n=6), 200μM (P<0.05; -17±5%, n=13) and 400μM (P<0.05; -
38±10%, n=10).  Typically at the low concentrations (50/100μM), the decrease in 
frequency reached a maximum 5-10 minutes after DEA NO was added to the perfusate 
and gradually recovered to near control levels approximately 5-10 minutes before 
washout. Burst frequency then remained at control levels for the duration of the drug 
washout period (Fig 3.3C).  
 
At higher concentrations (200/400μM), the peak decrease in frequency occurred 15-20 
minutes after the addition of DEA NO to the perfusate and gradually recovered to near 
control levels approximately 5 minutes before washout. During washout, frequency 
remained near control levels for approximately 15 minutes and then appeared to 
increase for the remaining 30 minutes of wash. After approximately 25 minutes of 
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wash, the frequency increased at 400μM and at 200μM the frequency of output 
remained elevated above control levels. 
 
The effects of DEA NO on the amplitude of bursts of locomotor-related output recorded 
from ventral roots were more complicated in comparison to frequency. The effect of 
DEA NO on burst amplitude varied between concentrations and within different 
preparations such that increases, decreases and biphasic responses, involving transient 
increases followed by longer lasting decreases, were observed.  
 
During application of 50μM DEA NO, the amplitude increased and reached a peak in 
the first 10 minutes and remained elevated above control levels during washout 
(P<0.05; 50μM, control, +9±4%; Fig. 3.3F). The higher concentration of 200µM DEA 
NO caused an increase, when compared to control, in the amplitude of locomotor-
related bursts in a subset of preparations (P<0.05; 200µM, +16±7%, n=7/13 and 
400µM, +19±8%, n=6/10 Fig. 3.3F), additionally, a decrease in amplitude was recorded 
during the DEA NO applications of 200µM (P<0.05; -15±5%, n=8/13) and 400µM 
(P<0.05; -24±8%, n=7/10). Significant NO effects on both frequency and amplitude 
were observed at 50, 200 and 400μM but not at 100μM DEA NO, with peak frequency 
effects observed at 400μM, the highest concentration used, and a concentration 
dependent change in amplitude across the concentration range. These DEA NO-
mediated effects indicate that exogenous sources of NO modulate burst output from the 
spinal locomotor circuitry.  
 
Burst coordination was then examined to determine whether or not NO-mediated 
signalling is involved in regulating the pattern of locomotor output, specifically 
left/right and flexor/extensor alternation. Strong L2/L2 and L2/L5 alternation (Section 
3.2.2. for definitions) was observed in control conditions (n=3). The fidelity of L/R 
alternation was maintained after the addition of 100μM DEA NO (P<0.05; Fig. 3.4Ai). 
However, mean vector values for L2/L2 alternation appeared to less uniform around the 
mean between control and drug conditions but the uniformity remained significant 
(P<0.05; Fig. 3.4Aii). This is most likely due to the longer L5 burst duration as opposed 
to a fundamental difference in control bursting between these roots or a DEA NO-
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mediated effect. However, a larger sample of experiments will need to be conducted to 
clarify the possibility of a DEA NO-mediated effect.   
 
Next, the effects of DEA NO on inter-burst activity were assessed to determine whether 
DEA NO modulates general excitation of the entire spinal circuitry or if its modulatory 
effects are specific to locomotor activity (Fig.3.5A and B). The amplitude of inter-burst 
activity recorded from ventral roots was not significantly affected by DEA NO 
application in these experiments, though a small increase in variability of inter-burst 
amplitude was noted. These data indicate that the NO-mediated effects observed on 
burst frequency and amplitude are specific to locomotor-related activity.  
 
Previously, it has been shown that NO acts via potentiation of inhibitory transmission 
(glycinergic and GABAergic transmission) to reduce the duration and increase the cycle 
period of tadpole swimming (McLean and Sillar, 2004). To investigate whether NO-
mediated effects on fictive mammalian locomotion occur via the modulation of 
excitatory or inhibitory transmission, DEA NO was applied to preparations in which 
disinhibited, synchronous activity was induced using bicuculline (10μM) and strychnine 
(1μM) in addition to 5HT (5μM) and NMDA (10μM). During pharmacological block of 
inhibition, the application of 50μM or 400μM DEA NO (Fig. 3.6A-F) were consistent 
with the effects seen in the presence of inhibitory transmission during the application of 
50μM or 400μM DEA NO. DEA NO significantly decreased the frequency of 
disinhibited rhythms at concentrations of both 50μM (P<0.05; -34±4%, n=5) and 
400μM (P<0.05; -59±12%, n=4; Fig. 3.6C and E). The decrease in frequency reached a 
maximum 15-20 minutes after the addition of 50μM and 400μM DEA NO to the 
perfusate and recovered, returning to near control levels after approximately 15 minutes 
of washout. 
 
The application of a low concentration of DEA NO caused an increase in the amplitude 
of locomotor-related bursts recorded in disinhibited preparations (P<0.05; 50μM, 
+18±15%, n=5). Amplitude continued to increase for the duration of DEA NO 
application and remained elevated above control levels but did not appear to increase 
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further during washout (Fig. 3.6D and F).  In contrast, high concentrations of DEA NO 
(400μM) did not significantly affect locomotor burst amplitude 
 
Given that the application of DEA NO to disinhibited spinal cord preparations resulted 
in changes to both frequency and amplitude, consistent with those that were observed in 
the presence of inhibition at low donor concentrations, the main effects of NO-mediated 
signalling on the mammalian locomotor circuit are likely to involve the modulation of 
excitatory interneurons and/or excitatory synaptic transmission. A role for NO in the 
modulation of inhibitory transmission is still feasible considering that DEA NO has no 
effect on disinhibited rhythmic spinal activity. 
 
3.3.2 Endogenously produced nitric oxide modulates fictive locomotion 
 
To investigate the potential role of endogenous NO-mediated signalling on the spinal 
locomotor circuitry, scavengers and inhibitors of NO were applied to isolated spinal 
cord preparations in which fictive locomotion was induced pharmacologically (5HT, 
10μM; NMDA, 5μM). 
 
Removal of both extracellular and intracellular endogenous NO by the membrane 
permeable NO scavenger, PTIO, significantly increased burst frequency and decreased 
burst amplitude (P<0.05; 400μM; +12±5% and -6±3%, respectively; n=8; Fig.3.7A-F). 
The increase in burst frequency was reversed on washout but amplitude during washout 
and appeared to remain lower than control levels. Experiments were also conducted 
using the extracellular NO scavenger, carboxy-PTIO (cPTIO). cPTIO caused a 
significant increase in frequency at a concentration of 400μM (P<0.05; +12±5%, n=8) 
but not at 200μM and frequency returned to near control levels during washout. 
Amplitude was significantly increased at 200μM (P<0.05; +10±5%, n=10) but not 
during application of 400μM DEA NO. Burst amplitude values returned to near control 
levels during washout after application of both 200μM and 400μM DEA NO (Fig.3.7E 
and F). During carboxy-PTIO application greater variability in the frequency and 
amplitude of locomotor burst output was noted within and between preparations.   
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Figure 3.3. Exogenous NO modulates pharmacologically-induced fictive locomotion. Raw A and 
rectified/integrated B locomotor bursts induced by 5μM NMDA and 10μM 5HT recorded from the left 
and right ventral roots (L2 segment, lL2/rL2 and l∫L2/ r∫L2 respectively) before (control), during (DEA 
NO) and after (wash) application of the NO donor DEA NO (grey, 50µM; black, 400µM).  Time course 
plots (data averaged in 1 minute bins) showing the effects DEA NO (grey, 50µM, n=7; black, 400µM, 
n=10) on, C frequency and D amplitude of locomotor bursts relative to control.  E, DEA NO significantly 
decreased frequency during application at concentrations of 50, 100, 200 and 400µM (10min, P<0.05, 
respectively: n=7; n=6; n=13; n=10). F, DEA NO significantly increased amplitude at a concentration of 
50µM (10min, P<0.05, n=7), 200µM (n=7/13) and 400µM (n=6/10) DEA NO caused a transient but 
significant increase (10min, P<0.05) followed by a significant decrease in amplitude at 200µM (n=8/13) 
and 400µM (n=7/10) DEA NO (10min, P<0.05). At the highest concentrations of 200µM and 400µM, an 
initial transient increase followed by a decrease in amplitude was observed (n=2/13 and n=3/10, 
respectively). Locomotor burst amplitude was not affected at concentrations of 200µM DEA NO. Data 
mean ±SEM.  
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Figure 3.4. DEA NO does not affect left-right or flexor-extensor alternation during fictive locomotion. 
Circular phase-diagram depicting the phase onset of locomotor bursts recorded from the Ai right L2 root 
in relation to the onset of activity recorded from the left L2 root (flexor/flexor) and Bi right L2 root in 
relation to the onset of activity recorded from the right L5 root (flexor/extensor) in control conditions and 
Aii, Bii during 100µM DEA NO application. The mean phase value is indicated by vectors emanating 
from the centre of the circular plot. The length of the vector indicates the concentration of events around 
the mean. Events clustered around 0.5 suggest that bursting alternates between the left and right flexor 
roots Ai and was not affected Aii by application of 100µM DEA NO. Bi clustering around 0.75 for plots 
of flexor vs. extensor activity was most likely due to the longer L5 burst duration. 
 
Figure 3.5. Inter-burst amplitude is not affected by DEA NO during fictive locomotion.  A Time course 
plot (data averaged in 1 minute bins) demonstrating no effect on inter-burst amplitude during application 
of 50µM DEA NO. B DEA NO does not affect inter-burst amplitude at 50, 100, 200 and 400µM 
concentrations (n=7; n=5; n=10; n=8, respectively). Bar in A indicates duration of application, and error 
bars are SEM. 
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Figure 3.6. DEA NO modulates disinhibited rhythmic activity. Raw A and rectified/integrated B 
locomotor bursts induced by 5μM NMDA and 10μM 5HT in the presence of 1µM strychnine and 10µM 
bicuculline recorded from the left and right ventral roots (L2 segment, lL2/rL2 and l∫L2/ r∫L2) before 
(control), during (DEA NO) and after (wash) application of the NO donor DEA NO (grey, 50µM; black, 
400µM).  Time course plots (data averaged in 1 minute bins) showing the effects DEA NO (grey, 50µM, 
n=5; black, 400µM, n=4) on, C amplitude and D frequency of locomotor bursts relative to control. E 
DEA NO significantly decreased frequency at concentrations of 50 and 400µM (10min, P<0.05, n=5 and 
n=4, respectively). F, DEA NO significantly increased amplitude at a concentration of 50µM (10min, 
P<0.05, n=5 ) but did not significantly decrease amplitude at a concentration of 400µM. Bar in C and D, 
indicates duration of application, asterisk denotes significance relative to control and error bars are SEM. 
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These data confirm that NO produced within or in close proximity to the locomotor 
network has an inhibitory effect on frequency (PTIO and cPTIO). The variation 
observed in experiments where cPTIO was used may be due to effects resulting from 
the production, by side reaction, of peroxynitrite (ONOO-) and possibly due to the 
inability of cPTIO to traverse cell membranes to effectively neutralise NO. 
 
Next, the NOS inhibitors L-NNA and L-NAME were used to prevent endogenous 
production of NO to clarify further the effect of endogenous NO on locomotor output. 
Both L-NNA and L-NAME were used in these experiments, as it has been previously 
shown that both compounds have the opposite effect to NO donors when applied to the 
tadpole during swimming (McLean and Sillar, 2000).  
 
L-NNA significantly increased the frequency of burst output during application of 
200μM or 400μM (P<0.05; +8±4%, n=6 and +7±4%, n=10; Fig. 3.7G and H). L-NNA 
caused a significant decrease in amplitude during application of both 200μM and 
400μM L-NNA (P<0.05; -9±3%, n=6 and -6±3%, n=10, respectively). The NOS 
inhibitor L-NAME is a methyl ester of L-NNA and has previously been shown to be an 
effective inhibitor of NOS involved in tadpole swimming (McLean and Sillar, 2002). 
200μM L-NAME significantly increased frequency and decreased amplitude of burst 
output (+24±9% and -10±4%, respectively; n=6; Fig.3.7G and H).  
 
Consistent with the exogenous application of DEA NO, the inter-burst amplitude was 
not significantly affected by L-NAME, PTIO, or cPTIO application, confirming that the 
NO-mediated effects observed in these experiments are specific to locomotor-related 
activity.  
 
In summary, inhibitors of NOS enzymes increase the frequency and decrease the 
amplitude of locomotor burst output, both effects being opposite to those observed with 
the application of exogenous NO at low concentrations. Scavengers of NO increase the 
frequency of locomotor burst output but either increase (cPTIO) or decrease (PTIO) the 
locomotor burst amplitude. These data suggest that a tone of endogenously produced 
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NO is involved in the control of the frequency and intensity of burst output generated by 
spinal locomotor circuitry. 
 
 
3.3.3 Involvement of the NO/sGC/cGMP pathway in NO-mediated modulation of 
the locomotor network  
 
NO exerts its biological effects by both direct and indirect mechanisms, involving 
biochemical reactions (nitrosative and oxidative stress, predominantly resulting in s-
nitrosation) and via second messenger signalling (NO/sGC/cGMP). The contribution of 
sGC-mediated signalling mechanisms to NO-mediated modulation of spinal locomotor 
networks was tested.   
 
The widely utilised membrane permeable partial PKG agonist, 8BrcGMP, was used to 
investigate the contribution of NO/sGC/cGMP mediated signalling towards changes in 
locomotor output that occur as a result of addition or removal of NO. Application of 
200μM 8BrcGMP caused a significant decrease in the frequency of locomotor-related 
activity (P<0.05, -10±5%; n=6; Fig. 3.8E). A significant decrease in locomotor burst 
amplitude was observed during application of 8BrcGMP (P<0.05, -9±3%; n=6;  
Fig. 3.8F). These results suggest the NO-dependent activation of sGC contributes to the 
modulation of both CPG and motor neuron output in the lumbar locomotor system.  
 
The soluble guanylate cyclase (sGC) inhibitor, ODQ, was used to investigate further the 
sGC-mediated effects of NO. Application of 200μM ODQ caused a transient increase 
followed by a significant decrease in frequency and a significant decrease in amplitude 
of burst output (P<0.05; -8±4% and -11±4%, respectively; n=6; Fig. 3.8E and F). 
During washout the frequency of burst output remained significantly reduced. Burst 
amplitude remained reduced over the course of ODQ application and during washout. 
ODQ is an inhibitor of sGC, reducing the sGC haem site. Inhibition of sGC using 
200μM ODQ caused an unrecoverable inhibition of frequency and amplitude; therefore, 
in an attempt to inhibit sGC without an immediate and immeasurable reduction in 
output, a low concentration of ODQ was used to inhibit sGC with the subsequent 
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addition of DEA NO to ascertain the sGC-dependent effect of NO. A lower 
concentration of 50μM ODQ was applied for 15 minutes before co-application of 50μM 
DEA NO to ascertain whether inhibition of sGC can ablate the effects of DEA NO (Fig. 
3.8A and B). ODQ caused a significant decrease in frequency (P<0.05, -6±2%; 
Fig.3.8C). During washout of both ODQ and DEA NO, the burst frequency increased 
significantly compared to control (P<0.05, +5±2 %). Greater variability in amplitude 
was noted in ODQ when compared to control, but at this lower concentration ODQ did 
not significantly change burst amplitude.  
 
The DEA NO effect on frequency but not on burst amplitude in the presence of ODQ 
suggests that the NO/sGC/cGMP pathway predominantly mediates the effects of NO on 
the intensity of locomotor-related motor neuron output. The DEA NO effect on 
frequency in the presence of ODQ suggests that a component of NO modulation of 
locomotor activity is mediated by a non NO/sGC/cGMP pathway, possibly s-
nitrosation. 
 
3.4 Discussion 
 
3.4.1 Nitric oxide modulates spinal neurons during rhythmic locomotor-related 
activity  
 
Prior to the present study, the role of NO in the mammalian hind limb locomotor 
network had not been investigated, though previous studies have shown a modulatory 
role for NO in the locomotor network of non-mammalian vertebrates such as the 
lamprey and the Xenopus tadpole. The results presented in this chapter demonstrate that 
NO modulates locomotor output generated by the mammalian spinal locomotor 
network. 
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Figure 3.7. Endogenous sources of NO modulate locomotor activity. Raw A and rectified/integrated B 
locomotor bursts induced by 5μM NMDA and 10μM 5HT recorded from the left and right ventral roots 
(L2 segment) before (control), during (PTIO) and after (wash) the application of the membrane permeable 
NO scavenger PTIO. Time course plots (data averaged in 1 minute bins) showing the effects PTIO 
(400µM, n=8) on the C frequency and D amplitude of locomotor bursts relative to control.  E removal of 
NO by scavengers PTIO and cPTIO significantly increased the frequency of locomotor output (400µM, 
n=8; 200µM, n=10; and 400µM, n=8 respectively. 10min, P<0.05).  F cPTIO significantly increased burst 
amplitude (400µM, n=8; 200µM, n=10) while the membrane permeable scavenger PTIO significantly 
decreased burst amplitude (400µM, n=8; 10min, P<0.05). G The NOS inhibitors L-NAME and L-NNA, 
significantly increased the frequency of locomotor output (200µM, n=6, 10min, P<0.05; 200µM, n=6 and 
400µM, n=10, respectively) H The NOS inhibitors L-NAME and L-NNA significantly reduced 
locomotor burst amplitude (P<0.05; 10min, 200µM, n=6, 200µM, n=6; and 400µM, n=10, respectively). 
Bar in A and B, indicates duration of application, asterisk denotes significance relative to control and 
error bars are SEM. 
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In both the lamprey and tadpole, NO affects the output of locomotor networks primarily 
by modulating synaptic transmission. However, the effects on synaptic transmission and 
the overall effects on locomotor output are different in the two species. In the tadpole, 
NO facilitates glycinergic transmission, via effects on another modulator NA, to reduce 
swim episode duration (McLean and Sillar, 2004). In addition to this, NO decreases 
motor neuron membrane conductance, enhancing the inhibitory effect of GABA release, 
and thus increasing cycle period (McLean and Sillar, 2002). In the lamprey, in contrast 
to the potentiation and facilitation of inhibition seen in the tadpole, NO increases the 
frequency of locomotor activity by facilitating post-synaptic on-cycle excitation and 
reducing mid-cycle inhibition by a presynaptic mechanism (Kyriakatos et al., 2009).  
 
In the present study, NO-mediated modulation of hind limb fictive locomotion is 
described. Fictive locomotion was induced using 5HT and NMDA, raising the general 
level of excitation in neuronal circuits, leading to the development and maintenance of 
rhythmic alternating output (Jiang et al., 1999, Miles et al., 2007). The NO donor, DEA 
NO, was used to increase the level of NO in the locomotor circuitry during 
pharmacologically induced fictive locomotion. DEA NO was utilised at concentrations 
in the micromolar range because although research has shown that in vivo levels of NO 
are in the nanomolar range, to achieve similar levels of NO in vitro, concentrations of 
NO in the micromolar range are needed (Boulton et al., 1995, Thomas et al., 2008). This 
is due to the reduction in NO concentration at any point in the solution due to diffusion 
and the natural scavenging properties of the cellular environment; that is, scavenging by 
endogenous antioxidants, haemoglobin and superoxide (Thomas et al., 2001, Thomas et 
al., 2008, Kuzkaya et al., 2005). 
 
DEA NO, and thus NO, caused a significant decrease in the frequency of rhythmic 
locomotor output produced by the locomotor CPG across the range of concentrations 
used. To investigate the potential involvement of modulation of inhibitory transmission, 
as described in the tadpole and lamprey, strychnine and bicuculline were used to inhibit 
glycinergic and GABAergic transmission (Bracci et al., 1996). 
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Figure 3.8. NO modulates fictive locomotor output by both cGMP-dependent and cGMP-independent 
pathways. Time course plots (data averaged in 1 minute bins) showing the effects of the sGC inhibitor 
ODQ (50μM) and the co-application of the NO donor DEA NO (50μM) in the presence of ODQ on 
locomotor burst A frequency and B amplitude. C ODQ significantly increased burst frequency while 
subsequent application of DEA NO, reversed this frequency-related effect. D, ODQ ablated the effects of 
DEA NO on burst amplitude. E ODQ significantly increased locomotor burst frequency (200μM; n=6, 
10min P<0.05). Inhibition of sGC by ODQ led to a long-term unrecoverable reduction in output while the 
partial agonist of PKG, a downstream signaling pathway of sGC, 8BrcGMP significantly decreased burst 
frequency (P<0.05; 200μM; n=6, 10min). F Both ODQ and 8BrcGMP significantly decreased locomotor 
burst amplitude. Bar in A and B, indicates duration of application, asterisk denotes significance relative to 
control and error bars are SEM.  
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Although the motor circuitry generates disinhibited burst activity as result of 
pharmacological block, it is not known whether the same network and population of 
neurons are involved in generating fictive locomotion as in the standard in vitro 
preparation.  In the absence of inhibition, the DEA NO-mediated decrease in frequency 
at the lowest concentration used in this study indicates that the effects of NO on 
frequency reflect a change in the properties of excitatory interneurons or synaptic 
transmission between excitatory interneurons within the central pattern-generating 
network. Modulation of excitatory components of the locomotor CPG by NO is 
consistent with findings in the lamprey locomotor network where NO facilitates on-
cycle excitation (Kyriakatos et al., 2009). In addition, in the mammalian respiratory 
system, NO enhances excitatory transmission during the transition to the inspiratory 
phase controlled by neurons in the brainstem (Pierrefiche et al., 2007) and in concert 
with phenylephrine, enhances long-term facilitation of XII motor neuron output 
(Saywell et al., 2010). Precedents for NO-mediated modulation of excitation have also 
been provided by studies in other regions of the mammalian CNS, including the 
trigeminal motor nucleus (Pose et al., 2011) and the Calyx of Held (Steinert et al., 
2008), where NO specifically modulates glutamatergic neurons. At the higher 
concentration of donor used in these experiments, a reduction in frequency analogous to 
that seen in the presence of inhibition suggests that either these effects are mediated 
primarily by inhibitory mechanisms or more likely by an alternative pathway such as s-
nitrosation, as NO is known to act as a thiol modifying agent at high concentrations 
(Thomas et al., 2008). 
 
The present study suggests that NO effects in the mouse occur predominantly via 
modulation of excitatory transmission as opposed to the tadpole where NO modulates 
inhibitory transmission. Interestingly, scavenging or blocking the production of NO in 
both systems increases locomotor burst frequency (McLean and Sillar, 2000). However, 
this is unsurprising given that an increase in burst frequency can occur by either a 
decrease in inhibition or an increase in excitatory transmission.  
 
In the absence of inhibition, the DEA NO-mediated decrease in frequency was reversed 
to near control levels during washout. In contrast, in experiments conducted in the 
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presence of inhibition, locomotor frequency increased above control levels following 
the washout of DEA NO. This difference, after the removal of DEA NO in the present 
study, suggests that NO could also modulate an inhibitory component of the locomotor 
network which may have longer-term effects on network output. NO has previously 
been shown to mediate long-term changes in the output of motor systems. In rodent 
hypoglassal (XII) motor neurons, NO enhances phenylephrine induced long-term 
facilitation of XII nerve activity (Saywell et al., 2010). In the lamprey, mGluR1 
activation leads to long-term increases in locomotor output frequency. This long-term 
potentiation involves endocannabinoid and NO signalling (Kyriakatos and El Manira, 
2007). The present study may have uncovered a similar long-term effect of NO in the 
mammalian locomotor CPG, though additional evidence will need to be gathered to 
prove this definitively. A modification to the protocols detailed in this chapter, to 
specifically address the long-term effects of NO, is needed.  
 
Fictive locomotion induced by addition of 5HT and NMDA to the circulating aCSF 
raises the level of excitation in an indiscriminate manner in all areas of the spinal cord. 
As a result of this, there is the possibility that NO applied in the same manner could 
affect non-locomotor-related activity. In light of this, the recordings made from ventral 
roots were scrutinised for evidence of non-locomotor-related changes in activity as a 
result of NO. Neuronal activity during the inter-burst interval was used to help assess 
the level of general activity, or biological noise, produced from the spinal neural 
network. The inter-burst amplitude, measured before and during application of all the 
NO-related pharmacological agents tested, was not significantly altered, suggesting that 
the modulatory effects of NO are directly related to locomotor activity.  
 
DEA NO, and therefore NO, caused a significant increase in the amplitude of 
locomotor-related output from motor neurons at all concentrations used. However, at 
high concentrations, a mixed response was observed with just over half of the total 
number of experiments showing an overall decrease in amplitude, a little under half 
showing an increase in amplitude, and a small number of preparations exhibiting a 
transient increase followed by a significant decrease in burst amplitude. The 
concentration-dependent effects of NO on locomotor burst amplitude suggest that, at the 
Chapter 3 
108 
 
level of motor neurons, NO-mediated signalling may be complicated by the existence of 
multiple signalling pathways with opposing actions or that tonically active signalling 
pathways might be desensitised in the presence of high concentrations of NO. NO-
mediated signalling might involve a balance between excitatory transmission and 
desensitisation or auto inhibition. For instance, initial activation of sGC with subsequent 
production of cGMP and initiation of PKG signalling may lead to increases in motor 
neuron output followed by desensitisation of the sGC haem causing cessation in cGMP 
production and reduction in PKG activity resulting in a reduction in motor neuron 
output (Fernhoff et al., 2009, Halvey et al., 2009). In addition, a cGMP-independent 
mechanism, such as s-nitrosation, might account for the broadly inhibitory action of NO 
at high concentrations. High levels of NO could result in the s-nitrosation of sGC, 
inhibiting cGMP production (Sayed et al., 2007) or potentially the s-nitrosation of 
NMDA receptors or other ion channels involved in excitatory transmission. 
Alternatively, the mixed, or biphasic, effect of NO on motor neuron output could reflect 
excessive excitation at the higher concentrations used, leading to a depolarising block or 
axonal conduction-block. Previous studies have shown that NO facilitates axonal 
conduction block (Redford et al., 1997, Smith et al., 2001) which has not been shown in 
the rodent locomotor preparation and would ideally be investigated in future studies of 
NO modulation of locomotion.  
 
Scavengers of NO and blockers of NOS were used to investigate the role of endogenous 
NO production in the modulation of the spinal locomotor CPG. Experiments utilising 
the membrane soluble and, therefore, both extra- and intracellular scavenger of NO, 
PTIO, or NOS inhibitors, revealed an increase in locomotor burst frequency when 
endogenous NO was reduced or removed. An increase in locomotor burst frequency 
was also replicated using the less lipophilic and thus, less membrane permeable 
scavenger, cPTIO. However, it should be noted that cPTIO is involved in generating 
peroxynitrite radicals and other reactive nitrogen species, which may have effects on a 
wide range of cellular targets (Thomas et al., 2008). The production and effects of 
peroxynitrite may account for the increase in variability of output frequency during 
cPTIO application. The variable cPTIO results may be due to a mixture of NO and NO 
radical reactions as opposed to changes as a result of NO alone. Nevertheless, data using 
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a range of NO scavengers and NOS inhibitors demonstrate that endogenous NO, from 
sources within the mammalian spinal cord, acts to regulate the frequency of the output 
from the locomotor CPG.   
 
Removal of NO by the membrane impermeable scavenger, cPTIO, potentiated motor 
neuron output as evidenced by an increase in the amplitude of locomotor bursts, 
whereas the membrane permeable scavenger, PTIO, decreased motor neuron output. 
The reason for this discrepancy is not clear, though it may be due to the relative 
membrane permeability of the two compounds or the propensity of cPTIO to generate 
peroxynitrite radicals. Non-specific NOS inhibitors reduced the amplitude of locomotor 
bursts consistent with the increase in amplitude during application of low levels of 
exogenous NO. The differences in effect on locomotor output by NO scavengers and 
NOS inhibitors might reflect the biochemical interaction of NO produced endogenously. 
Scavenging of NO and the breakdown and metabolism of NO involve the production of 
NO metabolites: peroxynitrite, nitrate and nitrite molecules, which are themselves 
biologically active and can also regenerate NO (Giovannoni, 1998, Lundberg et al., 
2008). It is plausible that increased production of nitrates and subsequent formation of 
NO may cause the increase in amplitude of locomotor bursts observed in the presence of 
NO scavengers, whilst inhibition of the synthetic enzyme completely prevents NO or 
NO metabolite signalling-induced effects leading to a decrease in the intensity of 
locomotor output.  
 
Support for peroxynitrite-mediated signalling as the cause of increased locomotor burst 
amplitude comes from the respiratory system. In inspiratory neurons of the ventral 
respiratory column, NO-mediated increases in excitation occur by both cGMP-
dependent and independent mechanisms and exogenous application of uric acid, an 
endogenous antioxidant which neutralises peroxynitrite, indicates that the cGMP-
independent increases observed are a result of peroxynitrite (Pierrefiche et al., 2007). 
 
These results show that in the mammalian locomotor network, both exogenous and 
endogenous sources of NO modulate locomotor network activity. Effects on locomotor 
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burst frequency involve NO-modulation of excitatory interneurons whilst the effects on 
amplitude appear to be more complex.  
 
 
3.4.2 Cyclic nucleotide dependent effects of nitric oxide on the locomotor 
network 
 
NO is known to exert its effects primarily via sGC, catalysing the production of cGMP 
which then initiates the PKG pathway. NO can also modulate cellular properties by s-
nitrosation, a reaction involving the production of reactive nitrogen species that modify 
thiol functional groups on proteins by addition of –NO (Thomas et al., 2008). As the 
main regulatory pathway for NO is via sGC, the present study assessed involvement of 
this pathway in NO-mediated changes in locomotor output.  
 
The PKG partial agonist 8BrcGMP was first used to assess involvement of the cGMP-
dependent signalling pathway in NO-mediated effects on the mammalian locomotor 
CPG. 8BrcGMP significantly affected both the frequency and amplitude of locomotor 
burst output. These data suggest that cGMP-dependent signalling is involved in the 
effects of NO on both locomotor burst amplitude and frequency. Further work is needed 
to ascertain whether or not the 8BrcGMP effect on amplitude observed in these 
experiments is concentration dependent compared to that of DEA NO. 
 
To investigate further the likely contribution of the NO/sGC/cGMP/PKG pathway to 
motor network function, the pathway was inhibited using ODQ, an inhibitor of sGC 
(Zhao et al., 2000). ODQ reduces the ferrous binding site of sGC. On binding to the 
haem, sGC still exhibits a basal level of activity, although stimulation of cGMP 
production by addition of exogenous NO is ablated (Zhao et al., 2000). Locomotor burst 
frequency increased significantly during high concentration ODQ application (200μM) 
before declining to below control levels; burst frequency did not recover during 
washout. Burst amplitude significantly decreased in the presence of high concentrations 
of ODQ, an effect that again could not be reversed by washout of the inhibitor. 
Although these data suggest involvement of activation of the sGC signalling pathways 
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by endogenous NO, the non-reversible, inhibitory effects of high concentrations of 
ODQ on both locomotor burst amplitude and frequency suggest that the block of sGC 
has a profound and detrimental effect on the ability of the network to function.  
 
To mitigate the detrimental effects of high concentrations of the sGC inhibitor and to 
investigate further the link between NO-mediated modulation of the locomotor network 
and the sGC pathway, a lower concentration (50μM) of ODQ was applied in 
combination with DEA NO. Burst frequency again increased during low concentration 
ODQ application and this increase was reversed by application of DEA NO. The initial 
increase in frequency as a result of sGC block indicates that a basal sGC activity is 
involved in maintaining locomotor frequency; whether this is due to endogenous NO 
production or some other mechanism is not clear. The subsequent reduction in 
frequency on addition of DEA NO suggests that NO modulates the frequency of 
locomotor output by cGMP-independent mechanisms or by further stimulation of sGC, 
though these mechanisms, again, have not been shown in the present study. In the 
respiratory system, NO modulates inspiratory drive by a cGMP-dependent mechanism 
and by a cGMP-independent mechanism, possibly peroxynitrite formation (Pierrefiche 
et al., 2007). To clarify this mechanism, additional experiments would need to be 
performed; for instance, extending the current protocol to include washout of DEA NO 
but not ODQ to determine whether burst frequency increases, or using antioxidant 
application to neutralise peroxynitrite. 
 
The ODQ-mediated block of sGC prevented all DEA NO-mediated effects on 
locomotor burst amplitude, indicating the involvement of the NO/sGC/cGMP pathway 
in modulation of motor neuron output. It is not clear why ODQ at lower concentration 
does not alter locomotor burst amplitude; perhaps this is a result of the complex 
concentration-dependent relationship between NO production and locomotor output. 
Despite this, these results confirm for the first time that the NO stimulation of sGC and 
the subsequent activation of the PKG pathway by cGMP directly modulates motor 
neuron output. 
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It is also possible that NO inactivates nNOS via a Fe
2+
-NO intermediate. NO is 
produced in pulses according to the turnover rate of the reaction to convert L-arginine to 
NO and L-citrulline (one pulse/140ms) and at high concentrations of NO (during high 
turnover), the inhibiting Fe
2+
-NO intermediate stabilises and inactivates the enzyme 
(Salerno and Ghosh, 2009, Fernhoff et al., 2009). This turnover-dependent inhibition of 
nNOS (auto-inhibition) can be compared to the high levels of NO used in the present 
study, taking into consideration that exogenous increases in the concentration of NO 
will add to the endogenous tone that exists during locomotor activity. This mechanism 
could explain the changes in locomotor burst frequency and concentration-dependent 
changes in amplitude observed on addition of DEA NO.  
 
Evidence for a NO-mediated positive feedback mechanism for the control of locomotor 
frequency has been put forward in the lamprey spinal cord where NO is produced in an 
activity-dependent manner and facilitates excitation via a presynaptic mechanism 
(Kyriakatos and El Manira, 2007). Data from the present study might support a negative 
feedback role for NO in the mammalian locomotor network. It is possible that by 
retrograde signalling NO could cause the amplification of presynaptic cGMP 
modulating neurotransmitter release. cGMP-independent inhibition by s-nitrosation of 
sGC, NMDA receptors or VDCC channels and auto-inhibition of nNOS might also 
effect a self-regulating negative feedback loop.  
 
 
3.5 Conclusion 
 
Future investigation into the effects of NO described here must be taken forward in the 
context of neuromodulation of the network. NO is known to exert its effects by directly 
activating secondary messenger pathways (sGC/cGMP/PKG; (Denninger and Marletta, 
1999, Garthwaite, 2010), modifying protein residues (s-nitrosation) (Choi et al., 2000), 
and metamodulating the actions of other neurotransmitters such as glycine and GABA 
(McLean and Sillar, 2002, McLean and Sillar, 2004, Wexler et al., 1998). Subsequent 
studies in the locomotor preparation must take into account the nature of 
neuromodulatory interactions to assign definitively a role for NO in the locomotor CPG, 
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as it is not known whether NO is involved in meta-modulation in the mammalian 
locomotor network. 
 
The divergent activity-dependent effects of NO in the present study may be a result of 
state-dependent modulation, and theoretically, a mechanism for state-dependent 
modulation in vivo. The endogenous availability of NO in combination with other 
neurotransmitters could be the cause of or exacerbate differing effects on the 
modulation of rhythmic output. For instance, NO enhances the postsynaptic effects of 
5HT release at the synapse between Lymnaea cerebellar giant cells (CGC) and B4 
motor neurons involved in feeding (Straub et al., 2007). In addition, in a behavioural 
study, NO inhibits the food intake stimulated by 5HT1A agonists injected into the rat 
midbrain raphe (Currie et al., 2011). In spinal motor neurons, 5HT1A receptors have a 
postulated role in inhibitory modulation at the motor neuron initial segment while 5HT2 
and 5HT7 are involved in initiating locomotion (Heckman et al., 2009). Also in the rat 
spinal cord, low concentrations of 5HT facilitate locomotion in the presence of the 
mGluR1 agonist DHPG, while at high concentrations of 5HT, DHPG disrupts 
locomotor output (Taccola et al., 2003). The complexity increases with the evidence 
that endocannabinoids and NO facilitate long-term depression in the lamprey spinal 
cord via mGluR activation (Kyriakatos and El Manira, 2007). Therefore, a potential 
modulatory relationship between NO and 5HT is theoretically possible, given that NO 
interacts with 5HT at invertebrate motor synapses and neuromodulation by 
metabotropic mechanisms involving pathways modulated by 5HT and NO occurs in 
both mammalian and non-mammalian vertebrates. 
 
The experiments reported by McLean and colleagues rely on the manipulation of fictive 
locomotion induced by electrical stimulation, whereas Kyriakatos and colleagues 
induced fictive locomotion with NMDA alone in their studies in the lamprey. Both 
NMDA and 5HT are used in the present study to induce locomotion before assessing the 
role of NO on the resulting locomotor output. If NO-mediated effects depend on the 
state, level or nature of excitation that initiates and maintains locomotion then 
modulation in these three systems must be calibrated to accommodate for the state-
dependent differences resulting from different methods of inducing locomotor output.  
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In the isolated mouse spinal cord preparation, stimulation of the cauda equina and 
subsequent generation of locomotion would provide an endogenous-activity model for 
the study of endogenous NO effects. Likewise, fictive locomotion induced by 5HT or 
by NMDA alone would enable better comparison with the findings in the lamprey and 
reveal neurotransmitter specific interactions which have not been reported in the context 
of NO and spinal locomotor CPG activity.  
 
If a state- or frequency-dependent interaction or action of NO exists in the lumbar spinal 
cord network, it could be revealed by further experiments manipulating the starting 
frequency; for example, by altering the concentrations of the neurotransmitters used to 
induce fictive locomotion. 
 
The data in this chapter show that NO from both exogenous and endogenous sources 
modulates mammalian spinal locomotor output. Exogenous NO inhibits locomotor burst 
frequency and this was corroborated by evidence that endogenous NO, as revealed by 
both inhibitors and scavengers, increased locomotor output consistent with NO having 
an inhibitory modulatory role modulating excitatory transmission. NO appears to 
modulate locomotor burst output by mechanisms both dependent and independent of the 
classical NO/sGC/cGMP pathway.  
 
Exogenous NO modulates locomotor burst amplitude in a concentration-dependent 
manner, potentiating burst amplitude at low concentrations and predominantly reducing 
burst amplitude at high concentrations. However, clarification of this concentration-
dependent relationship by scavengers of endogenous NO was less clear, complicated by 
possible side reactions to produce reactive NO derivatives. Care should be taken in 
future to account for or avoid possible side reactions when designing experiments of 
this kind. Inhibition of NOS suggests that NO modulates excitatory transmission in the 
spinal locomotor network.  NO appears to modulate locomotor burst amplitude by a 
cGMP-dependent mechanism, though further work is required to clarify the results 
detailed here.  
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Chapter 4: Nitric oxide-mediated modulation of the intrinsic 
properties of spinal neurons 
 
4.1 Introduction  
 
4.1.1 Background 
 
The spinal cord is populated by a cornucopia of neurons, the full cellular and 
behavioural function of which is not yet fully known. Motor neurons, identifiable by 
their size, transmitter phenotype, and firing properties, have been studied in detail and 
the resulting knowledge of how motor neurons function and integrate central commands 
has led to a greater understanding of other neurons and circuits in the CNS. Motor 
neurons are known generally as the effectors of muscle contraction and more 
definitively as single neurons characterised by transcription factor expression (hind limb 
motor neurons, Lim3, Isl1 and Hb9) and cellular architecture (ion channels, signalling 
pathways) ((Section 1.1.2; (Jessell, 2000, Brownstone, 2006)). Motor neuron activity is 
critical for normal behavioural function and consequently, has been the subject of 
intense research for over a century, with motor neurons representing the first 
mammalian neurons in the CNS in which intracellular recordings were performed 
(Brock et al., 1952). 
 
 
4.1.2 Properties of motor neurons 
 
Motor neurons innervating the hind limb muscles are located in the ventrolateral 
column from lower thoracic to sacral spinal cord. Motor neurons innervating the axial 
and hind limb muscles are located, respectively, in the medial and lateral motor pools 
(lamina IX) of the ventral horn of the lumbar spinal cord. Motor neurons have large 
somas and extensive dendritic branches that integrate synaptic inputs and influence the 
excitability of the soma. However, research into the properties of motor neurons usually 
involves recordings from the soma using microelectrodes. This technique has revealed 
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and continues to reveal most of what we know about the properties of neurons, how 
they behave and how their activity is influenced by other synaptic inputs.  
 
The intrinsic excitability of motor neurons is determined by the expression of ion 
channels at the cell membrane. Researchers have meticulously defined the stereotypical 
ion channel characteristics that determine motor neuron firing properties. At rest, the 
membrane potential is the result of inwardly rectifying (Kir) and leak K
+
 channels 
(outward), and external chloride levels. Synaptic input of large enough magnitude 
initiates the activation of K
+
 and Na
+
 channels (INa, IKNa) and VDCC, the result of this 
activation of cation conductances is that an action potential (AP) is fired. Spike 
frequency adaptation (SFA) during repetitive firing is a hallmark characteristic of motor 
neurons, mediated by the slow-inactivation of Na
+
 channels. After an action potential 
has been fired, the membrane repolarizes, which involves inactivation of depolarizing 
currents and activation of IKCa and transient K+ conductance through IA channels. A 
refractory period follows, during which no further action potentials can be generated. 
During this action potential AHP, the hyperpolarization activated Na
+
/K
+
 conductance 
(Ih) generates the post-inhibitory rebound (PIR) that can result in rebound firing of 
action potentials (Brownstone, 2006, Heckman et al., 2009, Miles et al., 2005, Rekling 
et al., 2000). 
 
Motor neurons release the neurotransmitter acetylcholine (ACh) and as such can be 
identified by the presence of the enzymes that synthesize ACh, Choline 
acetyltransferase (ChAT), and degrades ACh, acetyl cholinesterase (AChE) (Ferguson 
and Blakely, 2004). Motor neurons receive extrinsic modulation (from outside the 
spinal motor networks) in the form of neurotransmitter release and subsequent 
signalling which alters their intrinsic properties. These include 5HT and NA from 
supraspinal fibres as well as a large number of other both excitatory and inhibitory 
neurotransmitters, i.e. adenosine, Substance P and Thyrotropin (Section 1.1.3).  
 
The excitability of motor neurons determines the timing and intensity of action potential 
firing and subsequent contraction of muscles, such that an increase in excitability 
renders a neuron more likely to fire as a result of a given excitatory input. The 
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excitability of motor neurons, as a result of intrinsic properties or extrinsic modulation, 
heavily influences research into understanding motor neuron function and 
pathophysiology; for instance in ALS, where one of the current hypotheses to explain 
disease pathogenesis involves aberrant excitatory input to motor neurons leading to 
excitotoxicity and cell death (Boillee et al., 2006). 
 
NO has been identified as a putative neurotransmitter in the mammalian locomotor 
circuit, having already been identified as a facilitator of inhibitory transmission in the 
Xenopus spinal locomotor network and an excitatory neuromodulator in the spinal cord 
of the lamprey (McLean and Sillar, 2004, Kyriakatos et al., 2009, McLean and Sillar, 
2002, Kyriakatos and El Manira, 2007). The role of NO in mammalian motor control is 
not fully understood, providing the impetus for the present study. 
 
 
4.1.3 Nitric oxide transmission  
 
NO gas is produced on catalysis of L-arginine to L-citrulline and NO by NOS. There 
are three isoforms of the enzyme: neuronal (nNOS or NOS-1); endothelial (eNOS or 
NOS-3); and inducible (iNOS or NOS-2). The n/eNOS isoforms are constitutively 
expressed and require calcium for normal function whilst iNOS is produced on immune 
stimulation and is calcium independent. NOS is a NADPH diaphorase enzyme requiring 
calcium and several other cofactors for activity: (CaM (nNOS/eNOS only), FAD, FMN, 
haem, NADPH and BH4. The enzyme is associated at the cell membrane with the 
NMDA receptor subunit NR2B linked by PSD95 and a PDZ domain (Brenman et al., 
1996). NO acts via two main pathways, predominantly through secondary messenger 
cascades, such as protein kinase G (PKG), and direct modification of proteins by s-
nitrosation (Section 1.2.2.1 to 1.2.2.4). 
 
In Chapter 2, NADPH diaphorase reactive neurons were shown to be distributed in 
discrete populations in the mouse lumbar spinal cord. NADPH diaphorase reactive 
neurons were identified in the dorsal horn (laminae I-VI), the intermediolateral layer of 
lamina VII, dispersed throughout lamina VII, around the central canal (lamina X) and 
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very rarely in laminae VIII and IX. Over the developmental period P1-12, these neurons 
increased in number in all laminae, except laminae VIII and IX where intermittent 
staining was noted. Though NADPH diaphorase reactivity was largely absent from the 
motor pools, some light staining, not quantified in the present study. The spatial 
distribution of NO producing neurons in the ventral horn indicates that neurons 
potentially involved in or in close proximity to the locomotor circuitry produce or are 
influenced by the production of NO. Indeed, NO is free to diffuse from the site of 
production, unrestricted by lipid membranes, and is known to act as both an autocrine 
and paracrine agent.  
 
As a reactive, radical gas, NO is involved in a range of physiological processes 
including long term potentiation (LTP) in the hippocampus (Yanagihara and Kondo, 
1996), long term depression (LTD) in the cerebellum, modulation of inhibitory 
transmission in the hypothalamic paraventricular nucleus (Li et al., 2004), modulation 
of ion channel properties in the mammalian auditory complex (Steinert et al., 2011, 
Steinert et al., 2008), and excitability of cholinergic basal forebrain neurons (Kang et 
al., 2007, Toyoda et al., 2008). Evidence from invertebrates and non-mammalian 
vertebrates has shown that NO is involved in the regulation of locomotor output. 
However, until the present study, the role of NO in mammalian hind limb locomotor 
activity and its influences on neurons within mammalian motor networks has not been 
determined.  
 
 
4.1.4 Nitric oxide in locomotor activity 
 
In studies of locomotor activity, NO is known to reduce swim episode duration and 
increase cycle period in Xenopus tadpoles  (McLean and Sillar, 2000, McLean and 
Sillar, 2002)and in combination with endocannabinoid signalling, induce long-term 
potentiation of locomotor burst frequency in the adult lamprey Lampetra (Kyriakatos 
and El Manira, 2007). In the present study, NO has been shown to modulate mouse 
locomotor output by reducing locomotor burst frequency and either increasing or 
reducing locomotor burst amplitude in a concentration-dependent manner (Chapter 3).  
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The actions of NO have been studied in a number of model organisms at the level of the 
limb motor neurons. The reported effects on cellular properties in invertebrates suggest 
that NO is involved in excitatory transmission at the level of the locomotor network. In 
the sea angel Clione limacina, NO depolarises and activates both motor neurons and 
interneurons (Moroz et al., 2000). NO depolarises the membrane potential and increases 
firing rates of buccal ganglion B5 neurons leading to a depolarising block in Helisoma 
trivolvis (Artinian et al., 2010).  
 
In non-mammalian vertebrates, NO decreases membrane conductance and increases the 
amplitude of glycinergic mid-cycle and GABAergic terminating inhibitory postsynaptic 
potentials (IPSP) in the tadpole (McLean and Sillar, 2002). While in lamprey motor 
neurons, NO reduces the frequency but not the amplitude of mid-cycle miniature 
inhibitory postsynaptic currents (mIPSC) and increases the frequency and amplitude of 
the on-cycle miniature excitatory postsynaptic currents (mEPSC). This results in an 
increase in the frequency of locomotor output (Kyriakatos et al., 2009). NO modulates 
the synaptic activity of mammalian neurons. For example, in the rat auditory complex 
NO reduces the amplitude of AMPA and NMDA EPSCs in the Calyx of Held (Steinert 
et al., 2008) . While in the rat hypoglossal nuclei, motor neurons involved in the control 
of inspiration, the PKG agonist 8BrcGMP, also decreased the amplitude of AMPA 
mediated transmission (Saywell et al., 2010). Also in the hypoglossal nucleus, the use 
of the NOS inhibitor L-NAME has revealed NO-mediated facilitation of inhibitory 
inspiratory hypoglossal motor neuron activity (Montero et al., 2008). These studies 
suggest that NO in the mammalian CNS is involved in excitatory transmission. 
However, in terms of NO mediated transmission, it is highly likely that network and 
motor neuron pool specific roles will emerge as more research is conducted. For 
instance, in rat trigeminal motor neurons involved in control of oral motor tasks, NO 
decreased the frequency but not the amplitude of mEPSCs, suggesting that NO acts by a 
presynaptic mechanism only in these neurons (Pose et al., 2011). In mammals, 
specifically rodents, the role of NO has yet to be described at the level of the spinal 
motor neuron. 
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4.1.5 Scope and importance of this study 
 
The modulation of spinal locomotor networks by NO has been demonstrated, previously 
in the tadpole and lamprey and in the mouse, in Chapter 3 of the present study. Despite 
the research characterising NO effects on synaptic transmission, little is known about 
the NO-mediated modulation of intrinsic motor neuron properties. 
 
This chapter details the investigation of NO-mediated effects on the intrinsic properties 
of lumbar spinal motor neurons. The passive and active properties of motor neurons in 
lumbar spinal cord slices were recorded in response to the bath application of NO 
donor, DEA NO, and the membrane permeable scavenger of NO, PTIO. Identifying and 
clarifying a mechanism for the actions of NO observed on ventral root output during 
fictive locomotion will enhance our basic understanding of motor neuron physiology. 
Describing a mechanism for NO mediated effects in the context of the locomotor 
circuitry will also provide additional knowledge for consideration in dysfunctional and 
damaged circuits as a result of injury and illness.  
  
The aim of the present study was therefore to investigate potential NO modulation of 
lumbar spinal neuron intrinsic properties. 
 
 
4.2 Materials and Methods 
 
4.2.1 Tissue collection and preparation   
 
All experiments were performed in accordance with the United Kingdom Animals 
(Scientific Procedures) Act 1986. 
 
C57BL6 wild-type mice (P1-9) were obtained from Charles River Laboratories 
(Scotland, UK).  The mice were bred under conditions of a 12-h light/dark cycle in 
individual ventilated cages at a constant temperature of 22°C and 56% humidity and had 
free unrestricted access to food and water. All procedures were carried out at room 
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temperature (RT) (20-22°C). Following cervical dislocation, decapitation and 
evisceration, a segment of the spinal cord extending from the mid-thoracic to mid-sacral 
region was isolated in a sylgard-lined dissection chamber containing oxygenated (95% 
O2/5% CO2) dissecting solution on ice. The pia mater was removed and the nerve roots 
trimmed before the cord was mounted in an agar block and attached to a magnetic 
specimen plate using cyanoacrylate adhesive. The specimen plate was then moved to a 
buffer chamber containing oxygenated dissecting solution on ice. Transverse slices of 
lumbar spinal cord, 300μm thick, were cut from the immobilised block of spinal cord 
using a Leica VT1200 microtome with vibrating blade (Leica Biosystems, GmbH). 
Slices were transferred to oxygenated recovery solution and placed in a water bath set at 
35°C for 30-40 minutes before transferral to oxygenated recording solution at room 
temperature. For composition of solutions, see Section 4.2.6. 
 
 
4.2.2 Identification of neurons 
 
Neurons were classified as either motor neurons (MN) or interneurons (IN) based on 
location and size. In a subset of experiments, the fluorescent retrograde marker, Fluoro 
Gold (Fig. 4.1A-D), was used to confirm validity of the criteria used to select presumed 
motor neurons (Miles et al., 2005, Miles et al., 2007).  
 
Location 
Presumed motor neurons were selected from the lateral and medial motor pools (lamina 
IX) in the ventral horn of the lumbar spinal cord. Neurons located outside the motor 
pools and within the ventral region of the ventral horn, at the level of or below the 
central canal, were termed interneurons (Fig.4.2B, Fig.4.6C and Fig.4.10A). 
 
Size 
Cells were further identified by whole cell capacitance (Cm) calculated by pClamp 10 
software (Axon Instruments); cells were considered IN if the Cm values ranged from 
17-49pF and MN if the Cm values ranged from 50-139pF. 
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Retrograde labelling of motor neurons 
In a small subset of animals (n=2), the neuronal tracer Fluoro Gold was used as a 
retrograde marker for presumed motor neurons (herein the terms motor neuron, MN, 
and presumed motor neuron, pMN, are used interchangeably). As previously described, 
one to two days before experimentation intraperitoneal (i.p.) injections of FluoroGold 
(0.04 mg/g; Fluorochrome Inc., Denver, CO) were administered to mice in order to 
retrograde label MNs (Miles et al., 2007). Spinal cord slices were prepared as described 
(Section 4.2.1). FluoroGold-positive MNs were visualized with epifluorescence and 
infrared differential interference contrast (DIC) microscopy (Fig. 4.1A-D).  
 
 
Figure 4.1. Intracellular recordings were made from identified lumbar spinal motor neurons. A 
Recordings from motor neurons were made in 300µm slices of lumbar spinal cord (glass electrode 
indicated by dotted lines). B DIC image of motor neuron (dotted line indicates perimeter). C I.p. injection 
of retrograde neuronal tracer Fluorogold was used to confirm motor neurons location. D Fluorescent dye, 
Alexa 594 was added to the intracellular electrode solution to visualise neuron after successful recording. 
E Illustration of the lumbar spinal cord slice with approximate location of motor neuron and patch 
electrode. Image adapted from the original (Courtesy Dr Gareth Miles). F Sodium channels were 
activated using brief depolarizing voltage steps to confirm intracellular configuration and cell viability. 
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4.2.3 Data collection  
 
Patch-clamp signals were amplified and filtered (4-kHz low-pass Bessel filter) with a 
MultiClamp 700B amplifier (Molecular Devices) and acquired at ≥10 kHz using a 
Digidata 1440A A/D board and pClamp 10 software (Molecular Devices).  
Whole cell patch-clamp recordings were analysed using Clampfit software (Molecular 
Devices) and series resistance (Rs), whole-cell capacitance (Cm), and input resistance 
(Rn) values were calculated by pClamp 10 software. 
 
 
4.2.4 Whole-cell patch-clamp recording protocols and data analyses  
 
Experiments were performed on lumbar spinal cord slices obtained from neonatal mice 
aged P1-9. Experiments were performed in a recording chamber that was perfused at 
room temperature with oxygenated recording solution. Patch electrodes (3-4MΩ) were 
pulled on a horizontal puller (Sutter Instrument, Novato, CA) from borosilicate glass 
(World Precision Instruments, Sarasota, FL).  
 
Whole-cell patch-clamp recordings were made from neurons located throughout the 
ventral horn of the spinal cord (see Fig. 4.2B, Fig. 4.6C and Fig. 4. 10A). Neurons were 
visualized under infrared differential interference contrast (DIC) and fluorescent 
microscopy in experiments where the fluorescent compound, Alexa Fluor 594, was 
added to the intracellular electrode solution. 
 
As sodium currents drive action potential firing, Na
+
 current activation protocols were 
run in voltage-clamp mode to confirm whole-cell configuration and cell viability. Na+ 
currents were activated using a series of voltage steps (-70 to +20 mV, 2.5-mV 
increments, and 10-ms duration) from a holding potential of -60 mV in voltage-clamp 
mode (Fig. 4.1F). 
 
During current-clamp protocols, sub-threshold changes in the resting membrane 
potential were offset by direct current injection to maintain the resting membrane 
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potential at -60mV, except where resting membrane potential remained steady at rest 
(Vm  = -63 to -58mV). Current-clamp protocols were run in control recording solution 
and in recording solution containing pharmacological agents that manipulate NO-
mediated signalling. Protocols were run in the period immediately before addition of 
pharmacological agents to the perfusate (Control), and then repeated three to five 
minutes (unless otherwise noted) after addition of pharmacological agents to the 
perfusate (Drug condition).  Where possible, current-clamp protocols were then 
repeated after the circulating solution had been gradually replaced by fresh recording 
solution (Wash).  
 
Current-clamp protocols were performed to investigate the passive (rest, sub-threshold) 
and active (firing, supra-threshold) properties of neurons in Control, Drug condition, 
and Wash as previously described. 
 
Sub-threshold properties 
The input resistance (Rn) of neurons was determined by measuring the membrane 
potential changes in response to the input of incremental, depolarising steps of square 
current (1s) (between 5 and 20 steps) applied in the sub-threshold range. Steady-state 
input resistance was measured from the slope of the linear regression of the mean 
membrane potential response to the sub-threshold range of depolarising steps of square 
current (Fig. 4.2A-C).  
 
Supra-threshold properties  
Repetitive firing of action potentials was evoked in neurons by the injection of square 
depolarizing current pulses (1-s duration). Where the Vm was affected by sub-threshold 
changes in potential, these were offset by direct current injection. This ensured that any 
changes induced by the pharmacological agent on membrane potential were isolated 
from other potential modulatory effects specifically affecting firing properties. The 
steady-state frequency-current (f–I) relationship was measured using the slope (Hz/nA) 
of the linear regression of the average steady state frequency. Spike frequency 
adaptation (the time-dependent decrease in action potential discharge rate) is an intrinsic 
property of mammalian motor neurons (Miles et al., 2005). To avoid adaptation that 
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occurs during the initial phase of repetitive firing, only the firing evoked during the 
second half (between 500 and 1000ms of 1s pulse) of depolarising current steps was 
used to produce steady-state f-I relationships (Fig.  4.3A-C).  
 
The rheobase current, defined as the minimum current needed to elicit a single action 
potential (or the first current step to elicit action potentials), and the maximum firing 
frequency were also calculated using the f–I data (Fig. 4.3D and E). 
 
Depolarising current-ramps (1s) ranging from between 500 to 2000pA were used to 
investigate the voltage threshold (mV), maximum rate of rise (V/s), and amplitude (mV) 
of the first action potential generated. Differentiation of the voltage traces recorded in 
response to current ramps (arithmetic calculation performed in Clampfit 10 software) 
was used to calculate the onset of action potentials (defined as the voltage at which 
dV/dT reached 10mV ms
-1
) and hence their voltage threshold (mV), and the maximum 
rate of rise (V/s) of action potentials. The amplitude (mV) of the first action potential 
elicited by ramp protocols was measured from raw data (Fig.  4.4A-D).  
 
Single action potentials were elicited by brief (10-ms) current pulses of increasing 
magnitude in order to allow measurement of the AHP. AHP amplitudes were measured 
as the difference between the resting membrane potential (from holding membrane 
potential -60mV) or rest, where rest was -60mV) and peak AHP (Fig.  4.5A-C).  
 
 
4.2.5 Statistics 
 
All data are reported as mean ± SEM. Differences in means were compared using either 
the one way analysis of variance or repeated measures analysis of variance, with 
Bonferroni post test (ANOVA; GraphPad Prism software, Graphpad, La Jolla, CA). 
Values of P < 0.05 were considered significant and data are presented as mean ±SEM.  
Statistical significance is indicated by asterisk as follows; * = P<0.05, ** = P<0.01, *** 
= P<0.001, **** = P<0.0001.  
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4.2.6 Solutions and Reagents 
 
4.2.6.1 Solutions 
 
Solutions were made according to previously published protocols (Miles et al., 2005, 
Iwagaki and Miles, 2011). The spinal cord is fragile and neurons are very sensitive to 
mechanical and ischemic/excitotoxic damage. The modified dissecting solution is used 
to reduce excitotoxicity ischemia by reducing the circulating Na concentration by 
substituting NaCl with charge neutral sucrose and adding a non-selective glutamate 
receptor antagonist (Aghajanian and Rasmussen, 1989). The ionic balance of aCSF and 
intracellular solution were consistent with maintaining a resting membrane potential of -
60mV according to the Goldman-Hodgkin-Katz voltage equation. 
 
Dissecting solution 
The sucrose substituted, dissecting aCSF composition: 25mM NaCl; 188mM sucrose; 
1.9mM KCl; 1.2mM NaH2PO4; 10mM MgSO4; 1mM CaCl2;; 26mM NaHCO3; 25mM 
glucose; and 1.5mM kynurenic acid.  
 
Recovery solution 
The recovery aCSF composition: 119mM NaCl; 1.9mM KCl; 1.2mM NaH2PO4; 10mM 
MgSO4; 1mM CaCl2; 26mM NaHCO3; 20mM glucose;1.5mM kynurenic acid; and 3% 
dextran. 
 
Recording solution  
The recording aCSF composition: 127mM NaCl; 3mM KCl; 2mM CaCl2; 1mM MgCl2; 
26mM NaHCO3; 1.25mM NaH2PO4; and 10mM glucose. 
 
Intracellular solution 
The intracellular aCSF composition: 134mM potassium methane sulfonate, 10mM 
NaCl, 1mM CaCl2, 10mM HEPES, 1mM EGTA, 3mM Mg-ATP, and 0.4mM GTP-Na2 
(pH 7.2–7.3, adjusted with KOH).  
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4.2.6.2 Reagents 
 
Reagents obtained from Sigma-Aldrich Company Ltd., Dorset, UK were: 
2-Phenyl-4, 4, 5, 5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO); and 8-
Bromoguanosine 3′, 5′-cyclic monophosphate sodium salt (8BrcGMP). Described 
previously in Section 3.2.5.2   
 
Reagents obtained from Fluorochem Ltd., Derbyshire, UK were:  
2-(N, N-Diethyl amino)-diazenolate-2-oxide.Diethylammonium salt (DEA NO). 
Described previously in Section 3.2.5.2    
 
Reagents obtained from Invitrogen, Paisley, UK were:  
Alexa Fluor 594 hydrazide sodium salt, a fluorophore with excitation/emission maxima 
of ~590/617 nm (Molecular Probes). 
 
Reagents obtained from Fluorochrome, Colorodo, USA were: 
Fluoro-Gold (Hydroxystilbamidine), a fluorescent, retrograde neuronal tracer, incapable 
of trans-synaptic transport. Visualised using fluorescent microscopy, 
excitation/emission maxima of ~323/408 nm (Fluorochrome, LLC). 
 
 
4.3 Results 
 
4.3.1 Modulation of motor neuron properties by DEA NO 
 
DEA NO is used widely in bioscience research to increase experimental levels of NO. 
In the previous chapter, a concentration-dependent response to DEA NO was 
established in pharmacologically induced fictive locomotion (Chapter 3, Section 3.3.1). 
Recordings from ventral roots showed that increased concentrations of exogenous NO, 
delivered using DEA NO, caused a reduction in the frequency of fictive locomotion 
suggesting an inhibitory role for exogenous NO in the hind limb locomotor central 
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pattern generating network. DEA NO also caused an increase in the burst amplitude of 
fictive locomotor output at low concentrations (50µM), and a transient increase 
followed by a decrease in burst amplitude at higher concentrations (200 and 400µM). 
These effects on burst amplitude suggest direct modulation of motor neurons and/or last 
order interneurons by NO.  
 
These results clearly show that NO-mediated modulation occurs during locomotor 
network activity but do not indicate whether NO is produced as a result of network 
activity nor the mechanisms by which it exerts its effects. To ascertain whether or not 
NO modulates the properties of neurons in the locomotor network in the absence of 
induced activity, the whole-cell patch-clamp technique was used to investigate potential 
modulation, by DEA NO, of the intrinsic properties of spinal motor neurons. Motor 
neurons are a relatively homogenous population of neurons; identifiable by their size, 
location in the spinal cord and firing properties, additionally they are the final common 
pathways for central control of muscles in the periphery. These properties make motor 
neurons ideal for the characterisation of modulatory effects exerted by neurotransmitters 
such as NO, as their immediate and end organ effects can be observed. In the present 
study, the effects of NO were studied at the level of the motor neuron in the in vitro 
slice preparation.  
 
Whole cell recordings were made from forty-two presumed motor neurons, identified by 
size (capacitance) and location in the ventral horn (lamina IX) (Fig. 4.1A). From this 
collection of recordings, neurons with a resting membrane potential greater than -50mV 
and those that did not fire repetitively (a hallmark of motor neurons) during control or 
pharmacological manipulation were discarded from the following analysis (total 
neurons analysed: 10µM, n= 7; 50µM, n=7; 200µM, n=6).  
 
Protocols investigating the modulation of the firing properties of motor neurons before, 
during, and after exposure to DEA NO were run in current-clamp mode. During the 
current-clamp protocol, the resting membrane potential was maintained at -60mV, by 
offsetting sub-threshold changes in potential using direct current injection. DEA NO 
was bath applied at concentrations of 10µM, 50µM, 200µM and 400µM (n= 7, n=7, 
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n=1 and n=5 respectively) and the results for the 200-400µM experiments pooled and 
described as >200µM. These results describe the effects of the NO donor DEA NO at 
10µM, 50µM and >200µM on twenty motor neurons. The passive properties of the 
twenty neurons from which recordings were made are listed in Table 2.1. 
 
  
 
The results of DEA NO application to presumed motor neurons were collated by 
concentration: 10, 50µM and >200µM DEA NO. The effects of DEA NO on the 
following intrinsic neuronal properties were analysed: input resistance (MΩ); 
frequency-current (f–I) relationship (slope – Hz/nA); relative excitability; rheobase 
current; maximum firing frequency (Hz); action potential voltage threshold (mV); 
maximum rate of rise of action potential (V/s); fast AHP and slow AHP; and action 
potential amplitude (mV). For clear comparison between concentrations of DEA NO 
and motor neurons of different sizes (Cm range from 50-103pF), effects on these 
parameters are expressed as a percentage of the control value, unless stated otherwise. 
 
Sub-threshold properties 
Overall the resting membrane potential did not significantly change in the presence of 
10 and 50µM DEA NO. A small depolarisation was noted at >200µM DEA NO. 
However, the response of individual neurons to DEA NO varied at each concentration. 
The resting membrane potential hyperpolarised (ns; n=4/7) and depolarised (ns; n=3/7) 
in each group during application of 10µM and 50µM DEA NO, while during 
application of >200µM DEA NO, the resting membrane appeared to depolarise (ns, 
Δ3.5±2mV n=5/6). 
 
The input resistance (Rn) of motor neurons was determined before and after the addition 
of DEA NO by measuring the membrane potential changes in response to the input of 
incremental, depolarising steps of square current applied in the sub-threshold range 
Drug  Cell type  n Cm, pF Vm, mV Rn, MΩ 
DEA NO MN 20 86±4 -57±1 58±4 
DEA NO IN 5 31±5 -49±4 / 
PTIO MN  7 71±4 -57±2 94±11 
Table 4.1. Spinal motor neuron passive properties 
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(Fig. 4.2B). The mean membrane potential response to each current step was plotted to 
give the voltage-current (V-I) relationship (Fig.4.2C). Overall input resistance was not 
significantly affected by application of DEA NO (Fig.4.2D). 
 
DEA NO does not significantly affect the sub-threshold properties of motor neurons; 
there was no significant change in input resistance and resting membrane potential. 
Further confirmation that NO does not modulate sub-threshold properties would be 
gained by increasing the experimental sample size. 
 
Supra-threshold properties  
To investigate the effect of exogenous NO on supra-threshold motor neuron properties, 
DEA NO was bath-applied to lumbar spinal cord slices while recording from presumed 
motor neurons. The mean firing frequency was recorded during a series of incremental 
steps of depolarising current and the resulting firing frequency was plotted against the 
injected current (Fig. 4.3A and B). The frequency versus injected current, or frequency-
current (f–I) relationship, was determined in control conditions and during the 
application of DEA NO at concentrations of 10µM, 50µM and >200µM.  
 
At 10µM DEA NO, neurons appeared marginally more excitable compared to control 
and at the concentrations of 50µM and greater than 200µM, DEA NO did not cause a 
shift in frequency-current relationship or a change in the slope of the relationship (all 
concentrations, Fig. 4.3C). 
 
During repetitive firing protocols, the additional measures of excitability - rheobase and 
maximum firing frequency, were measured. This measure of rheobase should be taken 
as an approximation as the depolarising steps injected to elicit repetitive firing and used 
for this calculation are relatively large (100pA). DEA NO did not affect rheobase at 
10µM, 50µM and >200µM DEA NO (Fig. 4.2D). The maximum firing frequency was 
significantly increased at 10µM DEA NO (P<0.05; +48±14%, n=6) but no change was 
observed at 50µM and >200µM DEA NO (Fig. 4.3E). 
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A depolarising current-ramp, analogous to synaptic input, was used to elicit an action 
potential to determine the change in action potential parameters during control and drug 
condition.  The voltage response to a depolarising current-ramp was used to measure the 
action potential amplitude and the voltage response to a depolarising current-ramp 
differentiated to calculate the maximum rate of rise, firing threshold of the first action 
potential fired (Fig. 4.4A). 
 
The voltage threshold for the firing of an action potential was significantly 
reduced/hyperpolarized after the removal of 10µM DEA NO (P<0.05; -14±5%, n=6) 
and >200µM DEA (P<0.05; -34±10%, n=5) but no change was observed at 50µM (Fig. 
4.4C). The maximum rate of rise and action potential amplitude were not significantly 
changed during 10µM, 50µM or >200µM DEA NO application (Fig. 4.4B and D, 
respectively). 
 
The amplitude of the fast and slow AHP (fAHP and sAHP, respectively) was measured 
in control and during DEA NO application (Fig. 4.5A). The amplitude of the fAHP was 
not affected by application of 10µM, 50µM and 200µM DEA NO, furthermore, 
application of 10µM, 50µM and 200µM DEA NO did not significantly affect sAHP 
amplitude (Fig. 4.4C and D, respectively). However, during the washout of 50µM DEA 
NO the fAHP decreased in amplitude (P<0.05; -38±10%, n=4; Fig.  4.5C). 
 
These experiments suggest that, DEA NO, may have an excitatory effect on motor 
neurons. Application of DEA NO increased the maximum firing frequency at10µM and 
depolarised the resting membrane potential at higher concentrations (>200µM). The 
mechanism by which NO modulates spinal motor neurons is currently unknown, thus 
limiting the interpretation of this relatively small sample size, in the absence of further 
mechanistic information. These data are indicative of a potential role for NO-dependent 
modulation of the excitability of spinal motor neurons. However, as the effects of NO 
were relatively small and varied between cells, within and between the concentrations 
used in the present study, further experiments are necessary to clarify the trends and 
effects identified in the present study and the statistical significance thereof. 
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Figure 4.2. DEA NO does not affect the sub-threshold properties of spinal motor neurons. Cell plots 
indicating location of motor neurons exposed to Ai 10µM, Aii 50µM and Aiii >200µM. The change in 
membrane potential was recorded during Bi Control (aCSF alone), DEA NO (50µM) and Wash (aCSF 
alone) in response to Bii sub-threshold depolarising current steps. C Plot of the V-I relationship of a 
motor neuron obtained from the sub-threshold current step protocol in A. D Input resistance was not 
significantly affected by DEA NO application. Normalised input resistance of motor neurons in the 
presence of DEA NO (10µM, control and DEA NO n=7 and wash n=2; 50µM, control and DEA NO n=7 
and wash n=7; >200µM, control and DEA NO n=6 and wash n=5). 
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Figure 4.3. NO has a limited effect on the firing properties of spinal motor neurons. Ai Repetitive firing 
was recorded in Control (aCSF alone), DEA NO (50µM) and Wash (aCSF alone) in response to Aii 
incremental 1s square depolarising current steps (1100pA illustrated). B Firing frequency versus injected 
current (f-I) relationship shows no change during application of DEA NO (50µM). C The slope of the f-I 
relationship was not significantly affected by DEA NO at all concentrations (10µM, control and DEA NO 
n=7 and wash n=3; 50µM, control and DEA NO n=7 and wash n=6; >200µM, control and DEA NO n=6 
and wash n=5). D the current required to elicit a single action potential, rheobase, was significantly 
decreased at 50µM DEA NO (P<0.05; control and DEA NO n=7 and wash n=6). Rheobase was not 
significantly affected by application of 10µM DEA NO, (control and DEA NO n=7 and wash n=4) or 
>200µM DEA NO (control and DEA NO n=6 and wash n=5). E Maximum firing frequency was 
significantly increased during application of 10µM DEA NO (control and DEA NO n=7 and wash n=3) 
but no effect was observed at 50µM DEA NO (control and DEA NO n=7 and wash n=6) or >200µM 
DEA NO (control and DEA NO n=6 and wash n=5). Asterisk denotes significance. 
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Figure 4.4. NO has subtle effects on action potential parameters. Ai Action potentials were recorded in 
Control (aCSF alone), DEA NO (50µM) and Wash (aCSF alone) in response to Aii a depolarising ramp 
of current (2000pA illustrated). B The maximum rate of rise (MRR) of the first action potential elicited 
by the ramp was not affected by the application of DEA NO but the MRR was significantly reduced after 
washout of 50µM DEA NO (10µM, control and DEA NO n=7 and wash n=4; 50µM, control and DEA 
NO n=6 and wash, P<0.05, n=5; >200µM, control and DEA NO n=6 and wash n=5). C The voltage 
threshold for action potential generation was significantly reduced during application of 50µM DEA NO 
and after washout of 10µM and >200µM DEA NO (10µM, control and DEA NO n=7 and wash, P<0.05, 
n=4; P<0.05, 50µM, control and DEA NO n=6 and wash n=5; >200µM, control and DEA NO n=6 and 
P<0.05, wash n=5). D The action potential amplitude was not significantly affected by DEA NO but was 
significantly reduced after washout of 50µM DEA NO (10µM, control and DEA NO n=7 and wash n=4; 
50µM, control and DEA NO n=6 and wash, P<0.05, n=5; >200µM, control and DEA NO n=6 and wash 
n=5). Asterisk denotes significance. 
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Figure 4.5. NO modulates the action potential AHP. Ai, Bi Action potentials were recorded in Control 
(aCSF alone), DEA NO (50µM) and Wash (aCSF alone) in response to Aii an incremental depolarising 
square current pulse (300pA illustrated and Bii incremental 1s square depolarising current steps (1100pA 
illustrated). C The fast AHP was decreased by the application of 50µM DEA NO (10µM, control and 
DEA NO n=7 and wash n=5; P<0.05, 50µM, control and DEA NO n=7 and wash n=6; >200µM, control 
and DEA NO n=3 and wash n=2). D The slow AHP was not significantly affected by the application of 
DEA NO (10µM, control and DEA NO n=7 and wash n=3; P<0.05, 50µM, control and DEA NO n=7 and 
wash n=6; >200µM, control and DEA NO n=6 and wash n=3).  
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4.3.2 Endogenous modulation of motor neuron properties by nitric oxide  
 
In order to investigate the potential role of endogenously produced NO in the 
modulation of the intrinsic properties of spinal motor neurons, the nitronyl nitroxide NO 
scavenger, PTIO, was bath-applied to the lumbar spinal cord slices while recording 
from presumed motor neurons.  
 
PTIO is a NO scavenger, referred to as membrane permeable as it is considerably more 
lipophilic than the carboxy analogue (cPTIO) and therefore will scavenge NO in both 
extra- and intra-cellular environments. Recordings from ventral roots showed that 
removal of endogenous NO during fictive locomotion by PTIO caused an increase in 
locomotor frequency, possibly by inhibition of excitatory output from the CPG, and an 
increase in locomotor amplitude, by scavenging NO and preventing activation of sGC at 
the level of the last order interneurons or directly at the motor neuron (Chapter 3, 
Section 3.3.2). These experiments suggest that NO has an endogenous modulatory role 
in the locomotor network; thus, PTIO was used to investigate changes to the intrinsic 
properties of presumed motor neurons. 
 
Whole cell recordings were made from twelve presumed motor neurons, identified by 
size (capacitance) and location (Fig. 4.6C) in the ventral horn (lateral motor pools). 
From this collection of recordings, neurons with a resting membrane potential greater 
than -50mV were discarded. To maintain the resting membrane potential at -60mV, sub-
threshold changes in potential induced by drug applications were offset by direct current 
injection. The passive neuron properties of the eight neurons from which recordings 
were made are listed in Table 2.1. These results describe the collated effects of the NO 
scavenger PTIO on the eight motor neurons.  
 
The effect of PTIO on the following sub-threshold and supra-threshold intrinsic 
neuronal properties is reported: input resistance (MΩ); frequency-current (f–I) 
relationship (slope – Hz/nA); rheobase current; maximum firing frequency (Hz); firing 
threshold (mV); maximum rate of rise (V/s); fast AHP and slow AHP; and action 
potential amplitude (mV).  
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Sub-threshold properties 
Overall the resting membrane potential did not appear to change with the application of 
PTIO (50µM); the resting membrane did not change in four cells, though it was 
marginally hyperpolarised in three cells and slightly depolarised in one cell during 
application of PTIO (ns; mean ΔRm =3±3mV; n=8).  
 
The input resistance (Rn) of motor neurons was determined before and after addition of 
50µM PTIO by measuring the membrane potential change from -60mV in response to 
the input of incremental, depolarising steps of square current (1s) applied in the sub-
threshold range. The mean membrane potential response to each current step was 
plotted to give the voltage-current (V-I) relationship (Fig.4.6A and B). PTIO caused an 
increase in the slope of the voltage-current relationship (n=6/8; Fig. 4.6A and B) and 
did not significantly alter the input resistance of motor neurons. 
 
Supra-threshold properties 
Next, the effects of the removal of endogenously produced NO on the frequency versus 
injected current or f–I relationships of motor neurons was investigated. The mean firing 
frequency was recorded during a series of incremental steps of depolarising current and 
the resulting firing frequency was plotted against the injected current. 
 
In four of the eight cells from which recordings were made, an increase in excitability, 
indicated by the shift of the steady-state frequency-current relationship in an upward 
direction and to the left hand side, was noted in half of the neurons from which 
recordings were made (no change, n=4/8 and increase, n=4/8; Fig.4.7A and B). 
However, PTIO did not significantly change the excitability of motor neurons during 
repetitive firing as indicated by the slope of the relationship.  
 
During repetitive firing protocols, the additional measures of excitability, rheobase 
current, and maximum firing frequency were measured in the group of eight neurons. 
PTIO did not significantly affect rheobase current (the minimum current required to 
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elicit an action potential) and from the frequency-current relationship data no change in 
maximum firing frequency was noted (Fig.4.7D).  
 
A depolarising current-ramp, analogous to synaptic input, was used to elicit an action 
potential to determine the change in action potential parameters during control and drug 
condition.  The voltage response to a depolarising current-ramp was used to measure the 
action potential amplitude and the voltage response to a depolarising current-ramp 
differentiated to calculate the maximum rate of rise, firing threshold of the first action 
potential fired (Fig. 4.8A). The maximum rate of rise and action potential amplitude 
were not significantly affected during PTIO application (Fig.4.8B and D, respectively). 
The voltage threshold for the firing of an action potential remained unchanged (Fig. 
4.8C). 
 
The amplitude of the fast and slow action potential AHP (fAHP and sAHP, 
respectively) was measured in control and during PTIO application (Fig. 4.9A and B, 
respectively). Overall, during the application of PTIO, the amplitude of the fAHP and 
the sAHP were not significantly affected (Fig.4.8A to D, respectively). However, both 
the fAHP and sAHP decreased in amplitude after PTIO was removed from the perfusate 
(P<0.05; -43±23%, n=6 and -58±22%, n= 6; Fig.4.9C and D, respectively). 
 
From these data obtained from experiments using the NO scavenger PTIO to remove 
endogenous NO, it is likely that NO has an excitatory role in the modulation of motor 
neuron intrinsic properties as demonstrated by the decrease in both fAHP and sAHP, 
after removal of the NO scavenging agent, PTIO. These data suggest that endogenous 
NO is involved in the subtle modulation of the intrinsic properties of spinal motor 
neurons while the locomotor network is quiescent. 
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Figure 4.6. The NO scavenger PTIO does not alter the sub-threshold properties of spinal motor neurons. 
The change in membrane potential was recorded during Ai Control (aCSF alone), PTIO (50µM added to 
perfusate) and Wash (aCSF alone) in response to Aii sub-threshold depolarising current steps. B Plot of 
the V-I relationship of a motor neuron in control, PTIO and wash. C Cell plot indicating location of motor 
neurons exposed PTIO. D Input resistance was not significantly affected during PTIO application but was 
significantly reduced during wash (control and PTIO n=8 and wash n=5; P<0.05; asterisk indicates 
significance). 
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Figure 4.7. Endogenous sources of NO do not alter the firing properties of quiescent motor neurons. Ai 
Repetitive firing was recorded in Control (aCSF alone), PTIO (50µM added to perfusate) and Wash 
(aCSF alone) in response to Aii incremental 1s square depolarising current steps (900pA illustrated). B 
Firing frequency versus injected current (f-I) relationship exhibits a shift to the left-hand side indicating 
an increase in excitability during application of PTIO (50µM). C The slope of the f-I relationship was not 
significantly affected by PTIO at all concentrations (control and DEA NO n=8 and wash n=6). D the 
current required to elicit a single action potential, rheobase, was not significantly altered during PTIO 
application (control and PTIO n=8 and wash n=5). E The maximum firing frequency was not 
significantly affected by application of 50µM PTIO (control and PTIO n=8 and wash n=5).  
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Figure 4.8. Removal of endogenous NO does not alter action potential parameters. Ai Action potentials 
were recorded in Control (aCSF alone), PTIO (50µM added to perfusate) and Wash (aCSF alone) in 
response to Aii a depolarising ramp of current (1500pA illustrated). B The maximum rate of rise (MRR), 
C voltage threshold for action potential generation and D action potential amplitude were not 
significantly affected by the application of PTIO (control and PTIO n=8 and wash n=5). However, both 
the MRR and AP amplitude showed trends towards a decrease. A larger sample of neurons is needed to 
determine whether this trend is significant. 
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Figure 4.9. Endogenous NO modulates the action potential AHP. Ai, Bi Action potentials were recorded 
in Control (aCSF alone), PTIO (50µM added to perfusate) and Wash (aCSF alone) in response to Aii an 
incremental depolarising square current pulse (320pA illustrated and Bii incremental 1s square 
depolarising current steps (900pA illustrated). C The fast AHP was not affected by the application of 
50µM PTIO but was significantly reduced during washout (control and PTIO n=8 and P<0.05, wash 
n=6). D The slow AHP was not affected by the application of PTIO but was significantly reduced during 
washout (control and PTIO n=8 and P<0.05, wash n=6). 
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4.3.3 Modulation of interneuron properties by DEA NO 
 
The laminae of the ventral horn are populated by a heterogeneous population of 
interneurons. Developmental genetic studies combined with electrophysiological 
analyses have identified four heterogeneous classes of ventral interneurons (V0-V3) and 
at some level ascribed function to each class, as discussed in Section 1.1.2. These 
interneurons have been studied intensely to understand their role in the central pattern 
generating network and motor neuron output. In the present study, the effect of NO on a 
small group of unidentified, ventral interneurons was investigated. 
 
Whole cell recordings were made in a small subset of eleven interneurons identified by 
size (capacitance) and location (Fig. 4.10A) in the ventral horn (lamina VII or X). From 
this collection of recordings, neurons with a resting membrane potential greater than -
50mV, and those that did not fire repetitively during control or pharmacological 
manipulation, were discarded. To maintain the resting membrane potential at -60mV, 
sub-threshold changes in potential were offset by direct current injection. These results 
describe the effects of DEA NO (200/400μM) on the remaining 5 interneurons. The 
passive neuron properties of the 5 neurons from which recordings were made are listed 
in Table 2.1. 
 
From this collection of recordings, neurons with a resting membrane potential greater 
than -50mV, and those that did not fire repetitively during control or pharmacological 
manipulation, were discarded. To maintain the resting membrane potential at -60mV, 
sub-threshold changes in potential were offset by direct current injection. These results 
describe the effects of  DEA NO (200/400μM) on the remaining five interneurons. The 
passive neuron properties of the five neurons from which recordings were made are 
listed in Table 2.1. 
 
During these experiments, data investigating the sub-threshold changes due to DEA NO 
in interneurons were not collected. It is therefore unclear, within this group of five 
neurons from which recordings were made, whether or not there was a passive increase 
or decrease in resting membrane potential as a result of the application of DEA NO. 
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Supra-threshold properties 
The effect of >200µM DEA NO on the frequency versus injected current or frequency-
current (f–I) relationship was investigated as previously described. 
 
DEA NO caused a mixed response in excitability, indicated by the shift of the 
frequency-current relationship in an upward direction and to the left hand side in 2/5 
neurons and a shift to a less excitable downward right hand side in 3/5 neurons. There 
was no correlation between the direction of shift of the frequency-current relationship 
and the magnitude of the slope. Overall, no effect on the slope of the frequency-current 
relationship was observed after DEA NO application, though the response of individual 
neurons was varied (Fig. 4.10B). 
 
During repetitive firing protocols, the additional measures of excitability, rheobase 
current, and maximum firing frequency were noted. Neither the maximum firing 
frequency nor rheobase current, were affected by application of DEA NO (Fig. 4.10C 
and D, respectively).  
 
As previously described, the voltage response to the current ramp was used to calculate 
the maximum rate of rise, firing threshold, and action potential amplitude. The 
maximum rate of rise was not significantly affected during DEA NO application and 
from the ramp protocol data, it was noted that the voltage threshold for the firing of an 
action potential did not significantly depolarise (n=4; mean Δ threshold= 2±1mV; min.Δ 
=0mV, max.Δ=6mV; Fig. 4.10F). Overall action potential amplitude was not affected 
by DEA NO (Fig. 4.10G).  
  
The fast and slow action potential AHP amplitude was measured using the protocol 
described previously. The amplitude of both the fast and slow action potential AHP was 
not significantly affected by the application of DEA NO (Fig. 4.10H and I, 
respectively). 
  
  
Chapter 4 
145 
 
Figure 4.10. The effect of DEA NO the intrinsic properties of unidentified interneurons. A Cell plot 
indicating location of interneurons recorded from during DEA NO application. B The slope of the f-I 
relationship was not significantly affected by DEA NO (200µM, control and DEA NO n=5 and wash 
n=3). C The maximum firing frequency was not significantly affected by DEA NO (200µM, control and 
DEA NO n=5 and wash n=3). D Rheobase was not significantly affected by DEA NO (200µM, control 
and DEA NO n=5 and wash n=3). E The maximum rate of rise was not significantly affected by DEA NO 
(200µM, control and DEA NO n=4 and wash n=3). F The voltage threshold for the generation of an 
action potential was not significantly affected by DEA NO (200µM, control and DEA NO n=4 and wash 
n=3). G The action potential amplitude was not significantly affected by DEA NO (200µM, control and 
DEA NO n=4 and wash n=3). H, I Both the fast and slow AHP were not affected by application of DEA 
NO (200µM, control and DEA NO n=4 and wash n=2). 
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Though the effects of DEA NO on AHP were not significant, recordings from a larger 
sample of neurons, or identified subtypes of interneurons may reveal provide 
clarification of potential DEA NO-mediated reduction in the AHP of interneurons.  
 
These data are not conclusive but do suggest that NO may reduce interneuron 
excitability (trends towards depolarised firing threshold and reduced maximum rate of 
rise). Due to the heterogeneous nature of the interneuron population and the absence of 
any phenotypic markers in this study, these data are indicative of the possibility that NO 
modulates the intrinsic properties of interneurons. A larger sample of recordings, 
preferably in identified interneurons, is needed to confirm and clarify these findings. 
 
 
4.4 Discussion 
 
In the present study, recordings were made from lumbar spinal motor neurons during 
application of DEA NO and the membrane permeable NO scavenger PTIO. The results 
in this chapter provide evidence for NO-mediated modulation of the intrinsic properties 
of spinal neurons.  
 
4.4.1 DEA NO modulates the intrinsic properties of motor neurons  
 
Despite the mixed effect on motor neurons of DEA NO, the major finding in this 
chapter is that NO appears to directly excite lumbar spinal motor neurons. The 
mechanism of this excitatory action is as yet undefined and will require further 
investigation, particularly the hyperpolarisation of the action potential firing threshold 
and reduction in action potential AHP.  
  
DEA NO did not appear to modulate the sub-threshold properties of motor neurons. 
This is in agreement with the finding that NO does not change the resting properties of 
trigeminal motor neurons in the neonatal rat (Pose et al., 2011).  
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DEA NO appeared to increase the excitability of motor neurons by increasing the ability 
of motor neurons to fire repetitively at a higher frequency indicated by an increase in 
the maximum firing frequency was significantly increased during application of 10µM 
DEA NO. This subtle modulation of motor neuron properties, suggests that the role of 
NO in the quiescent network is excitatory and gives some suggestion as to the response 
to NO observed in Chapter 3. The mixed and, apparently, concentration-dependent 
actions of NO obtained in Chapter 3 – where DEA NO either increased or decreased 
burst amplitude during fictive locomotion – have not been definitively corroborated 
between the data in this chapter and the whole cord data. Comparison between the 
actions of NO during locomotion (whole nerve) and at the single cell level (whole cell) 
will require a larger sample population and the direct investigation of changes in the 
intrinsic properties of motor neurons in response to DEA NO during pharmacologically-
induced locomotion.   
 
It is possible to speculate on the likely mechanisms by which NO may modulate the 
intrinsic properties of spinal neurons. The main signalling pathway involved in NO-
mediated effects is by the activation of sGC and downstream PKG. At high 
concentrations of NO in these slice preparations, sGC may become desensitised, 
resulting in a drop in cGMP and therefore an inhibition of PKG-dependent targets.  
 
HCN channels underlie the Ih current and are expressed in motor neurons and NO 
activates HCN channels in deep cerebellar nuclei (Milligan et al., 2006, Wilson and 
Garthwaite, 2010, Neitz et al., 2011), but it is not clear from these data whether NO 
activates Ih, and additional experiments with adjusted protocols will provide 
clarification. It is likely that NO is modulating a number of targets at any time point; for 
example, an increase in excitability caused by NO could lead to depolarising block, 
while simultaneously nitrosative stress may cause modification of NMDA receptors 
(Choi et al., 2000) and subsequently cause a drop in excitability. Therefore, further 
experiments exploring the contribution of specific mechanisms potentially mediated by 
NO will provide further evidence of the range of NO targets and effects.   
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NO may facilitate or diminish excitatory transmission, however in the absence of data 
revealing the exact targets of NO, it is not possible to define the precise mechanisms of 
NO on synaptic transmission to motor neurons. Following on from the discussion in 
Chapter 3 where I postulated that NO may modulate the locomotor network in a state 
and/or activity-dependent manner, logically this may also be the case in relation to the 
direct modulation of motor neurons. The modulatory nature of NO may be very 
different in the active whole-spinal cord preparation compared to that in a quiescent 
slice, in the absence of network activity, that is, induced by inputs from the CPG. It will 
therefore be important to progress the results obtained in the present study to encompass 
the effects of DEA NO on motor neurons during locomotor activity. 
 
The apparent reduction in fAHP during DEA NO application and after removal of the 
NO scavenger PTIO, suggests a modulation of apamin-sensitive potassium channels. 
Apamin is a bee venom toxin (Apis mellifera) and highly selective of the Ca2+-activated 
K
+
-channel (IKCA (SK)), which underlies the AHP (van der Staay et al., 2008). Further 
experiments applying DEA NO in the presence of apamin will reveal the significance of 
this finding.  
 
The result of DEA NO application to a sample of interneurons does not rule out neuron-
specific effects of NO. Although the results from this small cohort of heterogenous 
interneurons showed did not reach significance, further recordings from identified 
excitatory interneurons will result in a better understanding of NO effects in future.  
 
It is difficult to draw further conclusions about the nature of NO-mediated effects on 
locomotor-related interneurons as they are a heterogeneous population and the present 
study does not incorporate a large experimental sample or identify or discriminate 
between classes of interneurons, which may be differentially modulated by NO 
(Goulding, 2009) . 
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4.4.2 Endogenous NO modulates the intrinsic properties of motor neurons  
 
In the previous chapters, it was shown that NO is probably not produced by lumbar 
spinal motor neurons (Chapter 2) and that removal of endogenous NO by the membrane 
permeable scavenger PTIO increased the frequency and amplitude of fictive locomotion 
(Chapter 3). The results in this chapter show that endogenously produced NO is 
involved in the modulation of motor neuron properties in the quiescent slice 
preparation. 
 
Endogenous NO modulates the firing properties of motor neurons; consistent with the 
excitatory effects observed on addition of DEA NO, PTIO increased both the fast and 
slow action potential AHP during removal of the NO scavenger PTIO. This indicates 
that NO directly modulates the membrane properties of motor neurons towards an 
increase in excitability.  
  
 
4.5 Conclusion 
   
The results discussed in this chapter suggest that NO may be a homeostatic regulator of 
motor neuron excitability.  However, these results are preliminary and it is difficult to 
speculate on the mechanisms by which NO modulates motor neuron properties without 
further experiments as suggested in Section 4.4. For instance, blocking apamin-sensitive 
potassium channels to confirm the modulation of these channels by NO to decrease the 
AHP. Blocking action potential-evoked synaptic transmission and recording miniature 
post-synaptic currents in control and in response to NO donors will go further and 
reveal the pre-synaptic and post-synaptic element of NO transmission. Crucially, 
whether NO is acting via cGMP-dependent or independent mechanisms will require 
additional experiments using a PKG agonist (8BrcGMP) or agonists of sGC (YC-1). 
State-dependent modulation of motor neurons will be revealed using induced fictive 
locomotion in concert with all of the aforementioned pharmacologically manipulations.  
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NO is difficult to manipulate in experimental conditions, even when donors are used, as 
the gas is free to diffuse to any number of specific and non-specific targets, potentially 
masking direct and relevant effects from observation. A slightly less blunt and more 
sophisticated approach would involve the use of pathway- or protein-specific 
pharmacological agents downstream of NO production to assess the impact of ablating 
or enhancing NO-mediated signalling. For example, using PKG agonists or antagonists 
to manipulate PKG signalling pathways, using HCN channel blockers to determine if 
NO affects these channels, and using PDE agonists or antagonists to manipulate the 
endogenous levels of cGMP. It is also possible that a meta-modulatory hierarchy exists 
in the mammalian locomotor network as it does in the tadpole (McLean and Sillar, 
2004) and pond snail (Straub et al., 2007) where NO may enhance or reduce an effect 
mediated by another neuromodulator. This role could of course only be assessed when 
the secondary modulatory system is engaged, again perhaps during locomotor activity.   
 
In their spectral investigation of NO pulse-production and nNOS auto inhibition, 
Salerno and Ghosh  (Salerno and Ghosh, 2009) summarise the findings of CE Shannon 
in The Mathematical Theory of Communication (Shannon, 1948) with the following 
statement: “By contrast, information transfer in the unmodulated steady-state is zero 
because information transfer depends on bandwidth.” Likewise in this study, in the 
absence of locomotor output (i.e. bandwidth) the true nature of NO modulation (i.e. 
communication) is difficult to categorically define.  
 
Nevertheless, despite the relatively small sample size and subtle modulation of neuronal 
properties, these data provide some evidence of potential concentration-dependent NO-
mediated effects in lumbar spinal neurons.  
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Chapter 5: A general discussion of the distribution and physiological 
roles of nitric oxide in locomotor circuitry of the mammalian spinal 
cord 
 
5.1 NO is an endogenous physiological signalling molecule 
 
The free radical gas NO is now an established signalling molecule in the central as well 
as the peripheral nervous system. Since the initial discovery that the molecule known as 
EDRF responsible for the vasodilation of vascular smooth muscle was in fact NO, the 
presence of NO synthases and the effect of NO have been recorded in many organs in a 
vast array of species. Most pertinent to the present study is the role of NO in central 
transmission, particularly the role of NO in the mammalian locomotor network, which 
has been largely under-studied. 
 
NO is produced after the activation of NOS, an NADPH diaphorase enzyme (Hope et 
al., 1991). The calcium dependent nNOS and eNOS are activated by an influx of Ca
2+
 
via glutamate binding to NMDA receptors/voltage dependent calcium channels or 
release from internal stores (Sun et al., 2001). The isozymes then catalyse the 
conversion of L-arginine to L-citrulline and NO at which point the gas is free to 
participate in cellular reactions in either an autocrine or paracrine manner. The sequence 
of events leading to NO production and the subsequent reactions - in which is a key 
component - appear to be tightly regulated within the cellular environment. In order for 
NO to reach its target receptor it must avoid inactivation by plasma scavengers and 
intracellular scavengers such as uric acid and ascorbate (Sunico et al., 2011) and auto 
regulation by feedback inhibition .  
 
NO is known to predominantly exert its effects via the NO/sGC/cGMP secondary 
messenger pathway as well as acting in some extent through the thiol modification of 
peptides. Although a plethora of cellular targets has been identified, putative targets for 
NO continue to be described and its action identified (Denninger and Marletta, 1999, 
Brown and Borutaite, 2007, Kang et al., 2007, Mironov and Langohr, 2007, Wilson and 
Garthwaite, 2010). The present study is an investigation of the role of NO in the 
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mammalian locomotor network and provides evidence that in keeping with the flexible 
and wide ranging signalling profile of NO in biological systems, NO is produced by and 
modulates the neuronal circuitry that initiates and maintains locomotion in vitro. 
 
 
5.2 NO is produced by the mammalian locomotor circuitry 
 
While it has previously been established that NOS is present in the mammalian 
nociceptive network located primarily in the dorsal horn of the spinal cord, there is now 
unequivocal evidence that NOS is present in discrete populations of neurons in close 
proximity to or directly involved in the maintenance and modulation of mammalian 
locomotor activity. In Chapter 2 of the present study, I have shown that NOS positive 
neurons, located in the ventral horn of the rodent spinal cord, increase during the first 12 
days of postnatal development and appear to be most numerous in regions known to 
contain the circuitry involved in the integration of locomotor commands (laminae X and 
VII). The pattern of NOS reactivity reported in the present study is consistent with that 
reported at various stages of development in other species (Dun et al., 1993, McLean 
and Sillar, 2000, Foster and Phelps, 2000, McLean and Sillar, 2001, Schreiberová et al., 
2006). Additionally, the present study reports the pattern of NOS reactivity with high 
temporal resolution over a developmentally relevant period –the first 12 postnatal days 
– during which the spinal locomotor networks have been shown to undergo a maturation 
process linked to the development of quadrupedal locomotion (Clarac et al., 1998, Jiang 
et al., 1999). 
 
I have shown that NOS reactivity is present in regions associated with locomotor-related 
activity, though it is not clear if these neurons belong to which, if any, of the defined 
neuron subpopulations currently identified by lineage or transmitter phenotype (Spike et 
al., 1993, Miles et al., 2007, Goulding, 2009, Kiehn, 2011).  Further anatomical studies 
(for instance, immunohistochemical characterisation) are needed to establish the 
transmitter phenotypes to identify the possible transmitter profile of NOS positive 
neurons. 
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Identification of NOS positive neurons using transgenic genetic tools (for example, 
expressing eGFP in selective neuronal cell types such as the Hb9 interneurons (Wilson 
et al., 2005) in combination with traditional immunohistochemistry techniques) will 
provide future investigations with definitive evidence of the involvement of NOS 
positive neurons in the locomotor circuitry. This would provide further evidence to 
consider in determining the role of NO in locomotion and whether it is produced by 
neurons integral to the locomotor circuitry or produced by neurons in close association 
with the network but not directly involved in locomotion (i.e. is NO a cell subtype 
specific paracrine or autocrine modulator of locomotor output). 
 
Consistent with the findings of previous studies, the present study confirms that NOS is 
largely absent from lumbar motor neurons (Dun et al., 1993, Collett, 2007). However, 
using the in vitro isolated spinal cord preparation, I have shown that NO does in fact 
modulate locomotor output at the level of the CPG and directly at the level of the motor 
neuron indicating that while motor neurons do not appear to express NOS, the sGC 
machinery is expressed and is stimulated by both the removal of endogenous NO and 
the wholesale increase in exogenous NO levels.  
 
 
5.3 NO modulates the physiological output of the mammalian locomotor 
circuitry 
 
Utilising the NO donor, DEA NO, to increase the exogenous level of NO at a range of 
concentrations significantly reduced the frequency of rhythmic locomotor output 
produced by the locomotor CPG. Additionally, DEA NO affected the amplitude of 
motor neuron output in a concentration dependent manner. Low concentrations 
significantly increased or did not significantly affect motor neuron output (50μM and 
100μM DEA NO respectively, Section 3.3.1), while high concentrations appeared to 
significantly increase and decrease motor neuron output (200μM and 400μM DEA NO 
respectively, Section 3.3.1).  In a subset of these experiments where a high 
concentration of DEA NO was used to investigate the effects of NO, biphasic 
modulation of motor neuron output was observed.  
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Consistent with the effects observed as a result of the increase in exogenous NO 
concentrations, the removal of NO by high concentrations of the scavenger molecules 
cPTIO and PTIO increased the frequency of locomotor output suggesting that NO may 
facilitate inhibition in the CPG network. Furthermore, experiments inhibiting NOS 
using the competitive, irreversible inhibitors L-NAME and L-NNA suggest that NO 
provides tonic inhibitory influence in the active locomotor network. Utilising the 
disinhibited preparation, which records the excitatory output from the locomotor 
network in the absence of inhibition (i.e. pharmacological block of glycinergic and 
GABAergic signalling using strychnine and bicuculline), DEA NO released NO reduces 
the frequency of rhythmic bursting indicating that NO is involved in inhibition of 
excitatory-driven rhythmic bursting in the locomotor CPG network. However, future 
studies to characterise this inhibitory effect of NO would be best designed in the 
presence of inhibition to clarify that NO mediated network modulation changes are due 
to the actions of NO and not due to significant alteration of the network as a result of 
pharmacological blockade by strychnine and bicuculline.  
 
High concentrations of the scavenger molecules PTIO and cPTIO reduce and augment 
motor neuron output, respectively (400μM PTIO and 200/4000μM cPTIO, Section 
3.3.2). While it appears that the more membrane permeable compound PTIO decreases 
motor neuron output, the more hydrophilic scavenger cPTIO increases motor neuron 
output. Scavenging of NO by membrane permeable PTIO results in a decrease in motor 
neuron output, consistent with an excitatory role for NO at the level of the motor neuron 
at relatively low concentrations. Scavenging of NO by the less membrane permeable 
cPTIO results in an increase in motor neuron output, consistent with an inhibitory role 
for NO at the level of the motor neuron at relatively high concentrations of NO donor 
used in the present study. If the discrepancy in response is due to the relative membrane 
permeability of these compounds, it can be concluded that low concentrations of NO, 
presumably from neurons in close proximity to the motor neurons, facilitate excitatory 
motor output confirming that while motor neurons do not produce NO, they express the 
machinery to process the NO as a result of paracrine activity.  
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These seemingly conflicting actions at the level of the motor neuron may be rationalised 
as a result of scavenging NO at distinctly different sites of action (either intra- or extra-
cellularly). The reactive chemistry of the imidazolineoxyl N-oxide compounds is such 
that nitrate and nitrites are produced as a result of NO metabolism, (Radi, 2004, 
Kuzkaya et al., 2005, Thomas et al., 2008) with the possibility of further NO mediated 
reactions taking place. However, it is unlikely that the discrepancy observed in motor 
neuron response to these compounds is due to differences in nitrate/nitrite production as 
both PTIO and cPTIO have been shown to react with NO in stoichiometric manner 
(Akaike et al., 1993). However, based on this pivotal characterisation study, it is not 
clear whether the additional carboxy side chain which confers the greater hydrophilic 
nature of cPTIO versus PTIO, is also involved in nitrate/nitrite production as these 
experiments monitored the production of the conversion of PTIO to PTI and not of 
nitrate/nitrite production.  Furthermore, NO may react with itself and its metabolites to 
produce peroxynitrite directly, in the presence of high concentrations of NO as well as 
on addition of cPTIO, especially in this experimental paradigm where O2 is in excess 
within the cellular environment.  
 
It is not clear why scavenging NO using cPTIO should result in a reduction of motor 
neuron output, opposite in sign to the effect observed with higher concentrations of NO. 
It is possible that the discrepancy is linked to the apparent concentration dependent 
effects of NO but further work is needed to clarify whether this is truly a result of NO 
scavenging at different locales, NO involved in both excitatory and inhibitory 
signalling, or side reaction chemistry of the scavenging molecules and the resulting 
biological effect of these by products in addition to the true effects of NO. Future 
studies should include the use of known peroxynitrite generators such as SIN1 to clarify 
the possible contribution of NO metabolites and generated reactive species in the 
modulation of locomotor output and/or the use of endogenous antioxidants, uric and 
ascorbic acid. Further work involving NO signalling will need to rely on manipulation 
of downstream signalling pathways as the obvious experimental control - application of 
depleted pharmacological agent (i.e. DEA NO) – may not result in definitive results. 
DEA NO metabolites include both nitrates and nitrites and any depletion experiment 
using this agent will need to first ascertain the effect of nitrates and nitrites alone on the 
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locomotor network. The most obvious and ideal pathway for manipulation is the 
metabolism of cGMP by phosphodiesterases as readily available commercial drugs 
target this portion of the signalling pathway (e.g. sildenafil). These experiments should 
be carried out in concert with manipulation of the PKG portion of the signalling 
pathway to provide substantive evidence of the downstream role of NO without the 
possibility of desensitising sGC by excessive stimulation with cGMP.The NOS 
inhibitors L-NAME and L-NNA increase the frequency of locomotor output, 
reaffirming the inhibitory role for NO in the CPG network. Lending some weight to the 
possibility that NO scavenging may be complicated by by-product side reactions, 
inhibition of NOS consistently causes a reduction in motor neuron output. Though these 
effects are subtle they are statistically significant and could be interpreted to support the 
metabolism and regeneration of NO from nitrates/nitrites as previously discussed.  
 
As NO is able to modulate synaptic function through coupling to G proteins and the 
initiation of signalling cascades as well as direct modification of proteins by s-
nitrosation, the contribution of the NO/sGC/cGMP pathway was investigated using the 
partial PKG agonist 8BrcGMP as well as the irreversible sGC inhibitor ODQ. The 
results show that inhibition of sGC by a high concentration of ODQ results in 
unrecoverable diminution of lumbar nerve output (Section 3.3.3). Although ODQ is an 
irreversible inhibitor of sGC, its simultaneous application with the NO donor DEA NO 
is justifiable in the protocols of the present study as it has previously been reported that 
at some level, inhibition of sGC NO binding sites occurs preventing NO mediated 
signalling without disruption to normal cellular function (Fernhoff et al., 2009, Cary et 
al., 2006, Derbyshire et al., 2010). The inhibition of sGC by a low concentration of 
ODQ, resulted in an increase in frequency of locomotor output followed by a 
subsequent decrease in frequency on addition of NO donor, again suggesting that NO is 
involved in maintaining an endogenous inhibitory tone during locomotor activity.  
 
The amplitude of motor neuron output is not significantly affected by a low 
concentration of ODQ or by the simultaneous application of ODQ and DEA NO 
suggesting that the predominant mechanism by which NO mediates its effects in lumbar 
motor neurons is through the NO/sGC/cGMP pathway. Surprisingly, the partial PKG 
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agonist reduces the amplitude of motor neuron output at the relatively high 
concentration used in the present study. To clarify whether this is a true conflict or a 
result consistent with results shown herein – that high concentrations of NO donor 
reduce the amplitude of motor neuron output – further experiments will need to be 
conducted using a similar range of concentrations of agonist as donor used in the 
present study. 
 
Taking into consideration the results from whole nerve recordings in the present study, 
initially it was not obvious whether NO is involved in maintaining an endogenous 
inhibitory tone during fictive locomotion by increasing inhibition or by a decrease in 
excitation. Using the disinhibited preparation, where glycinergic and GABAergic 
transmission is blocked, I have shown that the NO donor DEA NO produces results 
consistent with NO causing a reduction in excitation in the CPG network.  
Furthermore, donor released NO increases motor neuron output at low concentrations 
and but does not decrease motor neuron output at high concentrations. These results 
confirm that the concentration dependent effects observed in the presence of inhibition 
are mediated by similar mechanisms (i.e. by a reduction in excitation at low 
concentrations with an inhibitory component revealed at high concentrations). Although 
it is likely that the excitatory network activated in the absence of inhibition is not 
identical to that in the standard preparation, these results are still very strongly 
indicative of an actual role for NO in modulating excitatory transmission.  
 
Whole cell patch clamp recordings made from lumbar motor neurons in the presence of 
the NO donor DEA NO suggest that NO does modulate the excitability of motor 
neurons. As a result of NO donor application the firing threshold for action potentials as 
well as the action potential AHP are significantly reduced. These data suggest that NO 
increases the excitability of motor neurons, enabling them to fire more readily for a 
given synaptic input and increasing the ability of motor neurons to regenerate action 
potentials. Data from the whole nerve recordings indicate that the NO donor increases 
and decreases the amplitude of motor neuron output at low and high concentrations 
respectively. Taking into consideration the results obtained from whole cell recordings, 
it is possible that this NO mediated intrinsic increase in excitability results in increased 
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amplitude of motor neuron output at low concentrations but at higher concentrations, 
over excitation and thus, excitatory block may account for the decrease in amplitude of 
motor neuron output. Further data collection using whole cell recordings and targeting 
NO downstream signalling processes such as sGC conversion of GMP to cGMP (using 
YC-1) or PKG agonist 8BrcGMP, will confirm these results without the gross and 
indiscriminate activation of signalling pathways by bath application of NO. 
Furthermore, selective use of pharmacological agents can be used to confirm the NO 
mediated effects on firing threshold and action potential AHP. It would be prudent for 
future investigations to take into consideration the recent demonstration that the 
Na
+
K
+
ATPase is intimately involved in short-term memory of motor performance as 
well as cardiac function by clarifying the possible involvement of NO (Gan et al., 2012, 
Zhang and Sillar, 2012) 
 
Although NO clearly modulated both fictive locomotion and individual motor neurons, 
several questions remain unanswered and I have attempted to identify these in my 
summary of the results detailed in this thesis.  The task of taking forward these findings 
is to not only clarify the detailed sequence and mechanism of NO mediated effect but 
also determine the possibility that NO modulates locomotor output within a modulatory 
hierarchy or by action in concert with other neurotransmitters, as has already been 
described in the tadpole and lamprey (McLean and Sillar, 2004, Kyriakatos and El 
Manira, 2007). 
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Figure 5.1. Schematic diagram summarizing the findings and possible sites of NO modulation in 
representative A pre and B postsynaptic neurons in the spinal locomotor circuitry. 1, NMDA receptor 
activation triggers Ca
2+
 influx followed by the activation of NOS.  2, Activated NOS catalyses the 
production of NO from L-arginine and 3, NO binds to and activates sGC initiating the conversion of 
GMP to cGMP with the subsequent activation of secondary messenger pathways such as PKG. 4, NO is 
free to diffuse to both intra and extracellular targets (auto and paracrine). 5, NO diffuses across the 
synapse, 6 activating secondary messenger pathways in the postsynaptic neuron.  7, NO targets not 
investigated in the present study but of relevance to future studies include direct and indirect activation 
ion channels as well as protein modifications such as s-nitrosation. Pharmacological agents used in the 
present study are indicated near their propose site of action in grey text.  
NMDAR 
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5.4 A role for NO in neuropathophysiology 
 
The involvement of NO in pathophysiological conditions has been studied in relation to 
Multiple Sclerosis (MS) and Alzheimer’s Disease (AD) as well as Amyotrophic Lateral 
Sclerosis (Smith et al., 1997, Smith et al., 2001, Barber and Shaw, 2010). While NO 
does not appear to be a causative agent, the literature suggests that NO may be 
symptomatic or facilitative of disease progression. In Multiple Sclerosis research, NO 
primarily produced during the inflammatory response blocks axonal conduction and NO 
metabolites have been detected at high levels in the cerebrospinal fluid of MS patients 
(Giovannoni, 1998). Similarly, in Alzheimer’s Disease, peroxynitrite produced by the 
reaction of nitric oxide with superoxide has been shown to nitrate neurons including 
those that contain neurofibrillary tangles (Smith et al., 1997). In AD, phosphodiesterase 
inhibitors have been shown to ameliorate the adverse effects of pathogenic NO (Pifarre 
et al., 2011). 
 
As mentioned previously (Chapter 2, Section 2.1.4), in the mouse model of ALS, NO 
has been shown to facilitate axon retraction (C), synaptic stripping (C) and programmed 
cell death, by both cGMP dependent and independent mechanisms.  
Although it is unlikely that NO is a causative agent of motor neuron loss, the 
aforementioned effects of NO in the mouse model of ALS, coupled with the absence of 
data investigating changes in NOS expression or any other changes occurring early in 
development before symptoms appear, provide the impetus to consider what 
developmental role NO may play in ALS. Indeed, recent studies have shown increased 
excitability linked to aberrant behaviour of both Na
+
 and Ca
2+
 channels early in 
development (Pambo-Pambo et al., 2009, Quinlan et al., 2011). 
 
The present study has provided anatomical evidence that changes in protein expression 
are present in postnatal SOD
G93A
 mice. The NADPH diaphorase reactivity pattern in the 
SOD1
G93A
 and SOD1 wild-type lumbar spinal cord of littermates at P12 is similar to the 
pattern documented in other species (Dun et al., 1993, Schreiberová et al., 2006) and 
closely resembled that of the CD1 inbred strain from the same species (Chapter 2, 
Section 2.3.1). However, NADPH diaphorase reactivity in the IML of lamina VII was 
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considerably lower in SOD1
G93A
 mice compared to the SOD1 wild type (Chapter 2, 
Section 2.3.1). It is not possible to determine the relevance of this reduction in NADPH 
diaphorase reactivity based on anatomical evidence alone. It is also not possible to 
determine whether the reduction in NADPH diaphorase reactivity is a result of a 
reduction in NOS expression or a loss of NOS expressing neurons. It is known that 
neurons in the IML comprise of sympathetic preganglionic neurons and NO is known to 
facilitate vascular smooth muscle relaxation, but without further investigation it is not 
possible to give a putative role for NO in this cohort of neurons in this 
pathophysiological model. At this time, this is the first report and earliest developmental 
evidence that NOS reactivity is altered in the SOD1
G93A 
mouse model of human ALS. 
NO is likely to be symptomatic and not the causative agent of ALS progression and thus 
a full investigation into the extent of and cause of NOS expression changes in the 
SOD1
G93A 
mouse model of ALS is needed. The findings of the present study warrant 
further investigation, possibly using both whole nerve and single cell electrophysiology 
to determine the functional impact of this loss of NADPH diaphorase reactivity. 
Furthermore, additional anatomical studies are needed to determine the transmitter 
phenotype of the neurons that are not detected or are no longer NADPH diaphorase 
reactive. 
 
5.5 Conclusion 
 
In this thesis, I have shown that NO is produced by and acts as a potent modulator of 
locomotor related activity in the mammalian lumbar spinal cord. NO is produced by 
NOS which has long been established as an NADPH diaphorase enzyme. Utilising the 
NADPH diaphorase reaction, I have shown that in agreement with studies in other 
species, discrete populations of neurons express NOS in the developing spinal cord and 
that these neurons increase in number over the first 12 postnatal days. This thesis has 
reported the spatial and developmental distribution of NOS positive neurons in higher 
resolution than any other study at this time. The pattern of NOS reactivity in the 
SOD
G93A 
mouse model of human ALS was investigated at postnatal day 12 in both 
mutant and wild-type SOD mice. Consistent with the results of the inbred CD1 strain, 
SOD wild-type mice display similar number and identical distribution of NOS positive 
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neurons in the lumbar spinal cord. However, there is a marked reduction in NOS 
positive neurons in the IML lamina VII in SOD
G93A 
mice. This is the first report of a 
reduction in a distinct phenotype of neuron in the rodent ALS model at this postnatal 
stage of development and as such this result warrants further investigation and supports 
the investigation of NO mediated processes in neurodegenerative diseases.  
 
I have shown for the first time that in the rodent, NO modulates pharmacologically 
induced fictive locomotion in the isolated spinal cord preparation. Using the NO donor 
DEA NO, the results here show that over a range of concentrations, sources of 
exogenous NO inhibit the frequency of locomotor related activity and that NO acts in a 
concentration dependent manner to increase (low concentrations) and decrease (high 
concentrations) the amplitude of motor neuron output. Scavengers of NO (cPTIO/PTIO) 
and inhibitors (L-NNA/L-NAME) of the NOS enzyme confirm that endogenous NO 
modulates the locomotor network in a similar manner to exogenous NO. However, due 
to the propensity for highly reactive NO to participate in numerous side reactions with 
oxidants (such as O2 to form peroxynitrite), and with NO generated nitrates and nitrites, 
the results obtained using scavenger molecules such as cPTIO may conflate reactions of 
endogenous NO and therefore make interpretation of results obtained from experiments 
in which these agents are used difficult to interpret. Experiments utilising the 
disinhibited preparation, where inhibition is blocked using strychnine and bicuculline, 
suggest that NO predominantly exerts its effects through modulation of the excitatory 
neuronal locomotor network. I have also shown that NO alters the intrinsic properties of 
spinal motor neurons by reducing the threshold for action potential firing and reducing 
the action potential AHP.  
 
It has been established that NO predominantly exerts its effects through sGC and the 
subsequent initiation by cGMP of the PKG pathway. In this thesis I have shown that the 
NO mediated modulation of locomotor output occurs predominantly by the 
NO/sGC/cGMP/PKG pathway using firstly the inhibitor of sGC, ODQ and the partial 
PKG agonist 8BrcGMP, as well as the coapplication of DEA NO and ODQ, to show 
that the cGMP pathway is the mechanism of modulation of motor neuron amplitude but 
that a component of the effects observed on frequency may be a result of thiol 
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modification. In future studies this will need to be clarified using pharmacological 
agents that either generate or ablate the effects of NO metabolites.  
 
Taken as a whole, it can be concluded that NO modulates fictive locomotor output in 
the isolated mammalian spinal cord preparation by modulating the excitatory neuronal 
network although due to the complex reactivity of NO further research is needed to 
clarify and support the results herein.  
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